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1. Two steroids were identified for the first time as major steroid
components of urine collected from infants and plasma obtained from the
umbilical blood vessels. These compounds have the formula 3p,l6|3-
dihydroxyandrost-5-en-17-one and 3(3,17a-dihydroxyandrost-5-ene, but their
importance in the metabolism of steroids by the foeto-placental unit is not
known.
2. A method was developed for measuring steroids in plasma obtained from
the umbilical blood vessels and urine collected from infants. This depends
upon the separation of steroids by thin-layer chromatography, and their
assay on the thin-layer plates by developing colours with various spray
reagents and subsequent densitometric scanning. The accuracy and specificity
of the method is discussed.
3. This method was used to establish normal ranges for the excretion of
5
several 3|3-hydroxy-A steroids found in urine specimens obtained from infants,
and to determine the effects upon the excretion of steroids of administering
corticotrophin and human chorionic gonadotrophin to newborn infants.
4. The enzyme defects present in three infants with abnormal adrenal glands
were investigated by analysis of steroids in urine specimens obtained from
these patients.
5. Several 3(3-hydroxy-A"* steroids were measured in plasma samples prepared
from venous and arterial blood obtained from the umbilical cord. The
concentrations present in arterial plasma were higher than in the umbilical
vein, indicating a net uptake of these steroids by the placenta, where it is
4
thought that they are converted into 3-oxo-A steroids and oestrogens. The
relationship between the levels of 3(3-hydroxy-Asteroids in plasma obtained






















Quickfit and Quartz Ltd.,
Stone, Staffordshire, England
Shandon Scientific Co. Ltd.,
London, England.






Packard Corp., Downers Grove,
Illinois, U.S.A.
Unicam Ltd., Cambridge, England.






Most of the chemicals (including solvents) were of "analytical
reagent" (A.R.) grade and were obtained from British Drug Houses, Poole,
Dorset, England. The main exceptions are as follows:-
Silica gel HF 254 Merck AG, Darmstadt, Germany.
Aluminium oxide
Sephadex LH-20 AB Pharmacia, Uppsala, Sweden
Hexamethyldisilazane Applied Science Laboratories Inc.,
Trimethyltrichlorosilane P.O. Box 440, State College, PA, U.S.
Methoxamine hydrochloride Kodak Ltd., Kirby, Lanes., England.
Succus Entericus from the snail, L'Industrie Biologique Fran^aise S.A
Helix pomatia Gennevilliers, Seine, France.
Steroids Reference steroids were obtained
from three principal sources
(i) Koch-Light Laboratories,
Colnbrook, Bucks., England.
(ii) H.R.C. Steroid Reference
Collection.
Professor W. Klyne, Chemistry
Department, Westfield College,
Hax pstead, London, N.W.3.


























































1. Saturated metabolites of corticosteroids are indicated by the
prefixes "tetrahydro" (3a-hydroxy-5p) and "allotetrahydro" (3a-hydroxy-5a).
e.g. Tetrahydrocortisol - 3a,lip,17a,21-Tetrahydroxy-5p-pregnan-
20-one
2. Additional liydroxyl and ketone groups are indicated by the prefixes
"-0H-" and "-Oxo-" respectively.
e.g. 16a-OH-DHA - 3p,16a-Dihydroxyandrost-5-en-17-one
16-0xo-Androstenediol - 3P,17p-Dihydroxyandrost-5-en-16-one.
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One of the earliest signs that there was an alteration in steroid
metabolism during pregnancy was the discovery of a large amount of
pregnanediol (a metabolite of progesterone) in urine collected from pregnant
women. It has been known for several years that this pregnanediol originates
from progesterone secreted by the placenta (Diczfalusy and Troen, 1961).
The oestrogens are also present in considerable quantity in maternal urine
(Doisy et^ al., 1929; Marrian, 1930; Huffman et^aK, 1946) and it has been
assumed that these compounds are also secreted by the placenta. It is known,
however, that the placenta is not able to form from acetate all the steroids
it secretes, and it must have available ready-made precursors of, for
example, the oestrogens and progesterone. These precursors are produced
either by the mother or foetus.
Recently it has been shown that the foetus itself is capable of
contributing markedly to the metabolism of steroids in pregnancy, although
it had been known for 200 years that the foetal adrenal glands, the most
likely site of steroid synthesis, were proportionately much larger than
adult adrenals. Winslow, in 1766, describing the foetal adrenal glands
noted the problem: "Elles sont chez le foetus extremement grosses et
diminuent en volume avec l'age. Ce sont deux problemes qui m£ritent
attention." The relative weight of the glands reaches a maximum at
approximately the 16th week of pregnancy, after which it decreases
(Ekholm and Niemineva, 1950). Even at birth, however, the adrenals are
still proportionately 20 times as large as adult glands (Eberlein, 1965b).
As well as being relatively large, the foetal adrenals are anatomically
different from the adult organ as they have a large internal zone (foetal
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zone) which regresses after birth (Lanman, 1953, 1957). The significance
of this foetal zone is still puzzling endocrinologists, as little difference
between the foetal and cortical zones in steroid biosynthet c and metabolic
capabilities has yet been found by in vitro isotopic studies (Solomon et al.,
1958; Bloch & Benirschke, 1959; Hillman, Stachenko & Giroud, 1962). It
seems probable, however, that the foetal zone produces steroids which act
as precursors for the synthesis by the placenta of oestrogen and progesterone.
During the later part of pregnancy a cortical zone develops in the
foetal adrenal, and it is likely that this zone is responsible for producing
the corticosteroids which are essential to the foetus. The evidence
available at present suggests that the corticosteroids utilised by the
foetus are formed entirely by the foeto-placental unit* and hormones produced
by the maternal adrenal glands play little or no part in meeting the needs
of the foetus (Mills, 1967).
The steroid metabolism of the mother, the foetus and the placenta
considered individually and collectively will only be fully elucidated by
piecing together information obtained from a wide variety of experiments.
The first section of the introduction describes many of the techniques which
have been used in these experiments ; the subsequent sections describe
briefly the evidence which has been obtained so far and which has led to the
current understanding of steroid biosynthesis and metabolism by the foeto-
placental unit. Mitchell (1967) has conducted a more comprehensive review
of the literature up to 1966.
* Explanation of the term "foeto-placental unit":- At the twentieth week
of pregnancy, neither the foetus nor the placenta can perform the complete
synthesis of a number of steroids. This is because of the lack, or non-
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functioning, of certain essential enzymes. However, the enzymatic
activities which are lacking in the placenta are present in the foetus,
and those not present in the foetus are active in the placenta. Since
the foetus and placenta together are capable of elaborating all types of
steroid hormones, Diczfalusy (1966) coined the terra "foeto-placental unit"
when describing the synthesis of steroids by processes which involved




1. Methods used in the study of steroid metabolism during pregnancy
The early investigations into the production of steroids during
pregnancy depended on the identification and assay of the metabolites of
steroids present in maternal urine (Appleby and Norymberski, 1957;
Natoli _et al., 1957; Fotherby et al., 1965). These studies had only
limited value, since it was impossible to delineate the individual parts
played by the maternal endocrine glands, the placenta and the foetus in
producing the steroids excreted by the mother. To evaluate the contribution
of the foetus, the steroid metabolites present in the urine of newborn
infants and in blood collected from the umbilical cord have also been
examined, on the assumption that many of the compounds present in urine
collected from newborn infants would be similar to those produced by the
foetus ^n utero. At birth, blood can easily be obtained from the umbilical
cord, and the plasma fraction contains steroid metabolites which have been
elaborated by thefcetus. Unlike the urine samples, however, plasma
derived from the umbilical cord also contains a significant amount of
steroids which have come from the placenta: by comparing the concentration
of steroid in venous and arterial plasma obtained separately from the
umbilical vessels it is possible to define where the individual steroids
were formed. There is, for example, a greater concentration of progesterone
in plasma derived from blood in the umbilical vein (i.e. from blood going
to the foetus) than in corresponding samples obtained from the umbilical
arteries (i.e. blood going jto the placenta), so it may be assumed that the
placenta produces this compound.
Most of the recent work on steroid formation and degradation in
utero has involved the use of radioactively labelled steroids. In some
experiments these compounds have been introduced jLn vivo; for example,
by perfusion of a placenta while it is still attached to the uterine wall,
or by injection into the foeto-placental circulation. In other experiments
the metabolism of the radioactive steroid has been studied in vitro, by
using homogenates or slices of foetal or placental tissue. The experiments
conducted mi vivo approach most closely to the conditions prevailing
naturally in utero but, because of the danger to the foetus of harmful
radiation, these experiments cannot be carried out during the course of a
normal pregnancy, and must be associated with therapeutic abortion. Such
terminations of pregnancy are usually carried out before the 24th week of
gestation, since the foetus is held to be viable after this period.
Normally, the studies _in vitro have also been carried out on preparations
of foetal tissue obtained as a result of therapeutic abortion, but some
investigators have used tissue obtained from infants who died soon after
birth (Villee and Loring, 1965).
The principal types of experiment carried out with tissues collected
at terminations performed about the 20th week of a pregnancy are as follows
1. The analysis of steroids in extracts of foetal tissues.
2. The histochemical detection of enzymes involved in steroid
biosynthesis and metabolism.
3. Studies using radioactive steroids incubated in vitro with
slices, homogenates or minces of foetal or placental tissues.
4. Perfusion of radioactive steroids through
(a) The foetus alone, after removal from the uterus .
(b) The foetus, after operation for the removal of the
adrenal glands .
(c) The placenta alone, while still attached to the uterine wall
- 6 -
5. Administration of radioactive steroids into the intact
foeto-placental unit while the placenta is still attached
to the uterus.
6. Administration of steroids into the uterine artery, to
investigate the passage of steroids across the placenta.
7. Administration of steroids into the amniotic fluid, before
termination of pregnancy. The steroids are then taken up by
the foetus through swallowing, or by absorption through the
skin, or possibly they are absorbed by the placenta.
The metabolic fate of radioactive steroids is studied by analysing
for their metabolites in foetal and placental tissues, in blood collected
in the outflow from perfusion experiments and, in some cases, by examining
amniotic fluid and urine specimens collected from the mother.
It is possible, by employing the experiments listed, to study the
metabolism of steroids by the foetus, by the placenta and by the foeto-
placental unit. In addition, by introducing labelled steroids into the
mother, it is possible to determine whether steroids produced by the
maternal endocrine glands are able to cross the placental barrier, after
which they may be further metabolised by the foeto-placental unit.
2. The synthesis of progesterone by the foeto-placental unit
It was considered for many years that progesterone was formed from
cholesterol synthesised by the placenta, but it has recently been shown
that the placenta is almost unable to synthesise the steroid nucleus de novo.
Levitz et al. (1962) found only a very small production of cholesterol by
the placenta when perfused with acetate and mevalonate, and Van Leusden
and Villee (1965) reported only a minute conversion (0.002 - 0.005%) by
tissue minces of placenta. Since the placenta is unable to form the
- 7 -
steroid nucleus from acetate, it must use preformed steroid precursors
for the formation of progesterone.
The most likely blood-borne precursors of progesterone are
cholesterol and pregnenolone sulphate, which could be obtained from
either the maternal or the foetal circulation. There is a considerable
amount of evidence to suggest that the precursor is supplied principally by
the mother. Allen (1953) reported two cases of abdominal pregnancy where,
after removal of the child, the urinary pregnanediol excretion remained
high while the placenta was still in situ. Other workers have shown that
urinary pregnanediol excretion remains high after intrauterine death of
the foetus (Appleby and Norymberski, 1957; Klopper ejt al., 1961) and the
excretion of pregnanediol by women carrying anencephalic foetuses is little
different from normal (Frandsen and Stakeman, 1961), although these
monsters have hypoplastic adrenals which would be expected to produce
only a small amount of precursor able to be used for progesterone synthesis.
The evidence, therefore, suggests that sufficient precursor can be obtained
from the mother to provide for the synthesis of progesterone even in the
absence of a normal foetus. Insufficient pregnenolone sulphate is
supplied to the placenta by the maternal circulation to account for the
large amount of progesterone formed each day (Conrad et al., 1967), so it
is most likely that the major precursor is cholesterol, a compound which
has been shown to be able to be converted to progesterone by placental
tissue (Solomon, I960; Morrison et al., 1965).
The placenta can produce normal amounts of progesterone even though
the foetus is not viable or has been removed, but it is nevertheless
probable that, during a normal pregnancy, some progesterone is synthesised
from precursors produced by the foetus. When labelled progesterone or

















Progesterone is synthesised in the placenta from precursors supplied
by both the foetus and the mother. The major precursor of progesterone is
probably cholesterol, which reaches the placenta by the uterine arteries, but it
is likely, that cholesterol sulphate a d pregnenolone sulphate synthesised by
the foetus are also important.
pregnenolone sulphate was perfused through placentas at raid-term,
approximately 80% of the unconjugated steroid extractable from the tissue,
and approximately 50% of the unconjugated steroid isolated from the
perfusate was progesterone (Pion ejt al., 1965a; Palmer et al,, 1966),
which indicates that the placenta can utilise these steroids as
precursors of progesterone.
Eberlein (1965b) first identified pregnenolone sulphate in plasma
obtained from the umbilical blood vessels, and more recently it has been
shown that this compound is present in greater concentration in samples
of arterial plasma than in the venous plasma (Conrad et al., 1967); this
suggests that the placenta takes up pregnenolone sulphate from the blood
reaching it via the umbilical arteries. It has, therefore, been shown
that the foetus can supply pregnenolone sulphate to the placenta, and
that this organ contains the enzymes necessary for converting it into
progesterone.
The formation of progesterone by the foeto-placental unit is
illustrated in diagramn\«Kc form in Fig. 1. Although it has been
established that maternal cholesterol and foetal pregnenolone sulphate
are efficient precursors of progesterone, it is not yet known whether
cholesterol formed by the foetus also contributes to the synthesis of
progesterone.
It is unlikely that the foetus itself is capable of the total
synthesis of progesterone since most evidence suggests that the 3(3-
hydroxy-dehydrogenase which converts pregnenolone to progesterone is
4
* Two enzymes are required for the formation of a 3-oxo-A steroid from
a^-3(3-OH-A steroid: a 3(3-hydroxy-dehydrogenase for converting the 3(3-0H-
A steroid into a 3-oxo-A^ steroid, and a steroid A^j5 isomerase for
converting the 3-oxo-A^ steroid into a 3-0x0^^ steroid. In this thesis
3p-hydroxy-dehydrogenase refers to both these enzymes,
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not active in the foetus in utero. Iwamiya et_ al_. (1966) injected
pregnenolone into a raid-term foetus before termination of the pregnancy,
and subsequently extracted from the adrenals the sulphates of DHA,
pregnenolone and 17a-OH-pregnenolone, and from the liver 20a-dihydro-
4
pregnenolone sulphate. No 3-oxo-A steroids were detected in either
tissue. Several experiments carried out _in vivo by Diczfalusy and co¬
workers (Diczfalusy .al., 1965; Pion ej; al., 1965b; Bolte et al.,
1966) have also failed to demonstrate any activity of 3(3-hydroxy-
4
dehydrogenase in the foetus at mid-term but 3-oxo-A steroids can be
formed from pregnenolone by foetal adrenal tissue jln vitro (Villee and
Loring, 1965). It is thus evident that the enzymes required for the
various conversions are present in the adrenal, but they are somehow
rendered inactive.
It may be concluded that most of the progesterone is formed in
the placenta from cholesterol supplied by the mother, but it is probable
that a small portion is also formed from pregnenolone sulphate and from
cholesterol produced by the foetus.
3. The synthesis of oestrogens during pregnancy
The formation of the other principal hormones of pregnancy, the
oastrogens, is more complex and there have been indications for several
years that the foetus is directly involved in their synthesis.
Ten Berge (1958) reported an abnormally low level of oestriol in
urine obtained from a xroman bearing an anencephalic foetus. This finding
was verified by Frandsen and Stakeman (1961), who also found that
oestrone and oestradiol were excreted in reduced amount. These workers
noted a correlation between the degree of hypoplasia of the foetal
adrenal cortex and the amount of oestrogens excreted by the mother, and
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put forward the hypothesis that the foetal adrenal glands were
involved in the elaboration of oestrogens, by producing steroid
precursors (Frandsen and Stakeman, 1963).
Perfusion of placentas still attached to the uterus with DHA,
DHA sulphate, androstenedione or testosterone resulted in the finding
of large amounts of oestrone and oestradiol in the placenta and in the
perfusate (Bolte ejt al^., 1964 ). Oestriol, however, was not detected
in these experiments, and none was obtained when oestrone and oestradiol
were perfused through placentas at mid-term.
These findings from experiments conducted in vivo are in contrast
to the findings of Slaunwhite et al_. (1965), who found that microsomes
prepared from placentas in the third to fifth month of gestation were
capable of affecting the 16a-hydroxylation of DHA and oestrone. This
represents a further example of the need to interpret the results of
in vitro studies with caution.
It has been shown in vivo that the foetal liver can effect the
16a-hydroxylation of oestrone and oestradiol (Schwers et al., 1965a),
and of two sulphated steroids, DHA sulphate and oestrone sulphate (Bolte
et al., 1966; Schwers et al., 1965b). It is likely, therefore, that the
16a-hydroxy group of oestriol is supplied by the foetus. The foetus is
not able to synthesise oestrogens completely, however, due to the
inactivity of 3(3-hydroxy-dehydrogenase in foetal tissue, so the essential
step involving the formation of a 3-oxo-A -steroid must take place in
the placenta, which has an active 3(3-hydroxy-dehydrogenase. Since the
foetus can carry out all the other steps in the synthesis, including
aromatisation, the oestrogens could arise either by the action of
Fig. 2. The Synthesis of Oestrogen by the Foeto-Placental Unit













placental 3p-hydroxy-dehydrogenase and aromatase on 3|3-OH-A steroids
such as DHA or 16a-0H-DHA (Fig. 2a), or by foetal aromatisation of
4
3-oxo-A steroids produced by the foetal adrenal from progesterone
(Fig. 2b).
Magendantz and Ryan (1964) demonstrated that 16a-0H-DHA could be
converted into oestriol by placental microsomes, and this steroid has
recently been shown to be an active precursor of oestriol jLn vivo
(Dell1 Acqua ejt al., 1966). Since DHA and 16a-0H-DHA have been shown
to be active precursors of oestrogens in vivo, it is significant that
the sulphates of these steroids are found in large amount in plasma
obtained from the umbilical blood vessels. These compounds have been
assayed by Colas e£_£lj (1964), and by Easterling ejt al. (1966), and
were found to be present in greater concentration in the arterial than
in the venous plasma obtained from the umbilical vessels, indicating a
net uptake of these steroid sulphates by the placenta.
Some oestriol is, however, formed by 16a-hydroxylation of oestrone
and oestradiol produced from DHA sulphate synthesised in the maternal
adrenal glands. Evidence for this pathway has been supplied by
Kirschner et jkL. (1966), who showed that DHA sulphate administered to
the mother was converted to oestriol and that this conversion occurred
principally by phenolic intermediates. The DHA sulphate present in the
maternal blood is converted by the placenta into oestrone and oestradiol,
which are then released into the umbilical vein. Maner e£ al. (1963)
(
found only 2.8 /Llg. oestrone/100 ml. and 0.64 /Kg. oestradiol/100 ml. in
plasma from the umbilical vein, so it is unlikely that a significant
amount of oestriol is formed by 16a-hydroxylation in the foetus of this
- 12
oestrone or oestradiol. The concentration of DHA sulphate in plasma
obtained from the umbilical blood vessels is several times greater than
its concentration in plasma obtained from the mother (Colas et al., 1964);
this is further evidence that most of the precursors of oestrogens are
synthesised by the foetus.
It has recently been shown that foetal liver is able to aromatise
3-oxo-A^ steroids (Mancuso et al., 1965), so it is possible that oestrogens
can also be formed from androstenedione and testosterone produced in the
foetal adrenals from progesterone supplied by the placenta. It is probableJ
however, that this pathway (Fig. 2b) is only of minor importance, and from
the evidence available it is concluded that most of the oestrogens are
formed in the placenta from iihA sulphate and 16oc-OH-DHA sulphate produced
by the foetus.
4. The biosynthesis of corticosteroids by the foeto-placental unit
The general metabolic balance of the foetus during pregnancy is
not thought to be controlled to any extent by Cortisol supplied by the
mother, and it is likely that the foeto-placental unit is itself capable
of forming sufficient Cortisol for foetal use. Migeon et al. (1961)
14
showed that C Cortisol administered to the mother could cross the
placental barrier to the foetus, but by administering Cortisol into the
amniotic fluid, these workers demonstrated that it could also be transported
in the other direction. Mills (1967) considers that because plasma derived
from blood collected from themother has high cortisol-binding power, whereas
plasma obtained from the foetus has low cortisol-binding power, it is most
likely that throughout much of pregnancy the mother "steals" Cortisol
produced by the foeto-placental unit.













Note: Progesterone is not an intermediate in the pathway which is
proposed as an alternative route.
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The newborn infant is evidently able to produce sufficient
Cortisol to maintain life, but throughout most of pregnancy the
complete foeto-placental unit is probably required for the synthesis of
this compound, due to the inactivity of the 3[3-hydroxy-dehydrogenase in
foetal tissue. Because of this enzyme deficiency, the foetus requires
4
a 3-oxo-A precursor such as progesterone for the synthesis of Cortisol.
It has been estimated by Zander (1961) that half of the large amount of
progesterone produced in pregnancy (estimated at about 250 mg./day near
term; Pearlman, 1957) is secreted by the placenta directly into the
foetus. Autoradiographic studies carried out by Bengtsson e_t al. (1964)
on slices of foetal tissue perfused with radioactive progesterone
revealed an accumulation of radioactivity in the adrenals, indicating
that this was probably the major site of progesterone metabolism.
Several investigators have demonstrated iji vitro that the foetal
adrenals, ovaries and testicles cc i convert progesterone into a variety
of steroids. Of particular interest is fhe production of Cortisol by
incubating progesterone with minced adrenal tissue (Villee and Driscoll,
1965), or by organ cultures of foetal adrenals (Bloch et al_., 1965).
Solomon et al.(1967) perfused foetuses of gestational age 17-21 weeks
14
with " C progesterone and isolated the following radioactive steroids
from the adrenal gland; 16a-0H-progesterone, corticosterone sulphate,
20oc-dihydroprogesterone, Cortisol, 17a-0H-progesterone and pregrm. olone.
This important work indicates that the foetal adrenal at mid-term can
utilise circulating progesterone for the synthesis of corticosteroids.
It has, therefore, been established that the foetus at mid-term can
effect the 16a-, 17a-, 21- and lip-hydroxylation of progesterone,







Note: Progesterone is not an intermediate in the pathway which is
proposed here as an alternative route.
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waereas it has recently been shown that the placenta has little if any
ability to carry out these hydroxylations, its metabolism of
progesterone being limited to 6(3-hydroxylation and 20a-reduction
(Diczfa.usy, 1966). Experiments with adrenaiectomised foetuses (Wilson
et al., 1966) have indicated that most o the metabolism of progesterone
takes place in the adrenals; only 6p- and 17a-hydroxylation takes place
in other tissues. Small amounts of aldosterone have been isolated from
the adrenals of foetuses perfused with labelled corticosterone
(Pasqualini jet _al_., 1966), so it is apparent that, using placental
progesterone as a precursor, the adrenals of foetuses at mid-term are
capable of elaborating all the biologically important corticosteroids
(Fig. 3a, 4a).
Iwamiya et_ al^ (1966) have shown that the foetus lacks the 3(3-
hydroxy-dehydrogenase required for converting pregnenolone into
progesterone , but there are indications that other 3p-hydroxy-
dehydrogenases are active in foetal tissue and that these can convert
4
hydroxylated pregnenolone derivatives to their corresponding 3-oxo-A
steroids. Recently, Pasqualini and co-workers (1968) obtained Cortisol
from foetuses perfused with labelled 3p,17a,21-trihydroxypregn-5-en-
20-one, at mid-term, so it is possible that the foetus and the newborn
infant may obtain Cortisol by biosynthetic pathways not involving
progesterone as an intermediate. The possible formation of corticosterone
and Cortisol by these pathways is illustrated in Figs. 3b and 4b. Further
evidence that these routes may be important has been obtained by analysis
of the steroid metabolites present in urine collected from infants and
in plasma obtained from the umbilical cord. 21-0H-Pregnenolone
















Also tetrahydrocortisone Also allotetrahydrocortisone
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is a possible intermediate in the formation of corticosteroid (Fig. 3b),
and this steroid has been identified in these blood (Eberlein, 1965b)
and urine specimens (Birchall and Mitchell, 1965). A 3p-hydrcxy-
dehydrogenase is possibly present in the foetus and capable of converting
21-OH-pregnenolone to deoxycorticosterone; alternatively, 3p,11(3,21-
trihydroxypregn-5-en-20-one could be formed from 21-OH-pregnenolone and
then dehydrogenated directly to form corticosterone. Eberlein (1965b)
has tentatively identified other 3P-0H-A"* steroids in plasma from the
umbilical cord, including 17a-0H-pregnenolone, 3p,17a,21-trihydroxypregn-
5-en-20-one, and 3p,11(3,17a,21-tetraliydroxypregn-5-en-20-one, all of
which could be intermediates in the biosynthetic pathway illustrated in
Fig. 4b for the production of Cortisol. Further research is necessary
to determine which of these alternative pathways are important for the
production of corticoids by the foetus.
5. The structure of steroid metabolites in urine collected from infants
Qualitative analyses of steroids in urinary extracts have revealed
considerable differences between specimens collected from infants and
from adults. The major steroids excreted by adults are the 17-oxosteroids
and the 17-hydroxycorticosteroids; most of the compounds falling into
4
these groups are formed by reduction of 3-oxo-A steroids in the liver,
with the formation of 3a-OH-5a steroids and 3a-OH-5p steroids (Fig. 5).
These steroids are almost invariably excreted as their conjugates with
glucuronic acid. In urine collected from infants, however, the major
steroids present have the 3p-01I-A^ structure. This is due to the relative
deficiency of 3p-hydroxy-dehydrogenase in the adrenal glands of newborn
5
children. These 3P-0H-A steroids are almost entirely excreted as their
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sulphate conjugates, and there is relatively little steroid excreted as
the glucuronide conjugate in urine collected from the newborn infants.
When group assay methods were used to measure the 17-oxosteroids and
the Cortisol metabolites in urine samples from infants, results were
high but it has since been shown that the "adult-type" individual 17-
oxosteroids and Cortisol metabolites are only present in small amount in
these specimens (Cathro et al., 1963),
Among the Cortisol metabolites, tetraliydrocortisone and tetra-
hydrocortisol are the major reduced metabolites in the urine of adults,
but in infants neither is the dominant reducing compound. Only 10% of
14
the radioactivity injected into infants as C labelled Cortisol was
recovered as tetrahydrocortisone, tetrahydrocortisol and allotetrahydro-
cortisol (Bertrand et al., 1963) compared to approximately 36% when
labelled Cortisol was injected into adults (Flood ej: al., 1961), The
metabolism of Cortisol by infants is therefore very different from its
metabolism in adults.
In the newborn the enzymes which catalyse the reduction of the A
ring of the steroid nucleus are apparently relatively inactive
(Bongiovanni et al,, 1958; Migeon, 1959; Reynolds et al.. 1962), and
this deficiency results in a large proportion of the Cortisol being
either excreted unchanged or being further metabolised by other routes.
An important pathway in newborn infants is 6(3-hydroxylation (Ulstrom et
al., 1961), the resulting 6p-0H-cortisol being excreted unconjugated.
Cathro and co-workers (1963) determined the individual 17-oxosteroids
and reducing compounds by a paper chromatographic method, and found many
hitherto unidentified bands which were probably unknown 17-oxosteroids
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a d metabolites of corticosteroids. Many of these unidentified compounds
were quantitatively very important, and interfered with the attempts by
these workers to measure small amounts of the "adult-type" 17-oxosteroids
and tetrahydro metabolites of Cortisol*
Little is known, therefore, about the major routes for the
metabolism of the adrenal steroids in neo-natal life, and in recent years
most attention has been paid to the identification of SfJ-OH-A"' steroids,
since these are quantitatively the most important steroids in urine
collected from newborn infants. Some of these 3(3-OH-A^ steroids can act
as precursors for steroid syntnesis in utero, the most important example
being 16oc-OH-DHA, a compound which has been shown to be a maj#r precursor
of oestriol (Dell'Acqua et: a_l., 1966); this steroid was identified in urine
from newborn infants by Bongiovanni (1962).
Birchall and Mitchell (1965) identified 21-OH-pregnenolone in
extracts from urine collected from infants and it is possible that this
compound is a precursor of deoxycorticosterone and of corticosterone in
the foetus. Quantitatively the most important steroid in infant urine is
16a-0H-pregnenolone which was identified by Reynolds (1963), but the
function of this compound is not known, since it is unlikely to play a
part as a precursor in the synthesis of other steroids, and is more
probably a metabolite of pregnenolone formed prior to excretion in the
urine.
Although DHA is quantitatively the most important 3P-0H-A"* steroid
in urine collected from adults, little is found in urine obtained from
newborn infants (Cathro et al., 1963), presumably due to the high activity
of 16a-hydroxylase in the liver, both in the foetus and the newborn.
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6. The control of steroid production by the foetus and by the newborn
infant
In anencephalic foetuses the adrenal glands are severely hypoplastic
(Frandsen and Stakeman, 1961). This may be explained by the gross
disturbance of the hypothalaraic-pituitary-adrenal axis and may indicate
that the foetal adrenal is controlled by foetal adrenocorticotrophic
hormone. Further evidence that this is the case has been produced by
Simmer et al. (1966), who showed that corticosteroids administered to the
mother markedly lowered the levels of DHA and 16o-0H-DHA in blood collected
from the umbilical cord. This indicated that these steroids had crossed
the placenta and suppressed the production of adrenocorticotropic by the
foetus. It has also been shown that adrenocorticotropic stimulates the
synthesis of steroids by foetal adrenals in the third trimester (Bloch,
1966).
In the neonatal period, blood Cortisol is certainly under the
control of adrenocorticotrophic hormone, since Bertrand ejt al. (1962) and
Hillman and Giroud (1965) found considerable increases in its concentration
in blood after the administration of adrenocorticotrophin to infants.
Recent work by Lauritzen and Lehmann (1965, 1967) has shown that
human chorionic gonadotrophin as well as adrenocorticotrophin can affect
steroid excretion by the newborn. These workers found that administration
of human chorionic gonadotrophin caused a very significant increase in
DHA excretion. Since human chorionic gonadotrophin is produced by the
placenta in large amounts, particularly near the beginning of pregnancy,
this finding could have considerable importc ce.
It seems probable therefore that the synthesis of steroids by the
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foetus is regulated by adrenocorticotropic hormone and human
chorionic gonadotropin.
7. The purpose of the research undertaken for this thesis
In 1963, Cathro jat al.reported the presence of many unknown
steroid-like compounds in urine collected from newborn infants. It was
considered by these workers that the compounds were formed by biosynthetic
systems designed for special functions required for foetal life, and which
were still operating after birth. The research reported in this thesis
was undertaken in an attempt to identify and assay sane of these
uncharacterised compounds. It was considered that a more complete
knowledge of the excretion of steroids by newborn infants would be useful
in understanding the metabolism of steroids in the foetus and the newborn
infant. Since plasma obtained from the umbilical vessels also contains
steroid metabolites formed in the foetus, a method was developed for the
analysis of these compounds.
Since both human chorionic gonadotrophin and adrenocorticotrophin
appeared to be involved in the regulation of steroid metabolism in the
i
foetus (Lauritzen and Lehmann, 1965; Bertrand et al., 1962), a study was
undertaken of the effect of these trophic hormones on the excretion of a
number of steroids in urine collected from infants.
PART I
DEVELOPMENT OF A METHOD FOR DETERMINING STEROID METABOLITES IN URINE
SAMPLES COLLECTED FROM NEWBORN INFANTS, AND IN PLASMA SAMPLES
OBTAINED FROM THE UMBILICAL BLOOD VESSELS.
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I CHOICE OF TECHNIQUES
1. Introduction
In the last two decades many techniques have been developed for
the assay of steroids in biological fluids; most of these have been
useful aids for the particular topics being studied. Before developing
a new method for the determination of steroids in specialised biological
material it is, therefore, necessary to decide on the types of method to
be investigated. The choice will depend on the concentrations of the
steroids to be assayed, the accuracy needed, and the number and type of
steroids which are to be determined in any particular estimation. The
accuracy of a method designed specifically for measuring a single compound
is usually better than the accuracy of a method for the quantitative
estimation of many compounds. A balance must, therefore, be kept between
the requirements of reliability and practicability.
The methods of steroid assay can be divided into two main types.
Firstly, methods which assay groups of steroids containing a common
functional moiety, such as the 17-oxosteroids and the 17-hydroxycortico-
steroids; secondly, methods for the assay of individual steroids, which
have first been separated by chromatographic or other techniques.
It was found early in the study of steroid metabolism in newborn
infants that group assay methods suitable for adult work were not
satisfactory when applied to the determination of steroids in urine
collected from infants. Difficulties mainly arose because non-specific
chromogens interfered with the colorimetric assays of the groups (Migeon,
1959; Ulstrom £t al., 1959; Hughes et al., 1962), but there was also
the more serious limitation that these methods had been devised to mecsure
table 1
Methods for Measuring Individual Steroids by Chromatographic Techniques
Type of
chromatography Method of final measurement
Publications using these
techniques




Colo's £t al. (1964) The
measurement of DMA and
16a-0H-DHA in umbilical
plasma.
James et al. (1964) The
separation and assay of
lipids e.g. cholesterol.
Paper Elution of compound from
paper followed by colour
reaction in tube
2. Direct staining of c romato-
gram and deasitometric
scanning
Reynolds (1965a,b, 1966a.. b)
The measurement of 16a-0H-DHA
16a-OH-pregnenolone and
androstenetriol in urine
collected from newborn infants.
Cathro et al. (1963) The
assay of Zimmermann and bl' e
tetrazolium staining compounds
in urine obtained from
infants.
Thin-layer 1. Elution of compound from
(TLC) tain-layer material
followed by colour reaction
in tube
2. Direct spraying of colour
reagent on to plate followed
densitometric seaming
Hamman and Martin (1964)
Determination of the six
urinary 17-oxosteroids by
two-dimensional TLC.
Zollner et al. (1962) Tie
measurement of cholesterol
esters in plasma.
Gas-liquid Measurement of peak height
or area
Vihko (1966) The determination
of 3p-0H-AJ steroids in plasma.
Gardiner et al. (1966) The
measurement of all types of
steroids in urine specimens
obtained from adults and
infants.
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the principal metabolites occurring in the urine of adults.
Group methods for assaying steroids have been found useful in the
study of large numbers of clinical cases, and form the basis of many
routine methods performed in the clinical laboratory. However, in many
cases, measurement of individual steroids can reveal subtle changes not
detected by group assays. To elucidate the normal pattern of steroid
metabolism by the newborn infant a method was required that would allow
the determination of a wide spectrum of steroids. It was necessary to
5
separate and quantitate 3(3-OH-A steroids, 17-oxosteroids and the
metabolites of Cortisol.
Before individual steroids can be measured, they must first be
separated by chromatographic or other techniques. Four chromatographic
methods have been widely used: a) column chromatography; b) paper
chromatography; c) thin-layer chromatography (TLC), and d) gas-liquid
chromatography (GLC). Frequently, more than one of these methods have
been used in a particular assay. This section discusses some of the
methods used for separation and quantitative estimation using these types
of chromatography.
Table 1 shows how the four types of chromatography have been
applied to the quantitative measurement of individual compounds. The
examples given have been chosen for their applicability to the work to
be undertaken. Each type of technique will be described in more detail,
with particular reference to the requirements of the present study.
Fig. 6. Method of Colas et al. (1964) for Fractionating 33-OH-A"^ Steroids
Present in Plasma Obtained from the Umbilical Blood Vessels
Eluting Solvent
7. Ethanol in Benzene
0
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Alumina columns (o.4 x 5.5 cm.) were used for separation. The steroids




2.1 With colour development in the collection tube
Col&s and co-workers (1964) determined DHA and 16oc-OH-DHA in
plasma obtained from the umbilical vessels. They used a method which
depended on solvolysis of the steroid conjugates followed by column
chromatography. Very small columns were used (internal diameter 0.4 cm.,
length 5.5 cm.) and a typical separation is shown in Fig. 6. The
Pettenkoffer reaction (Fotherby, 1958), which is specific for 3f3-OH-A^
steroids, was used for colour development. The practicability of the
method is good but specificity is low, since there are many other compounds
which develop a colour in the Pettenkoffer reaction and which are present
in these plasma samples (Eberlein, 1965b); these other compounds have
similar polarities and the resolution of the columns used is not high.
16a-0H-DHA separated in this technique has been found recently to be
contaminated with 16-oxo-androstenediol (Col^s jst al., 1965).
2.2 With automatic determination
This method has only recently been developed, and has not as yet
been applied to the measurement of steroids. It has been included since it
will probably prove useful for the assay of steroids. A moving wire
passing through the eluant from the column collects a thin coating, and
any material eluted remains on the wire when the solvent is evaporated.
The wire passes to an oven where pyrolysis and vaporisation take place,
and any material present is then detected by an argon or flame-ionisation
detector cf the type used for GLC. Peaks due to the separated compounds
are registered on a recorder. This method has been shown to give
reproducible quantitative results when used for the separation of lipids,




The major metabolite in urine specimens collected from infants,
16a-OH-pregnenolone, was isolated by Reynolds (1963) using a method
involving paper chromatography. This technique was later developed for
the quantitative estimation or this compound and of two other important
metabolites, 16O-0H-DHA and androstenetriol (Reynolds, 1965a, 1966b). In
this procedure the sulphate esters were hydrolysed by solvolysis, and the
steroids obtained were separated by a single chromatographic run. Part
of the chromatogram was stained with phosphomolybdic acid, to determine
the position of the various compounds; these were then eluted from the
corresponding positions on the remainder of the paper. The material
obtained was further purified by using small columns of silica gel, and
. • v
the final measurement made the Oertel reaction (Oertel and Eik-Nes, 1959).
This method is satisfactory for the measurement of a small number
of compounds, but if many steroids are to be determined in a single sample,
then a method which makes use of a colour reaction developed directly on
♦
the paper chromatogram is preferable.
3.2 Direct staining and quantitation on paper
Birchall and co-workers (1963) developed a paper chromatographic
technique for investigating the types of steroid that were excreted by normal
nextfborn infants, but it was found to be impossible to delineate and elute
the many compounds detected. Therefore, different groups of steroids
were measured directly on the chromatograms by dipping the papers into
suitable staining solutions. For example, the blue tetrazolium reagent
was used for detecting o-ketolic steroids and the Zimmermann
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reage t for 17-oxosteroids. The spots were measured derisitometrically
using a modified spectrophotometer. A considerable disadvantage of
this method was the time taken to complete an estimation on a single
sample of urine, since several long paper chromatographic runs were
involved with the necessity of eluting steroids from one chromatogram and
transferring them to another.
4. Thin-layer chromatography (TLC)
There are two methods involving TLC, one of which relies on
elution followed by the development of a colour reaction in a tube, the
other depends on direct estimation, by spraying with a suitable reagent
followed by densitometric measurement.
4.1 Elution method
A method was developed by Hamman and Martin (1964) for measuring the
six principal 17-oxosteroids in urine. Separation was effected by two-
dimensional chromatography on alumina. This was carried out in duplicate
for each extract, one plate being used for locating the steroids; the
corresponding areas on the other plate were then scraped off and eluted.
The final assay was performed using the Zimmermann reagent. This method
is open to the same criticism as applied to the comparable method
involving elution after paper chromatography. To separate the steroids
sufficiently for elution to be reliably performed of spots containing
only one compound, two-dimensional chromatography was necessary. Th's
meant that only one sample could be run on each thin-layer plate.
4.2 Quantitative estimation by direct s- lining of thin-layer chromatography pUfes
A more practicable approach to quantitative TLC makes used of a
Fig• 7. Double Isotope Dilution Method for the Determination of Pregnenolone
Sulpuate in Plasma
14





PAPER CHROMATOGRAPHY (SYSTEM A)
I elution of freepregnenolone
ACETYLATION (~*H acetic anhydride)
wash
THIN-LAYER CHROMATOGRAPHY
elution of pregnenolone acetate
PAPER CHROMATOGRAPHY (SYSTEM B)
| elution of pregnenolone acetate
ADDITION OF CARRIER PREGNENOLONE ACETATE
RECRYSTALLISATION TO CONSTANT 3H/14C RATIO
from Conrad et al. (1967).
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system developed by Z'o'llner et al. (1962) for the measurement of cholesterol
esters in plasma. The steroids were separated by TLC and detected by means
of spray reagent consisting of antimony trichloride dissolved in chbroform.
The coloured areas that developed were scanned with a densitometer, and
the peak areas were related to those formed by standard compounds. Such
a method is particularly useful since many different spray reagents can be
used, including strong acids which would destroy paper chromatogrsms.
Another advantage is that runs are short compared to the time required when
using paper chromatography, and sensitivity is considerably incre^oo^ due
to the much smaller diameter of the spots. This last consideration is
particularly important when steroids present in small amount are to be
determined, for example in blood samples collected from the umbilical cord.
5. Double isotope dilution
The most accurate methods for measuring single steroids when present
in small amount often employ double isotope dilution together with one or
more of the above techniques. These methods have been used for several
years, for measuring such important compounds as aldosterone (Kliman and
Peterson, I960) and testosterone (Riondel jet _al., 1963). Recently the
technique has been developed for the measurement of pregnenolone in blood
samples collected from mothers and from the umbilical cords of their
infants (Conrad et al., 1967). Radioactive H pregnenolone sulphate is
added initially to plasma to monitor recovery. Multiple chromatograms are
14
run (see Fig. 7) before and after acetylation with C acetic anhydride,
and finally recrystallisation has to be performed until a constant ratio
3 ^ /i
of H/ C is obtained. This method is accurate and reliable, but it would
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be impossible to apply it to more than one or two important compounds;
it is not practicable for analysing many steroids in a single sample.
6. Gas chromatography (GLC)
Gas chromatography has been used for the determination of
oestrogens, pregnanediol, the 17-oxosteroids and testosterone and several
other steroids. It has recently been applied to the measurement of the
5
solvolysable 3(3-OH-A steroids present in plasma (Vihko, 1966; SjbVall
and Vihkoj 1966). The technique has good reproducibility and high
sensitivity, but problems arise with corticosteroids which are unstable
to heat; for these thermolabile compounds it is necessary to form
derivatives of either the hydroxyl or the ketone groups, or sometimes of
both groupings. Horning and co-workers <1967) have successfully separated
the complete range of steroid metabolites present in urine specimens
collected from adults or from infants by preparing the 0-methyloxi.ae
derivatives of the ketone groups and the trimethylsilyl ethers of hydroxyl
groups. The method was rendered specific by identifying the peaks that
were produced using a combination of gas-liquid chromatography and mass-
spectrometry. This technique has not yet been made quantitative, but when
it has been modified so as to allow the quantitative esterification of all
the functional groups, it may prove to be the method of choice for
investigating the steroids in urine samples collected from infants. If
the specificity afforded by mass-spectrometry is not available, quantitative
methods which depend upon specific colour reactions such as the methods




Two methods were selected because they showed the greatest promise;
(a) column chromatography followed by colour development (Colis et al.,
1964); and (b) thin-layer chromatography with colour development on the
chromatograms (Zollner, 1962). Both these techniques could be adapted
for the measurement of several groups of steroids, by utilising different
colour reactions. By using differential colorimetry, it did not appear
that it would be necessary to separate every steroid that was to be
measured, but only those producing a colour in a particular reaction.
For sensitivity with high resolution, it was finally decided to develop
a method based on separation by TLC using specific staining reactions
followed by densitometric scanning.
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II. DEVELOPMENT OF A THIN-LAYER CHROMATOGRAPHIC METHOD
FOR DETERMINING STEROID METABOLITES IN URINE AND IN
PLASMA
1• Preliminary treatment of plasma
Nearly all the known 3p-0H^A"' steroids, 17-oxosteroids and
corticosteroids are present in cord blood and in urine as sulphates and
glucuronides. Before determination, these conjugates are usually
hydrolysed by acid, by enzymes, or by solvolysis. The steroids that are
released are then extracted into organic solvents. Using enzymatic
hydrolysis, the steroids in urine can be released by adding enzymes
directly to urine, but plasma contains protein and fat which interfere
with the later stages of the method. Protein interferes with the mechanism
of extraction into organic solvents, and fat (which is extracted by the
solvent) interferes with the subsequent chromatography. It is therefore
necessary to remove protein and as much of the fat as possible prior to
the hydrolysis step.
1.1 The extraction of steroids by enzymatic hydrolysis and solvolysis of
a crude extract of plasma.
Initially, a simple method was investigated for extracting steroids
present in plasma samples obtained from the umbilical blood vessels. The
details are as follows
(a) Protein was precipitated with 4 vol. ethanol (v/v) and removed
by centrifugation. The supernatant was collected.
(b) The centrifugate was extracted with 4 vol. 80/i ethanol (v/v)
and the suspension centrifuged again. The supernatant was again
collected.
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(c) The supernatants were combined and evaporated to dryness on
a rotary evaporator.
(d) 30 ml. distilled water were added and the suspension was
extracted twice with 30 ml. ether. These extracts were combined;
they contained unconjugated steroids and some fatty material.
(e) The steroid conjugates remaining in the aqueous phase were
hydrolysed, and the liberated steroids extracted, using the
technique which is described later and which was developed for
determining steroids in urine samples obtained from newborn infants.
This method is described in detail in sections 2.3 (p. 37), 2.4
(p.38 ) and 2.5 (p. 39 ).
The final extract occasionally contained polar fatty material
which interfered with chromatographic separations. Since the polarity
of the fatty impurity was similar to the steroids to be measured, the
methods commonly used for removing fat, such as precipitation with 70%
methanol in the cold or extracting aqueous methanol with non-polar
solvents, were not successful. Silica gel column chromatography of
the final extract was also attempted, but the fatty impurity invariably
remained with the steroid fraction. From a preliminary investigation,
it appeared that this fat was being released during the hydrolytic
procedure, so it was considered necessary to obtain the steroid
conjugates in a purer state prior to hydrolysis. For this reason
other methods were investigated.
1.2. Methods based on the extraction of steroid conjugates from plasma
(a) Extraction of steroid sulphates as their pyridinium salts
McKenna and Rippon (1965) described a method for extracting steroid
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sulphates from plasma; this method was based on a technique developed by
McKenna and Norymberski (I960) for the extraction of steroid conjugates from
urine. By the addition of pyridinium sulphate to plasma,sodium salts of
steroid sulphates are converted into their corresponding pyridinium salts.
Unlike the sodium salts, the pyridinium sulphates of steroids are soluble
in organic solvents and may be readily extracted from the plasma into
chloroform.
The principle involved has already been applied to the measurement
of DHA sulphate and of 16a-0H-DIiA sulphate in plasma samples collected from
the umbilical blood vessels (Simmer et al., 1964; Easterling et al., 1966;
Simmer et al., 1966). The details of this technique are as follows
(a) 5.0 ml. plasma were shaken vigorously with 50 ml.
chloroform and the mixture was centrifuged.
(b) 4.5 ml. of the aqueous layer were transferred to a
centrifuge tube containing 4.5 ml. 3M pyridinium sulphate. After
mixing, 45 ml. of chloroform were added, the tube was shaken and
the two layers were then separated by centrifugation.
(c) 43 ml. of the chloroform layer were transferred to a flask and
evaporated to dryness on a rotary evaporator.
(d) The steroid conjugates present in the dried extract were
hydrolysed, and the liberated steroids were extracted using the
technique described in sections 2.3 (p. 37), 2.4 (p. 38) and
2.5 (p. 38).
The technique of McKenna and Rippon (1965) did not include an
prior To fUe_ li^dUjUhc V\
extraction with chloroform^ This step was added so as to remove much of
the fat that would otherwise have interfered with chromatography at a
TABLE 2.
The Extraction of Steroid Conjugates as Pyridinium Sulphates












After pyridinium sulphate is added to plasma, the sodium salts of
steroid sulphates are converted to pyridinium salts; these are soluble
in organic solvents and can be extracted with chloroform.
The suitability of this method for the extraction of steroid
sulphates from plasma obtained from the umbilical blood vessels was
5
investigated. This table shows the recovery of 3(3-OH-A steroids by
pyridinium sulphate extraction as a percentage of the results obtained
using the method employing Sephadex chromatography. Enzymatic hydrolysis
was used to hydrolyse the purified steroid sulphates, both after pyridinium










later stage. The extracts obtained were apparently free from all fatty
impurities but the results given in Table 2 show that overall losses of
steroid were considerable. Using a similar method, Easterling et al.
(1966) only recovered about 30% of the 16a-0H-DHA sulphate present in
plasma samples obtained from the umbilical blood vessels.
(b) The conversion of steroid sulphates to steroid acetates
Another technique has recently been applied to the extraction of
steroid conjugates from plasma (Eberlein, 1962). In this method, the
steroid sulphates are converted to steroid acetates, which can be
readily extracted into organic solvents. Eberlein (1965b) characterised
many of the steroids present in cord blood using this technique, but
some of the recoveries that he obtained appeared to be very low. For
instance, I6oc-OH-DHA, which is quantitatively the most important steroid
in plasma obtained from the umbilical cord, was found by Eberlein (1965b)
to be present at a concentration of only 2 plg./lOO ml. plasma, whereas
the concentration found in the present study, using the method finally
adopted, ranged between 190 and 560 jUg./lOO ml. plasma. Due to the low
recoveries obtained by Eberlein (1965b), this method was not investigated
in the present study.
1.3 The purification of steroid conjugates present in plasma samples
using chromatography on Sephadex LH 20
Vihko (1966) used Sephadex LH 20 to separate unconjugated steroids
from their monosulphate and disulphate conjugates. Sephadex LH 20 is
prepared from Sephadex by introducing 2-hydroxyethyl groups bound in
ether linkage to the free hydroxyl groups. This enables the Sephadex
to be used with organic solvents.
Fig. 8. Sephadex LH20 Chromatography of Steroid Conjugates Present in Plasma
Obtained from the Umbilical B1ood Vessels








This figure illustrates the separation by Sephadex LH20 chromatography
of steroid conjugates from lipid material present in the plasna. Methanol:
chloroform (1:1, v/v) was the eluting solvent used and 10 ml. fractions were
collected. Each fraction was hydrolysed by Helix pomatia sulphatase enzymes and,
following extraction, the steroids were separated on this chromatogram. It can
be seen from this figure that the fractions containing steroids are well separated
from those containing unwanted lipid material. Since diconjugated steroids require
a large volume of solvent to pass through the column before they are eluted, the
fractions containing these steroids are not illustrated in this figure.
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Figure 8 shows the separation of unconjugated steroids and
fatty impurities from steroid monosulphates by chromatography on
Sephadex LH20. A crude extract of the plasma steroid conjugates was
obtained using stages one to three of the method described on page 28
This crude extract was applied to the column of Sephadex LH20 (I7g.)
using a small volume of methanol:chloroform (1:1 v/v), which was also
the solvent mixture used for elution. Ten ml. fractions of the eluant
were collected, apart from the first and second fractions which were
30 ml. and 20 ml. in volume respectively .
The steroid conjugates present in the fractions of the eluate
were hydrolysed both by enzymatic means and by solvolysis. The details
of the methods used for enzymatic hydrolysis end for solvolysis, as well
as for subsequent extraction into organic solvents, are given in
sections 2.3 (p. 37), 2.4 (p.38 ) and 2.5 (p. 38). The compounds present
in the individual fractions were separated on thin-layer plates as
illustrated in Fig. 8.
The free steroids and fat began to appear in the eluant after
30 ml. of the eluting solvent had passed through the column; after 60 ml.
had been collected, almost all the free steroid and fat had been eluted.
The steroid monosulphates were eluted after between 140 ml. and 190 ml.
solvent had passed through the column, and the disulphated steroids were
eluted after between 350 ml. and 400 ml. had passed through. Only the
fractions comprising the first 240 ml. of eluant are represented on the
thin-layer plate shown in Fig. 8. This method was not reproducible when
the same columns were used repeatedly, and occasionally separation between
less polar material and steroid monosulphates was poor. The separations
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were improved if the solvent was saturated with sodium chloride, but
this meant that rnuca greater volumes were required for elution of
steroid disulphates (Vihko, 1966). Steroid monosulphates were eiuted
between 150 and 220 ml. but disulphates were in fractions between 550
and 650 ml*, the elution of non-polar material being unchanged.
Although time-consuming, the method which includes chromatography
on Sephadex LH20 was finally adopted for assaying steroids present in
plasma samples obtained from the umbilical blood vessels. The technique
was simplified, however, when used as a routine procedure. The free
steroid and fat were collected in one fraction comprising the first 100 ml.
of the eluting solvent (methanol:chloroform, 1:1, v/v; saturated with
sodium chloride). All the steroid conjugates were then obtained in a
second fraction by eluting off the column with 300 ml. metuanol. This
polar solvent removed botu steroid mo osulpiiates and disulpaates from
the column, a ,d also served to clean the column before it was used again.
After collection, the fraction containing the conjugates was hydrolysed,
and the free steroids were extracted into orga ic solvents using the
methods described in sections 2.3 (p. 37), 2.4 (p. 38) and 2.5 (p. 38).
The unconjugated plasma steroids present in the first 100 ml.
of eluate could be separated from most of the fat by preparative TLC;
they could tie be examined by quantitative chromatographic methods.
Since only small amounts of u conjugated 3(3-0H-A~^ steroid were present in
plasma, this procedure was not usually necessary.
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2• The hydrolysis of steroid conjugatesand the extraction of the
liberated steroids
2.1. Enzymatic methods of hydrolysis: selection of a method
It was necessary to measure both sulphate and glucuronide conjugates
of steroids, present in urine and in plasma samples. Enzymatic hydrolysis
was therefore chosen, since acid hydrolysis results in the destruction of
some steroids, and solvolysis only hydrolyses steroid sulphates.
The two commonly used sources of enzymes for hydrolysing steroid
conjugates are the visceral hump of the limpet (Patella vulgata), and the
crop fluid of the Roman snail (Helix pomatia). The enzymes in these
materials are not usually purified for this purpose. Leon ejt al. (I960)
showed that the limpet preparation was more efficient than the snail
preparation in hydrolysing glucuronides, but that the reverse was true
for the hydrolysis of sulphates.
Only the enzymes obtained from Helix pomatia can hydrolyse
sulphate esters of 3a-OH-5|3 steroids, but neither enzyme preparation will
hydrolyse the sulphate esters of 3a-OH-5a steroids. In adults, practically
all the 3a-OH-5a steroids are excreted as glucuronides, so the hydrolysis
of sulphate esters of this group of steroids does not present a problem.
In infants, however, steroid sulphates form the largest group of steroid
metabolites present in urine, and it is likely therefore that sulphate
esters of 3a-OH-5a steroids will be present; if this is the case, they
must be hydrolysed by solvolysis. During the present study, it was found
that 17a sulphate esters and 20a sulphate esters of steroids were present
in urine samples collected from infants. These esters are not hydrolysed
by the enzymes present in the preparation from Helix pomatia, so they
TABLE 3.
Evaluation of the Procedure Developed for the
Hydrolysis of Steroid Conjugates
Preliminary
Treatment 1 2 3 4 5
1. Adjust to pH 11.5 + - - - Pyridinium sulphate
2. Addition of Barium
chloride












DHA (added) 100 72 64 63 117
Compound
21-OH-preg enolone
100 78 62 53
>
85
16-oxo-androstenediol 100 45 36 21 58
16a-OH-DHA 100 96 79 44 90
Compound I^dbp-OH-DHA) 100 57 53 35 0
16a-0H-pregnenolone 100 103 87 65 105
Androstenetriol 100 105 94 46 0
Legend:
These experiments were carried out to determine the best method
the hydrolysis and extraction of urinary steroids. Five parallel experi¬
ments were carried out in duplicate on the same sample of urine, using
various modifications of the standard technique. The percentage recovery
of steroids by the various modified techniques are based on a recovery of
1007, for the standard method (l).
The results show that it is necessary to remove enzymic inhibitors
by precipitation with barium chloride at pH 11.5. It is also necessary to
wash the extracts with sodium hydroxide, since a very high background
colour develops when the thin-layer chromatograms are sprayed with reagents
if this is omitted. This background colour masks the colours given by the
steroids. The recovery of polar steroids (e.g. androstenetriol) and of
steroid disulphates (16J3-OH-DHA) is zero when the pyridinium sulphate
method is used.
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must also be hydrolysed by solvolysis.
A two stage hydrolytic procedure was finally adopted for the
hydrolysis of the steroid conjugates prese nt iix urine samples collected
from infants, a >d in plasma obtained from the umbilical blood vessels.
The urine (or plasma extract) was first treated with the enzyme
preparation from Helix pomatia, and the steroid sulphates, which
resisted this treatment, were then hydrolysed by solvolysis.
2.2 The removal of enzyme inhibitors from urine
Certain inhibitors have to be removed from urine before the
steroid conjugates can be uydrolysed by enzymes. The sulphatase
activity of Helix pomatia preparations is strongly inhibited by phosphate
ions (Henry and Thevenet, 1952). Similarly, Roy (1956) and Stitch et al.
(1956) reported that the activity of the enzymes obtained from Patella
vjlgata was inhibited both by sulphate and by phosphate ions.
Jayle and Baulieu (1954) showed that the sulphatase activity of
Helix pomatia was increased considerably when sulphate and phosphate ions
were removed by precipitation with barium chloride at pH 11.5; this
procedure also removed saccharo-1:4-lactone, a specific inhibitor of
^-glucuronidase (Marsh, 1962). The importance of this preliminary
treatment with barium chloride is shown by the results of the experiment
described in Table 3. However, some artifacts were formed, for instance,
16P-0H-DHA was completely converted into 16-oxo-androstenediol under these
alkaline conditions. Since 16|3-OH-DHA is present in urine samples
collected from infants mostly as its 3{3,16|3-diconjugate, which does not
isomerise, a considerable proportion of this steroid could still be
determined. It appears from this experiment that much of the 16-oxo-
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androstenediol assayed in urine arises as an artifact from 16(3-0H-WIA.
Another method for avoiding the effects of enzyme inhibitors
present in urine is to extract the steroid conjugates before subjecting
them to enzymatic hydrolysis. This principle was adopted by McKenna
and Norymberski (i960), who devised a simple method for the extraction
of steroid sulphates from urine* By adding pyridinium sulphate to give
a final concentration of 0.3 M, pyridiuium sulphates of steroids are
formed and these can then be extracted into chloroform* Menini (1966)
modified this technique by increasing the concentration of pyridiniura
sulphate to 1 M, and found that the steroid glucuroaides were also
extracted. After extraction, the conjugates were hydrolysed either by
enzymatic means or by solvolysis. Since steroid extracts of urine
obtained using this method contain little material other than steroids,
this method was attempted for the extraction of steroid conjugates
present in urine samples collected from infants. The details of the
method are as follows
(a) 10 ml. of 3M pyridinium sulphate was added to 20 ml. of
urine, and the mixture was then extracted with 30 ml. of
chloroform.
(b) 25 ml. of the chloroform layer was removed and dried.
(c) The extract after drying contained the steroid conjugates.
These conjugates were hydrolysed by enzymatic hydrolysis
and solvolysis in the manner described for plasma extracts
in sections 2.3, 2.4 and 2.5.
The results of this experiment are compared in Table 3 (experiment
*
5) with the results obtained by the method which involves direct
Fig. 9.
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It was found that only a very small amount of Helix pomatia enzyme
was required for the complete hydrolysis of the conjugates of urinary
tetrahydrocortisone and tetrahydrocortisol. However, the hydrolysis of
allotetrahydrocortisol glucuronide increased considerably with increasing
concentration of enzyme.
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enzymatic hydrolysis of urine samples. Satisfactory recoveries were
obtained for DHA, 16a-0H-BHA and 16a-0H-pregnenolone, but the
recoveries of polar compounds and of steroid disulphates were poor.
2.3 Conditions for hydrolysis
Urine:
After precipitation with barium chloride, the pH was adjusted
to 4.5 - 5.0 with 1CK, (v/v) 5M acetate buffer (5M acetic acid: 5M sodium
acetate, 2:3). The sulphatases of both the limpet, and the snail have
maximum activity at pH 5, and the glucuronidases are most active at pH
4.5 (Henry and Thevenet, 1952;Jarrige and Henry, 1952). The steroid
conjugates were hydrolysed at 37° for 48 hours, using 700 units/ml.
^-glucuronidase and 1000 units/ml. sulphatase. These same amounts of
the enzymes were added again after 24 hours, to replace inactivated
enzyme. The amount of Helix pomatia glucuronidase used is equivalent
to the amount used by Birchall and co-workers (1963), but is greater
than that advocated by Hobkirk and Cohen (I960) for the maximum release
of 17-oxosteroids and corticosteroids from their conjugates. The amounts
used were also satisfactory for the hydrolysis of the glucuronides of
tetrahydrocortisone and tetra ydrocortisol, but were not sufficient to
hydrolyse the conjugate of allotetrahydrocortisol completely; the
hydrolysis of conjugates of allotetrahydrocortisol increased with
increasing concentration of enzyme (Fig. 9), a finding also reported by
Nielsen (1966). It is possible that the glucuronide conjugate of
allotetrahydrocortisol may require a specific glucuronidase; if so,
there would appear to be only a small amount of this enzyme in the
extract obtained from Helix pomatia.
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Plasma:
The extract of steroid conjugates present in plasma was dissolved
in 5 ml. 0.5M acetate buffer (0.5 M acetic acid:0.5 M sodium acetate,
2:3, pH 4.5). The steroid conjugates were then hydrolysed by the enzymes
present in the Helix pomatia preparation (700 units ^-glucuronidase,
1000 units sulphatase) for 48 hours at 37°. A second amount of the
enzyme preparation, equal to the first addition, was added after 24
hours.
2.4 Extraction of the steroids after their release from conjugation
The steroids were extracted twice into two volumes of ether:ethyl
acetate (2:1, v/v), the solvent mixture used by Birchall and co-workers
(1963). Good recoveries of polar and non-polar steroids were obtained.
The extracts were washed repeatedly with N sodium hydroxide (one-tenth
the volume of tie organic phase), to remove phenolic compounds and
other impurities. Washing with sodium hydroxide was judged to be
sufficient when no more coloured material was extracted, and a final
wash with water (one-tenth volume) was then performed. After these
washings, the organic extracts were evaporated to dryness on a rotary
evaporator at 45-50°. The solid residue was then dissolved in a small
volume of chloroform and transferred to a test-tube, after wnich the
solvent was again removed by evaporation under a stream of nitrogen.
2.5 Solvolvsis of the remaining steroid sulphates
Some of the steroid sulphates present in urine collected from
newborn infants^ and in plasma obtained from the umbilical cord, are not
hydrolysed by the enzymes obtained from Helix pomatia; instead they have
to be hydrolysed by solvolysis. The method described by Burstein and
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Liebermaun (1958) was adopted; this uses organic solvents such as
ethyl acetate. The details of the technique are as follows:-
The urine (after enzyme hydrolysis and extraction) was saturated
with ammonium sulphate, and the pH adjusted to pH 1 by addition of
sulphuric acid (50%, v/v). Following these steps, the urine was
extracted with an equal volume of ethyl acetate, and the ethyl acetate
extract was incubated at 38° for 24 hours. This extract was then
washed repeatedly with N sodium hydroxide (one-tenth the volume of the
ethyl acetate) until the washings were alkaline, and finally the extract
vas washed with water.
This method gave poor recoveries of those steroid sulphates which
were also susceptible to hydrolysis by enzymatic methods. It is likely,
therefore, that the results obtained for the concentration in urine and
in plasma of steroid conjugates resistant to hydrolysis by sulphatase
are unduly low.
The steroid extracts obtained after hydrolysis by enzymes and
after solvolysis can either be combined or be kept separate for
subsequent chromatographic separations and quantitative examination.
3. Thin-layer chromatography
All chromatographic separations for the quantitative method have
been carried out using 0.25 mm. thickness of silica gel 1IF 254 spread on
20 cm. by 20 cm. plates. No activation of plates was necessary prior to
use, but they were allowed to dry for 24 hours after preparation. The
plates were developed at room temperature in tanks lined with a double
layer of chromatography paper. After the addition of solvent, tanks
were allowed to equilibrate for one hour before use. Fresh solvent
Fig. 10. "Running Up" of Thin-Layer Chromatograms
After the application of the spots, the plate is dipped into ethyl-
acetate :methanol (3:1, v/v) contained in a trough. When the solvent has
reached a level just above the spots, the plate is removed and dried. The
dipping and drying are repeated twice more; in this way the steroids are
concentrated into narrow bands, which helps in the subsequent chromatographic
separations.
Q Q © © © Q
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systems were repared daily for chromatography.
3.1 Application of material to thin-layer plates
Extracts and standards were applied in ethanolic solution, using
a series of micropipettes delivering between 5 pi. and 100 pi. The spots
were dried in a stream of cold air delivered from a domestic hair-dryer.
Care was taken to keep the spots to the same size, since the final response
given by the densitometer depended on the size of the spot as well as upon
its optical density. It was not difficult to keep the spots of equal size,
but when spots were produced that were too large they were reduced in size
by "running in" with ethanol before development. To "run in" a large spot,
drops of ethanol from a micropipette are placed around the spot; ethanol
carried the extract more into the centre of the area. Using a polar
solvent (ethyl acetateimethanol, 3:1) the round spots produced were "run
up" to form narrow bands at a new origin. This concentrating technique
considerably enhances separation and is illustrated in diagrammatic form
in Fig. 10.
Normally, up to six extracts were applied in duplicate to each
plate, spaced between four spots containing standard steroids in varying
amounts. For most of the determinations carried out during this study,
several compounds were present in each of the standard spots. Ideally,
each run of standards should contain as many as possible of the steroids
to be assayed but, in order to conserve valuable reference compounds, an
alternative method was occasionally used. For three of the positions
allocated to standards on the chromatograms, a single steroid was applied,
and the remaining steroids were present only in the fourth spot. Using
this method, the linearity of the standard curve was established for one
TABLE4.
Majoret bolitese sur dU nghQuantitativeMethod (Compoundslistenorderfinc a ingpola ity)
l
Urinefrom infants DHA CompoundU1 21-OH-pregnenolone Androstenediol 16-oxo-androstenediol 16a-0H-DHA CompoundU_ (160-OH-DHA) 16a-OH-pregnenolone Androstenetrioj. [Pregnanetriol]**





Pregnenolone DHA 17a-OH-pregnenolone 21-OH-pregnenolone Androstenediol*
Reducingcompou ds 3a,17a,21-trihydroxy-5p- pregnan-20-one (TetrahydrosubstanceS) Cortisol Tetrahydrocortisone Allotetrahydrocortisol
DHAAndrosterone AndrostenediolDHA I6a-0H-DHAAetiocholanolone Pregnenetriol11-oxo-androster ne Pregnanetriol**11-oxo-aetiocholanoloneTetrahydroc rtisol
16-oxc-androsteuedio''Andr sceuetriolll-OH-andr ste one 16a-OH-DHAll-OH-aetiocholanolone CompoundU„ (16(3-OH-DM) 16a-OH-pregnenolone Androstenetriol
*Thisisextractedonlyaft rsolvolysisicanbde ermi edseparately.
**Althoughnota3p-0H-Aŝteroidthiscompoundabde mi edu inghe antimonytrichloridereactio ,
[]Onlyquantitativelyimpor antad enaldis ders.
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compound, and the standard curves for the others were drawn in using
relative values for the intensity of the colours which these other
compounds developed, as revealed by their behaviour following the
separation of the mixed standards.
3.2 Separation and detection of steroids by thin-layer chromatography
This section describes reactions used for detecting the 17-
oxosterbids, the Cortisol metabolites and the 3p-0H-A"^ steroids, and the
solvent systems that were developed for their separation. The compounds
listed in Table 4 include many of the major metabolites present in the
biological fluids studied, and solvent systems were chosen which would
separate as many compounds as possible on a single thin-layer plate.
The individual systems used are listed in Table 5, but all separations
were achieved using more than one development, and often more than one
solvent system. Multiple running with solvent systems giving low Rf
values gave better separations than the more normally used procedure,
which attempts to produce a separation in a single stage. At each stage
of chromatographic development, there is a concentrating effect since the
lower part of the band moves while the upper edge is stationary (Dohmann,
1965).
As the method relies for quantitative assessment upon the direct
densitometric scanning of stained spots, investigations of specificity
were most important. Each coloured area which develops after spraying a
plate should contain a single compound responsible for the colour reaction.
For this reason, after describing the systems used for separation, there
is a paragraph on the evaluation of specificity.
TABLE 5
Thig Layer Chromatoaraphy Systems
Solvent Relative Proportions
Adsorbent: Silica Gel
A Benzene ; ethanol 99 : 1
B Benzene : ethanol 96 : 4
C Benzene : ethanol 95 : 5
D Benzene : ethanol 80 : 20
E CHC1~ :
j
ethanol 99 : 1
F CHC13 : ethanol 95 : 5
G CHC13 : ethanol 90 : 10
H Cyciohexane : ethyl acetate 50 : 50
I Cyclohexane : ethyl acetate : ethanol 45 : 45
J Ethyl acetate : water saturated n-hexane : 72 : 13
glacial acetic acid : ethanol
K Benzene : acetone : ethanol : water 30 : 30
.5 : 10 : 4.5
Adsorbent: Alumina
L Dichlorometliane : ether 80 : 20
TABLE6
Coloursproducedbytheantimonytrichlori ereactiw thvar us steroidsonsilica-gelth n-layerchr matograras 3p-Hydroxy-Asteroids
Androstenes■ 3{3-Hydroxyandro8t-5:16-dien 3p-Hydroxyandrost-5-en-17-one 3{3-Hydroxyandro8t-5,15-dien-17-one 3p-Hydroxyandrost-5-en-ll:17-dione 3p,16a-Dihydroxyandrost-5-en-17-one 3p,l6p-Dihydroxyandrost-5-en-17-one 3P,17p-Dihydroxyandrost-5-en-11-one 3p,17p-Dlhydroxyandro8t-5-en-l6-one 3p,13a,17p-Trihydroxyandrost-5-en 3p,16a,17a-Trihydroxyandro8t-5-en 3p,16a,17p-Trihydroxyandrost-5-en 3p,16p,17p-Trihydroxyandrost-5-en 3p,17a-Dihydroxyandrost-5-en 3P,17p-Dihydroxyandro8t-5-en la,3p-Dihydroxynndrost-5-en-17-one 3p,1lp-Dihydroxyandrost-5-en-17-one 3p,14a-Dihydroxyandrost-5-en-17-one 3P,lip,17p-Trihydroxyandrost-5-en. 3p,15P,17p-Trihydroxyandrost-5-en. 3P,7a-Dihydroxyandrost-5-en-17-one 3P,7p-Dihydroxyandrost-5-en-17-one 3P-IIydroxyandrost-5-en-7,17-dione.
.red .red .red .red .red .red .red .red .red .red .red .red .paleblue-grey .paleblue-grey .darkblue-grey .darkblue-grey .darkblue-grey .darkblue-grey .darkblue-grey .turquoise* .turquoise* .nocol ur
Othersteroids
3-Oxo-Asteroids Androat-4-en-3,17-dioneocol ur Andro8t-4-en-3,ll,17-trioneocol ur 17P-Hydroxyandrost-4-en-3-onec lour 17a-Hydroxyandrost-4-en-3-oneblue Pregn-4-en-3,20-dionecol ur l6a-Hydroxypregn-4-en-3,20-dioneocol ur 17a-Hydroxypregn-4~en-3,20-dionecolour 21-Hydroxypregn-4-en-3,20-dionecolour 16a,21-Dihydroxypregn-4-en-3,20-dione..ocol ur 21-Hydroxypregn-4-en-3,11,20-trione.........nocol ur lip,21-Dihydroxypregn-4-en-3,20-dionenoc l ur 17a,21-Dihydroxypregn-4-en-3,20-dionenoc l ur l7a,21-Dihydroxy-pregn-4~en-3,ll,20-trione..noc l ur 1IP,17a,21-Trihydroxypregn-4-en-3,20-dione...ncolour 6p,lip,17a,21-Tetrahydroxypregn-4-en-3,20-dione....no Androst-1,4,dien-3,17-dioneocolour 17p-Hydroxy-,4,dien-3-oneyellow
colour
Pregneneg 33-llydroxypregn-5-cn-20-onered 3p-Hydroxypregn-5,16-dien-20-onered 3p,l6a-Dihydroxypregn-5-en-20-oner d 3P,17a-Dihydroxypregn-5-en-20-oner d 3p,20p-Dihydroxypregn-5-en..ed 3P,21-Dihydroxypregn-5-en-20-oner d 3p,17a-Dihydroxypregn-5-en1,20di n.e{j 3P,17a,21-Trihydroxypregn-5-en-20-one..d 3P,20p,21-Trihydroxypregn-5-ened 3p,20a-Dihydroxypregn-5-enblue-grey 3p,17a,20a-Trihydroxypregn-5-enblue- rey 3p,17a,20p-Trihydroxypregn-5-enblue- rey 3p,17a,20a,21-Tetrahydroxypregn-5-en...bluc-gr y Cholestenes Cholesterolviolet 7a-Hydroxycholester lturquois * 7p~Hydroxycholesterolturquoi e* Saturatedsteroids 3a,17a,21-Trihydroxy-5P-pregnan-20-onenocol ur 3a,17a,21-Trihydroxy-5P-pregnan-ll-20-dione.nocol ur 3a,17a,21-Trihydroxy-5a-•regn n-ll-20-dione.noc l ur 3a,lip,17a,21-Tetrahydroxy-5P-pregnan-20-one.noc l ur 3a,lip,17a,2l-Tetrahydroxy-5a-pregnan-20-one.noc l ur 3a-Hydroxy-5p-androstan-17-onenocol ur 3a-Hydroxy-5P-androstan-ll,17-dioneoc l ur 3a,1lp-Dihydroxy-5P-androstan-17-onencol ur 3a-Hydroxy-5a-androstan-17-oneocol ur 3a-llydroxy-5a-androstan-ll,17-dio e..."ncolour 3a,lip-Dihydroxy-5a-andro8tan-17-onencol ur 3p-Hydroxy-5a-andro8tanyellow 3p,17p-Dihydroxy-5a-androstanellow 3a,17p-Dihydroxy-5p-androstanellow 3p-Hydroxy-5a-pregnan-20-oneellow 3P,16a-Dihydroxy-5a-pregnan-20-oneellow 3a,20a-Dihydroxy-5p-pregnanyellow 3a,l7a,20a-Trihydroxy-5p-pregnanyellow 3a,17a,20a-Trihydroxy-5p-pregnan-l1-oneyellow 3a,6u-Dihydroxy-5P-pregnan-20-oneorange
Hiseellaneous Androst-5-en-3,11,17t io enoc l ur 3P-Hydroxycholest-4-enred* 3p-Hydroxycholest-l-enred* Cholest-5-en-3-onenocol ur
Chromatogramswe edevel pedith10Ji .fs oidinachc se *Immediatecolourproduc dwithoutheating.
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(i) Separation and detection of 3P-0H-AJ steroids
Detecting reagent
Two spray reagents have been used recently for the determination of
3P-0H-A"* steroids on thin-layer plates. Eberlein developed a reagent for
the determination of steroids in plasma obtained from the umbilica blood
vessels (Eberlein, 1965a, 1965b). The composition of this reagent was
36 ml. acetic acid containing 100 mg. picric acid, and 6 ml. 70% (v/v)
5
perchloric acid. 3p-0H-A steroids gave red spots with this reagent but
4
no colour developed with 3-oxo-A steroids or with saturated compounds,
2
even at a concentration of 100-250 /ig/cm . The other reagent which has
been used is a saturated solution of antimony trie iloride in chloroform.
5
Although this latter reagent is relatively specific for 3P-0H-A steroids
when the chromatogram is viewed in daylight (Neher, 1964; Lisboa, 1965),
all types of steroid give a fluorescent reaction when the sprayed
chromatogram is viewed under ultra-violet light of wavelength 365 m/JL
(Neher, 1964). The reagent has also been used in a thin-layer densitometric
method for measuring cholesteryl esters (Zollner, 1962).
The antimony trichloride has the advantage of being a "dry
reaction". The chloroform evaporates soon after it is sprayed on to the
plate and less background colour develops and less diffusion of spots
occurs than with Eberlein's reagent.
An extensive investigation was carried out to determine the
specificity of the antimony trichloride reagent since it was required in
the method being developed to measure 3P-0H-A"* steroids in the presence of
4
3a-hydroxy steroids and 3-oxo-A steroids. The colours given by 10 fJg. of
a variety of steroids are shown in Table 6. All the 3p-0H-A^ steroids
Fig. 11
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In order to ensure that the thin-layer chromatography plates are
evenly covered with detecting reagent, a definite "pattern" of spraying
is followed. Normally the plates are sprayed for a total of 30 seconds.
- 43 -
determined gave a strong colour except when a 7-oxo group was present.
Most gave a red to blue colour after heating for five min. at 100°, but
those containing a 7-hydroxy group gave an immediate turquoise reaction
at room temperature. The only other compounds which gave a similar
5 4
colour to the 3(3-OH-A steroids were 3(3-OH-A steroids but these could be
distinguished since they gave an immediate colour without heating.
Pregnanediol and pregnanetriol gave yellow spots, a reaction which can be
used for the specific assay of these compounds.
Particular care must be taken to ensure that plates are evenly
covered with the reagent, as uneven spraying leads to great inaccuracies
when the method is used quantitatively. The plates were therefore
sprayed in a definite pattern (Fig. 11) for 30 seconds.
5
The separation of the 30-OH-A steroids present in urine chlrnined
from newborn infants
The Rf values of many reference 3p-0H-A^ steroids for single runs
in the most important thin-layer systems are given in Table 20 (Appendix).
Usually the separation of steroids present in urine and plasma required
more than one development in a thin-layer system. If a thin-layer plate
has been developed three times in system C, for example, then the system
used is often reported as system C (x 3).
The separation of the quantitatively important 3P-0H-A"* steroids
present in urine collected from infants (Table 4) can be achieved by
running a plate three times in system E (to separate compound from
21-OH-pregnenolone), and three times in system B (to separate 16-oxo-
androstenediol from 16<x-0H-DHA). This separation is illustrated in
Fig. 12. It was occasionally necessary to vary slightly the percentage
of ethanol in each of these systems when using different batches of silica
Fig. 12. The Separation of Medium Polarity 33-OH-A"* Steroids Present in
Urine Collected from Infants
Solvent system - E (x3), B (x3).
Detecting reagent - Antimony trichloride
This figure illustrates the assay of steroids in the urine of a single
infant during the first six days of life. This infant showed a relatively low
excretion of the major steroids on the first two days of life. The absence of
DHA from the urine of newborn infants is also apparent from this figure.
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Steroids illustrated: Pregnenolone (1); DHA (2); Unknown 1 (3);
21-0H-pregnenolone (4)j androstenediol (5);






gel. The 16-oxygenated compounds were often present in much greater
concentration in urine than 21-OH-pregnenolone and compound , and it
was not always possible to determine all these steroids on the same
chromatogram. In these cases it was necessary t< repeat the chromatographic
separation using a larger amount of extract.
Towards the end of this study, two plates were almost invariably
used for determining the urinary 3p-0H-A"/ steroids that had medium
polarity. One plate was used for the assay of compound and 21-OH-
pregnenolone, and was developed twice in system F. The other plate was
used for separating the 16-oxygenated 3p-0H-AJ steroids, and was run
three times in system C.
Since androstenetriol is much more polar than the other compounds
to be measured, when adequate distribution of the main group was obtained
it moved only a short distance from the origin and was often poorly
separated from neighbouring substances. For this reason another
chromatogram was normally prepared and run twice in the more polar
system G (Fig. 13). In patients with congenital adrenal hyperplasia,
pregnanetriol is of diagnostic importance and can also be measured using
this system (Fig. 32).
17a Androstenediol and pregnenetriol are both present in the
solvolysis extract; these compounds are separated by almost all systems,
and two developments in system H were found to give a satisfactory
separation.
Specificity and identification:
Extracts of urine were run first in orie direction with the systems
normally used for quantitation, and a second development was then carried
Fig. 13. The Separation of Polar 33-OH-A"* Steroids Present in Urine
Collected from Infants
Solvent system - G (x2)
Detecting reagent - Antimony trichloride
This figure illustrates the assay of androstenetriol in the urine
of a single infant during the first six days of life. The presence of
several 3P-0H-A steroids of unknown structure in the urine of infants is
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out at right angles to the first, using solvent systems C, F, H and J.
In no case could an interfering chromogen be separated from a spot
normally assayed. In addition, another form of two-dimensional
chromatography was carried out, but in this case the steroids were
acetylated jLn situ after completing the run in the first direction.
Acetylation was achieved by spraying the edge of the plate containing
the separated extract with acetic anhydride:pyridine (1:1 v/v). After
standing for two hours, the plates were "run up" at right angles to the
line of the first development, thereby forming a new origin for a second
chromatographic run, which was then carried out using system A. For the
compounds normally assayed, no other spots staining with antimony
trichloride could be separated.
Using an extract prepared from urine collected from several infants,
50 to 100 Hg of DHA*, androstenediol, 16-oxo-androstenediol, 16a-0H-DHA,
16a-OH-pregnenolone and androstenetriol were isolated by the following
method:-
The extract was streaked along the origin of a thin-layer plate, and
this was developed in the chromatographic system used for quantitative
assay of steroids present in urine samples collected from infants. The
plate was "masked" using a clean glass plate, except for one edge which was
sprayed with the antimony trichloride reagent. The colours were allowed to
develop at room temperature, to protect the steroids on the rest of the
plate from possible destruction by heat. The reaction was much slower at
* DHA was only identified in urine samples collected from infants treated
with human chorionic gonadotrophin during the first few days of life.





MASKED PART SPRAYED PART
The steroid extract is applied as a band across the chromatogram.
After development most of the layer is masked with a glass plate. The edge
of the separated band is left unmasked and this part is sprayed with detecting
reagent in order to display the position of the required compounds. The plate
is then viewed under ultra-violet light (254 m/i) as it can usually be seen
from the position of the absorbing bands whether the band has run regularly
along its length. Allowing for any irregularity, the required zone is scraped
off the plate and is eluted with solvent.
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room temperature and it normally required about 15 minutes for the
colour to become reasonably intense.
Although the positions of each compound on the preparative plate
could be determined by spraying the edge of the band with antimony
trichloride reagent, it could not be assumed that the compounds had each
run evenly right across the chromatogram. Bands of material do not usually
run regularly, and it was important to determine the degree of
irregularity before the band containing the desired steroid was removed
from the plate. Detection was achieved by viewing the chromatogram under
ultra-violet light of wavelength 254 m/1., when compounds capable of
absorbing ultra-violet light and present in the urinary extract gave a
clear indication of the extent of irregularity in the running of the
chroraatogram. The bands could then be scraped off the plate by following
\
lines parallel to the ultra-violet absorbing bands. Figure 14 illustrates
this technique in diagrammatic form.
For eluting the steroids, silica gel was placed in 15 ml.
centrifuge tubes, a drop of water was added and the steroids were eluted
with ether. The "whirlimixer" was used for agitation; this instrument
mixes by producing a vortex in the tubes. The tubes were centrifuged,
the solvent decanted, and the elution with ether was repeated twice more.
The compounds obtained in this way were identified by combined gas
chromatography-mass spectrometry. The details of the methods used in this
identification are given in Part 3 (p. 85 ), in the section which describes
the identification of urinary steroids.
Gas chroraatographic-mass spectrometric analysis of the steroid
trimethylsilyl ethers indicated that the major peaks had the same
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retention times as the reference compounds, and gave identical mass-
spectra. There were no significant peaks on the GLC record apart from
the compounds which had been identified. Since the compounds analysed
xjere originally separated by preparative methods using the same thin
layer chromatographic systems as had been developed for quantitative
determinations of the steroids, this in itself provided a good test of
specificity as well as a means of identification. Figure 37, for
example, illustrates the gas chromatographic record of I60&-OH-DHA.
prepared from urinary extracts. The only other large peak present
corresponds to 16-oxo-androstenediol, a contaminant to be expected
because of the nature of the thin-layer system used for the separation
(Fig. 12).
21-0H-Pregnenolone x*as identified by means of infra-red
spectroscopy in urine samples collected from infants. For compounds to
be analysed by infra-red spectroscopy, they must be obtained in a
completely pure state; for this reason 21-OH-pregnenolone was obtained
from the steroid disulphate fraction after separating the urinary
conjugates on Sephadex LH 20. By this means, most of the other steroids
were removed before hydrolysis, and it was then easier to remove the
remaining unwanted steroids by TLC. Systems C (x3), F (x2) and H (x2)
were used for the preparative separation. The compound was eluted with
ether from the first two plates in the same manner as for other steroids
but, after the final preparative chromatography, Analar acetone (2 x 5 ml.)
was used for eluting 21-OH-pregnenolone from the silicd gel. This solvent
proved suitable for infra-red spectroscopy without distillation. The
acetone extract was dried and 21-OH-pregnenolone was transferred to an
Fig. 15. Infra-Red Spectra of Authentic 21-OH-Pregnenolone and of the




internal-reflectance plate (p. 92) with about 200 /Jl. of acetone. The
infra-red spectrum produced was essentially identical with the spectrum
of a standard specimen of 21-0H-pregnenolone (Fig. 15).
The separation of the 33-OH-A^ steroids present in plasma samples obtained
from the umbilical blood vessels
Steroids present in plasma samples collected from the umbilical
blood vessels cannot be separated by the same thin-layer system as the one
used for the separation of steroids in urine samples collected from infants.
This is because 17a-0H-pregnenolone and pregnenediol are present in plasma
obtained from the umbilical artery and vein, but were not detected in the
urine samples. 17a-0H-Pregnenolone is only separated from 21-OH-pregnenolone
in system H, and the most satisfactory separation of the steroids present in
plasma samples has been obtained by developing the chromatograras once in
system C, followed by two runs in system H (Fig. 16).
Androstenediol and pregnenetriol, present in the extract obtained
after solvolysis, were separated by two runs in system H.
Specificity and identification
The extracted compounds gave the same colour reactions and had the
same Rf values as standard steroids in several different solvent systems.
After two-dimensional chromatography (first direction system G, second
direction, systems C, E, H and finally J), it was not possible to detect other
33-OH-A^ steroids - these would have interfered with the quantitative
determinations.
The separation of 33-OH-A^ steroids present in urine samples collected
from adults
Urine samples collected from adults contain less 3P-0H-A"* steroid
*ig. 16. ,Sqp«ffltJLqa 3(3-011-4 Steroi<jf Plasma Obtained frees
the Ifabillcal Vein
Solvent system - C, H (x2)
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Fig. 17. The Assay of 3P-0H-A Steroids Present in Urine from Adults
Solvent system - H, F (x2)
Detecting reagent - Antimony trichloride
This figure illustrates the separation of urinary 3(3-OH«^A5 steroids.



















S ~ standard steroids
- 49 -
than urine samples collected from newborn, infants. Pregnenetriol is
quantitatively important, and is present in the extract containing steroids
liberated by the enzymes present in the Helix pomatia preparation. In
urine samples obtained from infants, the conjugate of pregnenetriol is
only hydrolysed by solvolysis. For adults, therefore, the problems of
separation are different but less complex, and a procedure utilising a
single chromatographic separation has been chosen.
The plates are run once in system H, then twice in system F, and
it can be seen from Fig. 17 that androstenediol and pregnanetriol have
moved sufficiently far from the origin to be separated and measured.
16oc-OH-DHA and 16-oxo-androstenediol are not separated, but there is in
fact little (if any) 16-oxo-androstenediol in urine samples obtained from
adults.
Specificity and identification
The specificity of the separation of 3J3-OH-A"* steroids was
determined for adults in the same way as with steroids obtained from infants,
using two-dimensional chromatography with and without acetylation. The
steroids were identified by their ability to develop specific colours with
antimony trichloride, and by comparing their Rf values with those of
standards in the thin-layer systems C, D, 6, H, I and J.
(ii) Separation and detection of reducing compounds
Detecting reagent
The blue tetrazolium reaction was used for detecting all compounds
with an a-ketol group, i.e. steroids containing a hydroxyl and a ketone
group on adjacent carbon atoms (the hydroxyl group is in the "a" position
with respect to the carbonyl group). The major compounds of this type in
Fig. 18. The 31ue Tetrazolium Reaction.
and steroids containing an a-ketol group develop blue colours
with blue tetrazolium. The four steroids illustrated all give the blue tetra¬








* An a-ketol group consists'of a hydroxyl group attached to the carbon.atom
adjacent (a) to a carbonyl group.
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urine samples collected from adults are the 20,21 ketols, tetrahydro-
cortisone, tetrahydrocortisol and allotetrahydrocortisol. In urine
obtained from newborn infants the 16,17 ketols, 16a-0H-DHA, 16p-0H-DHA
and 16-oxo-androstenediol are quantitatively more important (Fig. 18).
The blue tetrazollum reagent was made up just before use from
the following constituents: 17. (w/v) blue tetrazolium in ethanol (2 parts);
3.5 N potassium hydroxide in ethanol (5 parts); and water (3 parts).
This reagent contains less water than the similar reagent used for
staining paper chromatograms (Birchall jet al., 1963), since it was found
that excessive amounts of water caused the spots to diffuse and the silica
gel layer to break up. The plates were sprayed until uniformly soaked,
and colour development took place while the plates were being dried by a
draught of hot air from a domestic hair-dryer. Good colour reactions
have also been obtained by heating the plates at 50° prior to spraying.
In this method the spots show up immediately after spraying, and it is
not necessary to heat with a hair-dryer. Both these methods give a light
background, and in this respect are superior to the heating of plates in
an oven after spraying.
The intensity of colour developed by different steroids varied
considerably from plate to plate and it was necessary, therefore, to have
standards present for every compound to be measured. This was particularly
noticeable with the three a-ketolic androstenes, 16-oxo-androstenediol,
16ct-0H-DHA and 16|3-OH-DHA. 16a-0H-DHA initially gave a very weak reaction
compared to the other two compounds, but if left for several hours the
intensity of its colour increased.
Cortisol was present in urine samples collected from those infants
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that had been treated with adrenocorticotropic hormone (ACTH). When
the thin-layer plates used for the quantitative measurements were viewed
under an ultra-violet lamp, Cortisol showed up as a dark area due to the
presence of an additive in the silica gel which fluoresces at 254 m/i. In
urine collected from these infants, Cortisol was assayed by comparing
visually the absorbance given by the Cortisol spot in the urinary extract
with the absorbance of varying amounts of Cortisol that had been applied
to the thin-layer plate as reference compound.
Thin-layer system
Tetrahydrocortisone, tetrahydrocortisol and allotetrahydrocortisol
were separated by two runs in system G (Fig. 19); this also separates these
*
compounds from tetrahydrodehydrocorticosterone, tetrahydrocorticosterone
aid 3a, 17a,21-trihydroxy-5(3-pregnan-20-one (tetrahydro substance S).
These latter steroids are sometimes present as a result of malfunctioning
of the adrenal glands.
In system G (x 2) separation of the polar steroids that react with
blue tetrazolium and which can be extracted from urine collected from
infants demonstrated that the tetrahydro metabolites of Cortisol were
quantitatively of minor importance (Fig. 19), and these steroids could not
be measured quantitatively. It was possible, however, to estimate
steroids of polarity similar to tetrahydrocortisol and allotetrahydro¬
cortisol in urine samples obtained from infants treated with adrenocortico-
trophin.
Specificity and identification;
The Rf values of tetrahydrocortisone, tetrahydrocortisol and allo¬
tetrahydrocortisol obtained from urine were the same as the corresponding
.^/VIG^
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standards in solvent systems D, I and J, and no other blue tetrazolium
staining compounds could be separated from them when two-dimensional
chromatography was carried out on urinary extracts.
Cortisol was prepared from the urine of infants treated with
adrenocorticotropic, and was identified by infra-red spectroscopy. Two
plates were used for purification; the Cortisol was first separated as
a band in system G (x 2); after elution, it was further purified by two-
dimensional chromatography in systems J and I (x 2). The purification
4
of 3-oxo-A steroids is simple, since the band, or spot, to be eluted
can be detected under ultra-violet light of wavelength 254 m/i, if silica
gel containing a fluorescent additive is used.
(iii) The separation and detection of 17-oxosteroids
Detecting reagent
The 17-oxosteroids were detected using the Zimmermann reaction,
xtfhich gives blue to violet colours with unsubstituted methylene groups
adjacent to a carbon atom containing a ketone group. This reaction was
used to detect steroids present in urine excreted by adults,where the
amount of steroids containing carbonyl groups at the 3 and 20 positions
of the steroid molecule is relatively small compared to the 17-oxosteroids.
In urine collected from infants, however, there are too many Zimmermann
chromogens present, apart from the 17-oxosteroids, for the reaction to
be useful for the quantitative estimation of steroids by densitometry of
the thin-layer chromatograms.
The reagent consisted of 27, (w/v) metadinitrobenzene in ethanol
(2 parts), and 3.5 N potassium hydroxide in ethanol (1 part). It was made
up before use from solutions kept in a deep-freeze. The plates were
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sprayed by the method described previously for the blue tetrazolium
reaction (p. 50).
The seven principal 17-oxosteroids gave violet spots; the
intensity of colour developed by the ll-oxo-17-oxosteroids was about
twice as great as the colour developed by the ll-deoxy-17-oxosteroids and
the ll-hydroxy-17-oxosteroids.
Thin-layer system
The principal 17-oxosteroids present in urine excreted by adults
(Table 4) were separated by running the chromatogram three times in
system C; the results are illustrated in Fig. 20. There are only very
small amounts of the classics? 17-oxosteroids present in urine samples
collected from newborn infants; when these are measured by the Zimmermann
reaction, the 17-oxosteroids are often interfered with by other compounds
giving an unspecific reaction. Measurement of 17-oxosteroids is of value,
however, when infants are suspected of having congenital adrenal hyper-
plasia, as this disorder is frequently associated with an abnormally high
excretion of these compounds.
Specificity and identification
Two dimensional chromatograms, with.and without acetylation after
development in the first direction, were prepared in the manner described
for the 3(3-OH-A^ steroids. The spot which was identified as DHA was shown
to contain a second chromogen when subjected to chromatography in
system H (x 2); the colour formed by the contaminant indicated that it
was present at one-tenth of the concentration of DHA. This substance
was shown to have the same Rf values as epiandrosterone (3p-hydroxy-5oc-
androstan-17-one) when compared with standards in three solvent systems.
Fig. 21. Densitometer Tracing of the 3P-0H-A"J Steroids Present in Urine
Collected from Infants after Separation by Thin-Layer Chromatography
Following separation by thin-layer chromatography, steroids present in
urine collected from infants are detected by the antimony trichloride reaction
and assayed by reflectance densitometry. This figure illustrates the tracing
5
drawn by the densitometer recorder of the medium polarity 3P-0H-A steroids;
the separation is illustrated in Fig. 12. This figure also illustrates the
method of delineating overlapping peaks and drawing the baseline.
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The 11-oxygenated metabolites also showed the presence of small amounts of
impurities (probably due to epimers) when the chroma'cograms were developed
further by running agai at right angles in system Hj quantitatively these
impurities also amounted to about one-tenth of the major constituents in their
spots, and these ar unts were not considered to be sufficient to affect the
value of the method oer . sly.
3.3 Quantitation
Following development of the c< ur reaction the steroids were determined
by scanning the thin-layer plates by reflectance densitometry. A "C romoscan"
was used for this purpose. The light earn was produced by a slit of dimensions
1x7 mm. and green filters were used f.ir all colour reactions (wavele gth
490 mjLt for the antimony trichloride reaction, 520^iox the Zimmermann reaction
and 550 m/I for the blue tetrazolium reaction). A recording made by tae
densitometer of steroids in urine obtained from infants is illustrated in
Fig. 21. Tne steroids were determined jy comparing peak areas produced
(measured by planimeter) to peak areas given by known amounts of standard
compounds. Although the Chromoscan i irument possessed an integrator, this
could not be used since the background colouration was not constant, resulting
in an uneven baseline. For this reason the baseline was drawn by hand and
overlapping peaks were delineated by dropping perpendicular lines to this
baseline (Fig. 21). After measuring the areas of peaks produced by reference
compounds (Fig. 22), standard curves were drawn (Fig. 23), from which the
concentration of steroids in the biological sample could be determined.
4. Sunroary of routine method
Since the description of the method in the previous sections has
included results of a considerable amount of preliminary work, this section
will describe briefly the routine method that was in use in the later stages
of this study.
Fig. 22. Densitometer Tracing of Standard Steroids
Legend:
Normally four spots are applied to each plate of
standards, each spot containing several steroids. These standard
spots, as a rule, contain the same steroids but in increasing
amount. After separation and spraying with reagent for their
detection, the coloured spots are measured quantitatively using
a densitometer. This figure shows densitometer tracings of the
four standard spots used for the assay of steroids in plasma
obtained from the umbilical blood vessels. The quantity of each
reference compound in each standard spot is given. A planimeter
is used to determine the areas under the peaks and standard curves
are then plotted for each compound. Figure 23 illustrates the
standard curves obtained for these steroids.



















— A — 16a-OH-DHA
—-V— Pregnenolone
—13— 16a-OH-Pregnenolone
A standard curve is drawn for each of the reference compounds determined
by densitometric scanning (Fig. 22). The concentration of steroid in extracts
of urine and plasma can then be measured by relating the areas of the peaks
produced to the areas given by standard steroids.
Fig. 24. Flow-Sheet of Method Used for Extraction of Steroids from Plasma
Plasma Sample (normally 5 ml.)
H Pregnenolone sulphate (0.05 jtlc) added for
evaluation of recovery of.steroids
Proteins precipitated with 20ml. acetone:ethanol
(1:1, v/v).
Precipitate extracted with a further 20 ml.
acetone:ethanol (1:1, v/v)
Extract dried, dissolved in chloroform:methanol (1:1)






This fraction contains steroid
monosulphates and disulphates
Enzymatic hydrolysis









4.1 Preliminary treatment and hydrolysis
Urine:
Normally 1/16 of a 24 hour collection of urine from infants and
1/60 of a 24 hour collection from adults was used for analysis.
The urine was treated as follows
3
1. H Pregnenolone sulphate (0.05 /He) was added to the urine to monitor
the recovery of steroid sulphates through the whole procedure.
2. The urine was brought to pH 11.5 with 4 N sodium hydroxide. At this
pH saccharo-1:4~lactone is precipitated (this compound inhibits 0-
glucuronidase activity).
3. Barium chloride (10%, w/v) was added until no more barium sulphate
was precipitated. (Sulphate ions inhibit suipuatase activity and must be
removed before e zymatic hydrolysis).
4. The urine sample was adjusted to ph 4.5 by adding 5 N acetate buffer
(5 N acetic acid:5 N sodium acetate, 23, v/v). The volume of this buffer
that was added was equivalent to one-tenth the volume of tae urine.
5. 0.1 ml. of the succus entericus of helix pomatia was added per 20 ml.
urine. The urine was then incubated at 37-38° for 48 hours, a further
0.1.ml. of the enzyme preparation being added after 24 hours.
Plasma:
A summary of the method used for the extraction of steroids from
plasma is illustrated in Fig. 24. Duplicate assays were normally carried
out on arterial and venous plasma. Five ml. of plasma was generally used
for each analysis.
The plasma samples were treated as follows
3
1. H Pregnenolone sulphate (0.05 /ic) was added to 5 ml. plasma.
2. The plasma proteins were precipitated with 20 ml. acetone:ethanol
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(1:1, v/v) and were then removed by centrifugation. The precipitate was
washed by suspending in a further 20 ml. acetone:ethanol and the centrifugation
repeated. The acetone:et a k>1 extracts were combined and dried on a rotary
evaporator. The protein precipitate was discarded.
3. The dried extract was applied to the Sephadex column (17 g. Sephadex
LH 20 in columns 2 cm. in diameter) with 2 x 5 ml. methanol:chloroform, 1:1
(saturated with sodium chloride). The flask was washed with a further 90 ml.
of the eluting solve it; tnis was then put in the column reservoir.
4. The first 100 ml. of solvent which passed through the column were collected
and dried; this fraction contained free steroids, cholesterol and fat.
5. Monosulphates and disulphates were washed off the column with 300 ml.
methanol. No attempt was made to separate the monosulphates from the disulphates.
The eluate was dried.
6. The dried extract, containing the steroid monosulphates and disulphates, was
dissolved in 10 ml. 0.5 N acetate buffer (0.5 N acetic acid: 0.5 N sodium
acetate, 2:3). Incubation was then carried out for 48 hours at 37-38°, with
0.05.ml. of the Helix pomatia enzyme preparation. A further 0.05 ml. of the
Helix pomatia enzyme preparation was added after 24 hours.
4.2 Extraction Procedure
Urine and plasma
1. After enzymatic hydrolysis, the steroids were extracted twice with two
volumes of ether:ethyl acetate (2:1, v/v).
2. The solvent extract was washed repeatedly with N sodium hydroxide (an
amount equivalent to one-tenth the voliane of the extract), until the washings
were colourless.
3. Further washings were carried out once with water containing a few drops
of acetic acid, and once with water alone.
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4. The extract was dried on a rotary evaporator at 45°.
5. The dried extract was transferred with chloroform to a small tube,
and the chloroform was removed under a stream of nitrogen. This extract
contained the steroids which were released by enzymatic hydrolysis.
6. Sulphuric acid (50%, v/v) was added to the aqueous phase (from stage 1)
to bring it to pH 1. The aqueous phase was then saturated with ammonium
sulphate.
7. The steroid sulphates remaining in the aqueous phase were extracted
into an equal volume of ethyl acetate. One half of the ethyl acetate
extract was incubated for 24 hours at 38°, the other half was discarded
with the urine.
8. Stages 2-5 were repeated. The extract obtained contained the steroids
released from conjugation by solvolysis.
4.3 Use of extracts
(a) Urine from infants
Extract following enzymatic hydrolysis
The steroid residue was normally dissolved in 0.5 ml. ethanol. The
tubes containing extracts were kept stoppered at -20° when not in use.
For the determination of overall losses, 25 fJl. of the extract
solution were taken for measurement of the radioactivity by liquid
scintillation counting.
Chromatography:
The following portions of each extract, with standards, were applied
to and run on three thin-layer plates. Due to the wide variation in the
urinary excretion of steroids by infants, it was often necessary to repeat
assays using either more or less of the extract.
(i) 50 /Jl. was used for the determination of compound U^ and 21-0H-
TABLE 7
Standards
Steroid (jUg. per spot) sPot
1 2 3 4
STANDARD 1
Medium polarity Pregnenolone 1.25 2.50 3.75 5.00
3P-OH-A"5 steroids DHA 1.25 2.50 3.75 5.00
21-OH-pregneno1one 0.625 1.25 1.875 2.50
16a-OH-DHA 1.25 2.50 3.75 5.00
16a-0H-pregnenolone 1.25 2.50 3.75 5.00
Aixdrostenetriol 0.625 1.25 1.875 2.50
STANDARD la 17a-0H-pregnenolone 0.625 1.25 1.875 2.50
STANDARD 2
Solvolysis Androstenediol 1.25 2.50 3.75 5.00
Steroids Pregnenetriol 0.625 1.25 1.875 2.50
STANDARD 3
Polar steroids Androstenetriol 1.25 2.50 3.75 5.00
STANDARD 4
Adult 3p-0H-A5 DHA 1.25 2.50 3.75 5.00
steroids Androstenediol 1.25 2.50 3.75 5.00
16a-OH-DHA 1.25 2.50 3.75 5.00
Pregnenetriol 1.25 2.50 3.75 5.00
Pregnanetriol 1.25 2.50 3.75 5.00
Androstenetriol 1.25 2.50 3.75 5.00
STANDARD 5
17-oxosteroids Androsterone 2.50 mm 5.00 _
DHA 1.25 2.50 3.75 5.00
Aetiocholanolone mm 2.50 - 5.00
11-oxo-androsterone 2.50 - 5.00 -
11-oxo-aetiocholanolone - 2.50 - 5.00
11-OH-androsterone 2.50 - 5.00 -
11-OH-aetiocholanolone - 2.50 - 5.00
STANDARD 6
Reducing Tetrahydrocortexolone mm 2.50 - 5.00
steroids Allotetrahydrocortisone 2.50 - 5.00 -
Cortisol - 2.50 - 5.00
Tetrahydrocortisone 2.50 3.75 5.00 7.50
Allotetrahydrocortisol 2.50 - 5.00 -
Tetrahydrocortisol 2.50 - 5.00 -
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pregnenolone.
Standard 1 (Table 7) was applied to the thin-layer plate, which was
then developed in system F (x 2).
(ii) 20 fJl, was used for the determination of the 16-oxygenated steroids.
Standard 1 (Table 7) was applied to the thin-layer plate; this was
then developed in system C (x 3).
(iii) 25 /XL. of the extract was used for the determination of androstenediol.
Standard 3 (Table 7) was applied to the plate, which was then
developed in system G (x 2).
Initially, 21-0H-pregnenolone, compound and the 16-oxygenated
steroids were determined on the some chromatogram after six developments in
chromatographic systems [system E (x 3) and system B (x 3)].
Solvolysis extract
One quarter of the solvolysis extract was used for the assay of
androstenediol.
Standard 2 (Table 7) was used for quantitation, and system H (x 2)
for development.
(b) OriA*.
One sixth of the extract was normally taken for the determination of
the 3p-0H-A^ steroids, the 17-oxosteroids and the Cortisol metabolites.
For chromatography, the following standards, development systems and
staining reagents were used:-
3p-0H-A^ steroids Standard 4 (Table 7), development in
system H followed by system F (x 2).
Detection by the antimony trichloride
reagent.
17-oxosteroids Standard 5 (Table 7), development in
system C (x 3).
TABLE 8
Precision of Pat ..rminations as Shown by the Concordance of
Areas Under the Peaks of Chromatogram Scans
Compound Number of duplicate Standard deviation



















* The standard deviation lias been calculated from the formula
~7~
where d = % difference between duplicate areas and
N = the number of duplicate assays.
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Detection by the Zinimermann reagent.
Cortisol metabolites Standard 6 (Table 7), development in
system G (x 2).
Detection by the blue tetrazolium reaction.
(c) Plasma
Free steroid extract;- This was not normally used.
Extract following enzymatic hydrolysis
For the determination of overall losses, two portions equivalent to
1/40 of the total extract were taken for liquid scintillation counting.
Chromatography
5
16a-0H-DHA was present in much larger quantity than the other 3P-0H-A
steroids and for this reason two portions of different amount were applied to
the same plate. One quarter of the total extract was used for the determination
of 16a-0H~DHA, and one half for the determination of the remaining 3j3-OH-A"*
compounds.
Standards 1 and la (Table 7) were used together.
The plates were developed once in system C and twice in system H.
Solvoly6is extract
One half of the extract was used for chromatography. The extract
itself usually represents only one half of the solvolysable steroids as the
remainder was discarded at stage 7 of the extraction procedure.
5. Precision of the method
The precision, defined as the concordance of measurements of the same
quantity, has been determined by calculating the standard deviation from the
differences between the chromatogram peak areas for duplicate runs; all the
steps of the procedure were performed in duplicate. Table 8 shows the results
obtained with the 3f3-OH-A"' steroids, the blue tetrazolium reacting steroids
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and the Zimmermann staining compounds. In investigating the precision, widely
differing values were occasionally found in the duplicate determinations, but
these have not been included since such clearly unacceptable determinations
were always repeated.
6. Accurr:y of the method
Accuracy, defined as the concordance between the determination and the
true value of the quantity measured, was assessed by measuring the recovery of
D1IA from DM sulphate, and aetiocholanolone and tetrahydrocortisone from their
glucuronides.
Dehydroepiandrosterone sulphate (250 {Jg.) was added to six 10 ml.
portions of urine collected from infants; after hydrolysis and extraction 1/50
of each extract was separated by TLC, and the DM assayed. The recoveries of
DM for the six determinations ranged between 73 and 90% with a mean of 80% +
6.2 (S.D.*).
To estimate the recovery of steroids from steroid glucuronides, known
amounts of aetiocholanolone glucuronide and tetrahydrocortisone glucuronide
were added to ten equal portions of urine. Aetiocholanolone and tetrahydro¬
cortisone were then assayed after hydrolysis of the urine samples. The results
obtained were compared with the results for the analysis of these steroids in
ten portions of the same urine to which no steroid glucuronide had been added.
The recovery of tetrahydrocortisone from its glucuronide was 72% + 5.4 (S.D.),
and the recovery of aetiocholanolone from aetiocholanolone glucuronide was
91% + 6.9 (S.D.).
* The standard deviations have been determined using the
formula
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The accuracy of the method for steroids in plasma was
3
determined by adding 0.5 jUc. H pregnenolone sulphate to the plasma
3
samples. The H pregnenolone present after hydrolysis was determined
by counting a portion of the steroid extract in a Packard liquid
scintillation spectrometer. For the plasma samples, the recovery of
3 3
H pregnenolone from H pregnenolone sulphate varied between 76 and 99%
with a mean of 89% + 7.9 (S.D.). Since this method depends on the
3
radiochemical purity of the H pregnenolone sulphate, experiments were
carried out to check whether all the radioactivity in the standard
3 3
solution was associated with the H pregnenolone sulphate. When H
pregnenolone sulphate was developed on a thin-layer chromatogram using
system K only one peak, corresponding to pregnenolone sulphate, was
detected when the plate was scanned for radioactivity using a Nuclear
Chicago radiochromatogram scanner. Similarly, after enzymatic hydrolysis
3
of the H pregnenolone sulphate, all the radioactivity was found to be
3 3
associated with H pregnenolone. It was therefore concluded that the II
pregnenolone sulphate was radiochemically pure.
62 -
III DISCUSSION OF THE METHOD
The method tnat has been developed is particularly useful for the
determination of 3(3-OH-A"^ steroid metabolites present in urine obtained
from infants. It is preferable to other methods developed in recent years
since it permits the determination of a wider range of steroids.
Reynolds (1965 a, b; 1966 a, b) described a technique for the assay of
16a-0H-DHA, 16a-OH-pregnenolone and androstenetriol in urine collected
from infants. The method described in this thesis, however, permits the
measurement of several other steroids as well, including 21-OH-pregnenolone
and pregnanetriol, the measurement of which is particularly useful in the
diagnosis of congenital adrenal hyperplasia. The presence of any
abnormal steroid which reacts with one of the three spray reagents is also
immediately evident.
Two methods have recently been described for the measurement of DHA,
sulphate and 16a-0H-DHA sulphate in plasma obtained from the imbilical
blood vessels; a method based on column chromatography (Colas_et_al., 1964)
and the paper chromatographic technique developed by Simmer and co-workers
(Simmer et al., 1964, 1966; Easterling at al., 1966). Eberlein (1965b)
showed that plasma obtained from the umbilical blood vessels contains other
5
impori-ant 3(3-OH-A steroids and the technique described here makes possible
the determination of several of these, including pregnenolone, 16a-0H-
pregnenolone, 17a-0H-pregnenolone and 21-OH-pregnenolone, as well as DIIA
and 16a-0H-DHA.
The sensitivity is adequate for the measurement of the steroids so
far determined, as there is generally sufficient material in about 1/400
of a 24 hour sample of urine collected from an infant to permit measurement
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of the principal 3J3-OH-A"' steroids. In order to assay minor, but
important, components such as DHA and pregnenolone accurately, it will
be necessary to develop the method further by including a step for
removing many of the steroids present in large amount.
To measure the metabolites of pregnenolone and DHA in plasma
obtained from the umbilical vein and artery, an amount of extract
equivalent to 2.5 ml. of plasma is applied to the thin-layer plates.
It is usually possible to obtain at least 5 ml., and often 10 or 20 ml.
of arterial and venous plasma from the umbilical blood vessels, so the
method is sufficiently sensitive for the material available.
The precision obtainable is adequate for the purposes for which
the technique is designed. The standard deviations shown in Table 8
refer to single assays, but in practice the average of duplicate
measurements is used and the precision is thereby considerably increased.
The accuracy, judged by the recovery of added steroid conjugates, is
5
satisfactory. Since no more 3j3-OH-A steroids are released by solvolysis
after enzymatic hydrolysis, apart from those steroids which are only
released from conjugation by solvolysis, it may be assumed that the
hydrolytic procedure releases almost all steroids. The specificity has
been thoroughly determined for the 3P-0H-A"' steroids present in urine
collected from infants since most of the compounds have been identified
by combined gas chromatography-mass spectrometry. The steroids in plasma
obtained from the umbilical cord, and in urine collected from adults,
have not been so thoroughly identified. These steroids, however, gave
the same colour reactions as standards, and their mobility on TLC was
identical to the standard compounds.
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By using the Zimmeraann and blue tetrazolium reactions, the
method was extended for the assay of the major group of steroid metabolites
excreted by adults, namely the 17-oxosteroids and the metabolites of
Cortisol. A particular advantage of this technique is that it can be used
without any elaborate equipment since it is possible to assess visually,
with satisfactory accuracy, the quantity of steroid present in any
chromatographic spot, providing a suitable number of standards have been
run simultaneously. The method can therefore be used routinely for the
investigation of adrenocortical function. It has not yet proved possible
to determine accurately the individual 17-oxosteroids and Cortisol
metabolites present in urine collected from infants, but these groups of
steroids are quantitatively of minor importance in these samples and it




QUANTITATIVE RESULTS OBTAINED FROM THE ANALYSIS OF STEROIDS
PRESENT IN URINE AND PLASMA.
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ii THE MEASUREMENT OF 33-OH-A5 STEROIDS IN URINE COLLECTED
FROM NORMAL NEWBORN INFANTS
The earlier analyses in this study were on urine obtained from
normal infants born in the Simpson Memorial Maternity Pavilion, Edinburgh,
The urine was collected in plastic bags, refrigerated soon after collection,
and stored at -20° until assayed. Most of the later steroid determinations
have been carried out in conjunction with Professor Ch, Lauritzen of Kiel,
Germany, to study the effect of adrenocorticotrophin and of human chorionic
gonadotrophin on steroid excretion by the newborn infant. In these
experiments, six day urine collections were made from four normal untreated
infants as controls, and ten infants treated with human chorionic gonado¬
trophin or adrenocorticotrophin during the fourth, fifth and sixth days
of life.
Table 22 (Appendix) gives the quantitative results for the
excretion of all the 3p-0H-A^ steroids, together with the weight of the
infants at birth and the length of gestation. In an attempt to detect
possible changes of steroid excretion with foetal maturity, ratios have
been calculated of 16a-0H-pregnenolone/ l6a-0H-DHA, 16a-0H-pregneuolone/
21-OH-pregneaolone, 16a-OH-DMA/16(3-OH-DHA, and 16a-0H-DHA/aadrostenetriol.
It was envisaged that any correlation in desmolase, 17|3-reductase and 16a-
and 21-hydroxylase with infant weight, would be apparent from these railzzi
5
Table 9 gives the range, and mean for the excretion of 3(3-01I-A
steroids; this table also shows the mean steroid ratios and their range.
In the earlier part of this work 21-0H-pregnenolone and compound
were not separated by TLC, so these steroids were determined together.





















































The mean values for the excretion of 21-OH-pregnenolone and compound
were obtained only from the first 24 hour collection of the fourteen
German infa.its.
Scatter diagrams have been drawn for the excretion of four of
5
the principal 3|3-OH-A steroids; these are illustrated in Fig. 25 and
26. The steroid excretion has been related to infant birth-weight.
Five of the German infants were possibly under stress as they had to be
treated with adrenocorticotrophic hormone for therapeutic reasons (see
p. 68 ). It was noticed that these infants tended to give a rather high
excretion of steroids in the control period (first three days of life)
so they have been illustrated differently (with open circles) on the
diagram. Two infants with adrenal disorders have also been studied;
one with adrenal hyperplasia and the other with adrenal hypoplasia.
The steroid excretion of these infants is described in more detail later
(see p. 73 ) but to illustrate their excretion of the 16-oxygenated
5
3P-0H-A steroids relative to the excretion of these steroids by normal
newborn infants, they have also been included on the diagrams.
Table 22 in the Appendix gives the daily excretion for the four
infants studied for six consecutive days as controls for the infants
treated with adrenocorticotrophin and human chorionic gonadotrophin.
Fig. 27 illustrates the excretion of the principal compounds by these
infants in the form of a histogram. From the mean values, a slight
increase in excretion towards the middle of the period is apparent, but
individual infants show widely variable results. Infant CON 1, for
example, showed a fivefold increase in the excretion of 16a-0H-
pregnenolone throughout the six days, whilst infant CON 2 showed a fall


























































Fig. 27. 33-OH-A5 Steroid Excretion by Normal Infants During the First Six
Days of Life
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in the excretion of this compound during the same period. In both these
infants there is a gradual change apparent, but all four infants showed
a considerable fluctuation in steroid excretion from day to day.
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II. THE EFFECT OF ADRENOCORTICOTROPHIN ADMINISTRATION
ON STEROID EXCRETION BY NEWBORN INFANTS
The infants used for the study were all male and were being
treated with adrenocorticotrophic hormone for prematurity, hyperbilirubin-
aemia, anorexia with dyspepsia, or laryngitis subglottica. It was
considered that in all cases the disorders were of non-endocrine origin
and that the results found should not differ markedly from those to be
expected in normal individuals. Adrenocorticotrophin was administered
intramuscularly, twice daily, at a dose of eight units per day for three
successive days. Urine was collected from these infants during treatment,
and for the three days prior to treatment.
Table 23 (Appendix) gives the particulars of the infants studied
and the results of the individual steroid assays for each infant. It
5
was noted that the excretion of 3P-0H-A steroid during the three control
days was higher than for normal untreated control infants (Fig. 25).
These infants may be producing a greater than normal amount of adreno¬
corticotrophin because of the "stress" of the clinical symptoms for which
they were being treated. If there was an increase in endogenous adreno¬
corticotrophic hormone due to stress, this would result in stimulation
of the adrenal glands to produce more steroid.
In nearly every case the excretion of all the 3p-0H-A^ steroids
was elevated after adrenal stimulation by administered adrenocortico¬
trophin. The average daily excretion of steroids for each infant for
the three days prior to treatment, and the three days during treatment,
was determined and the percentage increase calculated. The percentage
increase for each infant for all the compounds assayed, and the average
Fig. 28. The Excretion of Steroids by Infants Treated with Adrenocorticotropic
Hormone (ACTH)
Histograms illustrating the increased excretion of Cortisol, I6a-0H-DHA
and 16a-0H-pregnenolone by infants treated with adrenocorticotrophin.
Infants
ACTH I ACTH 2 ACTH 3 ACTH 4 ACTH 5 MEAN DAILY
EXCRETION
J CORTISOL-i il. id ill
■ ^ l6a-OH-DHA
I 1 1 t i lb
P__ )6a-OH- PREG M
Lfll L11A
123456 123456 123456 456789 123456
DAY OF LIFE
□ - Control period
I - Days on which adrenocorticotrophin was administered
16a-OH-PREG - 16a-0H-pregnenolone
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percentage increase of all the infants is given in Table 10. By
comparing these results with the results given previously for four
untreated infants whose urine was collected for six consecutive days
(Table 22 and Fig. 27), it was apparent that adrenocorticotrophin
administration gave rise to a very significant stimulation of 3(3-OH-A^
steroid production. This was particularly noticeable for 16a-0H-DHA and
16a-OH-pregnenolone. Figure 28 shows the increased production of these
two compounds for the five infants studied. It may also be significant
that the 16a-OH-pregnenolone/l6a-OH-DHA ratio increased from about 1.0
to 1.5 on treatment with adrenocorticotrophin. A higher ratio than
normal was also found in cases of congenital adrenal hyperplasia where
it is likely that adrenocorticotrophin is being produced in abnormally
large amount (see Table 11).
Since DHA and pregnenolone are difficult to measure accurately
due to their low concentration in urine, the assay of these steroids was
only attempted for two of the infants studied. Both showed a considerable
increase in the production of DHA and pregnenolone during treatment with
adrenocorticotrophin; the absolute values for DHA excretion, however,
remained very small in comparison to stimulation by human chorionic
gonadotrophin (Table 24, Fig. 29).
The increased production of Cortisol and its metabolites was even
more significant. In the control period these compounds were generally
not determined due to their low concentration in the urine, but an
estimate was made of the smallest quantity that could be determined on
each of the thin-layer plates, and the control values were reported as
"less than" this figure. It was apparent that the increased excretion
TABLE 10
The Increase in Excretion of Steroids by Infants
Calculated from -a total excretion of each steroid by five infants in the three
As a control, the average increase in excretion of steroids between the 4th, 5th
























































ACTH 1 None 290 <50 <50 320 190 98 1087
ACTH 350 <50 <50 336 495 88 4052
% increase 5 160 -10 200
ACTH 2 None 205 31 37 1140 352 713 2213
ACTH 274 91 110 1024 285 527 1787
% increase 300 198 —10 -19 -26 -19
ACTH 3 None 31 12 12 382 436 713 2573
ACTH 265 18 19 462 711 1027 5130
7. increase 50 58 21 63 44 100
ACTH 4 None 127 <50 <50 260 213 98 1320
ACTH 198 <50 <50 413 407 167 2253
7o increase 91 90 70 71
ACTH 5 None 290 <50 <50 633 207 70 2040
ACTH 323 <50 ^ 50 1173 647 75 2240
% increase 85 213 7 10
Grand None 547 275 338 1827
Average ACTH 681 509 377 2935
1-5 % increase 25 82 11 59
Grand 1st 3 days 820 243 69 1162
Average 2nd 3 days 585 226 65 1106
of 4 un- % change -29 7 6 5
treated
infants
Treated witi Adrenocorticotrophia (A.C.T.H.)
days prior to treatment and t ne tnree days during treatment.
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3240 886 5813 1153 2400 2733
95 >29 136 >2 500 1000
1887 1775 860 680 200 120
5080 1480 4653 1707 550 816
170 16 441 151 161 580
740 226 920 673 <100 <70
1967 586 2827 1007 1200 632
166 159 207 50 1100 802
1107 1533 2993 1467 <100 110
2815 2193 5933 1393 1080 737
156 41 98 -5 983 570
1371 1002 1707 1064 170 116
3430 1215 4863 1406 1250 1200
150 21 185 32 >600 >1000
975 853 1039 767
932 604 1211 816
4 -29 16 6
of Cortisol and Cortisol metabolites during stimulation by
adrenocorticotropic was much greater than the increase in the
excretion of 3(3-OH-AJ steroids.
Determination of the individual 17-oxosteroids present in the
urine of these infants before, and during, treatment was also
attempted but there was no apparent increase in any Zimmermann reacting
compounds.
Fig. 29. The Excretion of Steroids by Infants Treated with Human Chorionic
Gonadotrophin (HCG)
Infants









■ - Days on which human chorionic gonadotrophin was
administered
16a-OH-PREG - 16a-OH-pregnenolone.
This figure illustrates the increased excretion of DHA by two infants
treated with human chorionic gonadotrophin: no increase was found in the other
three infants. The excretion of the most important metabolite of DHA,
16a-OH-DHA, was not significantly increased even in those infants who showed
a marked elevation of DHA production.
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III. THE EFFECT OF HUMAN CHORIONIC CONADOTROPHIN
ON STEROID EXCRETION
The five infants chosen for this study were being treated with
human chorionic gonadotrophin for the therapeutic effect of this hormone
on undescended testicles. There was no reason to consider that any of
these infants was endocrinologically abnormal.
After a three day control period, during which urine was
collected to determine the normal vdues of steroid excretion, 5000 i.u.
of human chorionic gonadotrophin was administered intramuscularly on the
fourth, fifth and sixth days of life. The quantitative results for the
excretion of 3p-0H-A^ steroids by these infants is given in Table 24.
From the work of Lauritzen and Lehmann (1965, 1967), it was
expected that the infants studied would show a greatly increased
excretion of DHA during treatment with human chorionic gonadotrophin; two
of the infa ts (HCG 1 and HCG 2) showed this effect (Fig. 29), but no
significant increase in the production of DHA was apparent in the other
three infants (HCG 3, HCG 4 and HCG 5).
The daily excretion of the major metabolite of DHA, 16a-0H-DHA,
was only slightly increased (average increase 26%) during treatment with
human chorionic gonadotrophin, even in the two infants who showed a large
increase in DHA excretion. No significant elevation in the production
5
of the other 3|3-OH-A steroids was apparent.
In order to investigate whether any increase in the production
of Cortisol occurred, the polar blue tetrazolium reacting steroids were
separated and detected. In contrast with the effect of adrenocortico-
trophin administration to newborn infants, the excretion of Cortisol
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and its metabolites was not affected by human chorionic gonadotrophin.
It is possible that the hormone preparation administered to
the three infants who showed no response was inactive, since the infants
who showed a response in the form of increased DHA excretion were
treated with a different batch of human chorionic gonadotrophin.
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XV. STEROID EXCRETION BY INFANTS WITH CONGENITAL
ADRENAL ABNORMALITY
The steroid excretion of three abnormal infants has been
determined during the course of this study. Congenital adrenal hyper¬
plasia was the diagnosis in two cases, and congenital adrenal hypoplasia
in the third.
Congenital adrenal hyperplasia. Infant S.G.
This infant had a normal birth after 40 weeks gestation. His
weight was above average, at 4432 g., and he appeared healthy at birth.
On the fourth day of life he started vomiting; this was accompanied by
loss in weight, and these symptoms continued for several days. Between
the fifth and twelfth days of life there was a fall in the concentration
of plasma sodium associated with an increase in the plasma potassium
concentration. This electrolyte imbalance is often associated with
congenital adrenal hyperplasia due to a defect in the production of
Cortisol. On the twelfth day of life the condition of the baby
deteriorated rapidly and because of the provisional diagnosis of
adrenal hyperplasia, he was given intravenous injections of Cortisol.
Twenty-four hour urine collections were taken on the seventh, eighth,
twelfth, thirteenth and fifteenth days of life so that individual steroid
assays could be carried out to determine the type of enzyme deficiency,
if any, that was present in this patient.
The quantitative results for all the steroids determined are listed
in Table 11, but the individual findings using the three staining reagents
will be described in more detail for each day of collection. Fig. 30
illustrates in diagrammatic form the daily excretion of the principal steroids.
TABLE 11
The Excretion of Steroids by Infants with Congenital
(/lg/24 hr.)
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* Birth weight and gestation period not known
** The 17-oxosteroids were not assayed
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<100 665 775 34,893 2.00 11.05 7.46 5.08 No treatment
600 500 553 13,125 2.89 31.36 15.00 1.50 No treatment
985 408 416 3547 4.59 49.00 13.91 0.41 Cortisol 150 mg.
1170 220 235 2612 6.40 >64.00 16.66 0.38 Cortisone acetate 75 mg.
208 155 160 640 7.84 >20.40 >5.20 0.65 Cortisone acetate 50 mg.
<50 <50 2320 15.50 31.00 5.00 0.42 Adrenocorticotropliin 20 units.
Dexamethasone 1 mg.
Deoxycorticosterone acetate 1 n
<10 -** 183 0.40 >4.0 >9.8 >9.8 No treatment
Fig. 30, The Excretion of Steroids by an Infant with Congenital
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This diagram illustrates the excretion of some of the
principal steroids by patient S.G., an infant with congenital
adrenal hyperplasia. Steroid assays carried out on the seventh
day of life gave little indication of the enzyme deficiency since
che urine contained a large amount of 21-0H-pregnenolone, and
pregnanetriol could not be detected. However, the excretion of
pregnanetriol had increased by the eighth day of life.
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Steroid excretion on the seventh day of life
Antimony trichloride reaction:
All the 3p-0H-A^ steroids measured were excreted in increased
amount, generally between five and ten times the amount present in
urine from normal newborn infants; this indicated a probable deficiency
of 3(3-hydroxy-dehydrogenase in this infant. This diagnosis was also
considered probable due to the high excretion of 21-0H-pregnenolone, a
compound which would be expected to be present in urine in small amounts
if the adrenal hyperplasia was due to a deficiency of 21-hydroxylase.
The ratio of 16a-0H-pregnenolone to 21-OH-pregneaolone was slightly more
than ll/l which was greater than the average ratio found in normal
infants (Table 9), but within the normal range. No pregnanetriol was
detected, which also suggested that a deficiency at 21-hydroxylase was
unlikely.
Blue tetrazolium reaction:
After separation of the medium polarity steroids in thin-layer
system C (x 3), 21-OH-pregnenolone was again measured, this time using the
blue tetrazolium reaction to check the identity of this compound.* The
separation of the medium polarity blue tetrazolium staining compounds is
illustrated in Fig. 31 . The polar blue tetrazolium reacting steroids
were separated using system G (x 2) and these appeared to be present in
normal amount: this may not be significant as the identity of the major
blue tetrazolium reacting steroids in urine obtained from normal infants
is not known, and some are probably not metabolites of the corticosteroids.
No specific measurement of Cortisol metabolites was possible.
* As an additional precaution, 21-OH-pregnenolone was identified
by combined gas chromatography-mass spectrometry.
Fig. 31 • The Medium Polarity «-Retolic Compounds Excreted by
Patients S.G. and B.O.
Solvent system - C (x3)













Patient S.G. Patient B.O.
Legend: ->
This figure illustrates the large amounts of 16oc-OH-DHA,
16-oxo-androstenediol, 16p-0H-DHA and 21-OH-pregnenolone present
in the urine of patient S.G. on the seventh day of life. The levels
of these compounds had fallen considerably by the eighth day
(particularly 21-OH-pregnenolone), but a new blue tetrazolium-
reactlng steroid had appeared (Unknown BT); steroid assays on
urine collected on the twelfth day of life indicated that the
excretion of this compound had increased. A similar compound was
detected in urine from an infant with congenital adrenal hypoplasia
(Patient B.O.).
Fig* 32. Separation of the Antimony tomtim 6tw>14» Excreted
by a Normal Infant and by Patient S.G.
Solvent systats - <G (x2)






















rule figure illustrates the presence of pregnanetriol in the urine
of patient S.G, (8th day of life) and the absence of this compound from urine
obtained from normal infants. Other quelits ive differences are also illustrated
by the chromatographic separation.
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Zimmermann reacting steroids
The separation of these compounds in system C (x 3) is illustrated
in Fig. 20, together with the pattern shown by an extract from urine
collected from normal infants. It was not possible to measure accurately
the excretion of the ll-deoxy-17-oxosteroids nor the ll-hydroxy-17-
oxosteroids, due to the presence of many unidentified Zimraeriaann
chromogens, but 11-oxo-androsterone and 11-oxo-aetiocholanolone gave
clear spots and were present in abnormal amount.
Steroid excretion on the eighth day of life
Antimony trichloride reaction:
The 3|3-OH-iA"' steroids were present in lower concentration than the
previous day, but were still in greater amount than in urine from normal
infants. A particularly interesting trend was seen in the relative amounts
5
of 21-0H-pregnenolone and the other 3(3-OH-^A steroids. The ratio of
16a-OH-pregnenolone to 21-0H-pregnenolone increased to 31/1 on the eighth
day of life. This was greater than the figure for the seventh day (11/1)
and much greater than the ratio obtained for normal infants (Table 9).
In contrast to the fall in excretion of 21-0H-pregnenolone, there was a
marked increase in the excretion of pregnanetriol*. Taken together, these
measurements indicated a probable deficiency of 21-hydroxylase, a deficiency
that was not apparent from steroid determinations carried out on urine
collected on the previous day.
Blue tetrazolium reaction:
The assay of the medium polarity blue tetrazolium reacting steroids
also showed a decrease in 21-0H-pregnenolone, and this was associated with
* The presence of pregnanetriol in urine is easily detected by thin-
layer chromatography (Fig. 32). This compound was finally identified
in urine obtained from patient S.G. by combined gas chromatography-
mass spectrometry.
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the appearance of an abnormal steroid ,see Fig. 31). This blue
tetrazolium reacting compound (hereafter referred to as "Unknown BT")
was intermediate in polarity between 21-QH-pregnenolone and 16-oxo-
andrcstenediol when stained after developing the thin-layer plate three
times in system C; it was present in greater amount than 21-OH-
pregnenolone. A blue tetrazolium reacting compound of this polarity
has never been detected in urine obtained from normal infants, although
a similar compound was the principal "steroid" excreted by an infant
with adrenal hypoplasia (infant B.O.). There is, however, little
evidence to prove that this compound is a steroid.
The polar steroids (possibly corticosteroid metabolites) assayed
by this reaction were not present in such large amount on the eighth day
of life (Fig. 31). When considered with the finding of a reduced amount
of 21-OH-pregnenolone and an increased excretion of pregnanetriol, this
probably represents a progressive decline in the ability of the infant to
form 21-hydroxylated corticosteroids.
Zimmermann reacting steroids:
11-oxo-androsterone and 11-oxo-aetiocholanolone were again present
in much greater amount than in urine samples from normal infants, and the
levels of these compounds were similar to those found for Day 7.
Steroid excretion on the twelfth, thirteenth and fifteenth days of life
During this period Cortisol was administered, because of the rapid
deterioration in the condition of the baby. Consequently, there was
suppression of steroid production and the appearance of Cortisol
metabolites in the urine.
The excretion of 3p-0H-A^ steroids decreased and, by the fifteenth
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day, the excretion of the 16-oxygenated compounds was below the average
value for normal newborn infants. However, the urinary excretion of
pregnanetriol and Unknown BT increased considerably during the first two
days of Cortisol administration. The excretion of the ll-oxo-17-
oxosteroids decreased with cc tisol treatment.
Congenital adrenal hyperplasia. Infant B.J.
The steroid excretion of this infant was determined early in this
study, before suitable techniques had been developed for a full
investigation of the steroid production by newborn infants. The baby
had abnormal male external genitalia, and showed evidence of salt
imbalance. Urine was collected on the third and fourth days of life,
but since birth the infant had been treated with dexamethasone,
deoxycorticosterone acetate and adrenocorticotrophin so the steroid
assays could not give an accurate picture of the untreated disorder.
The results of the assay of 3|3-OH-AJ steroids are given in Table 11.
16a-OH-pregnenolone was present in relatively large amount compared to
the other steroids. Although they ware not accurately assayed, the
17-oxosteroids did not appear to be present in abnormal amount.
Pregnanetriol was detected but not measured quantitatively; by visual
assessment, it was estimated that the excretion of pregnanetriol was
about 200 /lg/24 hr. The disorder therefore appeared to be congenital
adrenal hyperplasia due to 21-hydroxylase deficiency.
Congenital adrenal hypoplasia. Infant B.O.
Infant B.O. was born after 38 weeks gestation and weighed 1710 g.
The baby was male but had maldeveloped gonads. He died from respiratory
failure after 30 hours of life. An abnormally low level of oestriol was
Fig. 33. Infrared Spectrum of ti-; Unknown Blue Tetrazolium Reacting
Steroid (Unknown BT) Extracted from the Urine of Infant B.O.
wavenumber
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found in plasma obtained from the mother before the baby was born; this
suggested hypoplasia of the foetal adrenals. Post-mortem examination of
the infant revealed the presence of small adrenal glands, thereby confirming
the diagnosis.
A complete 24 hour collection of urine was taken for steroid
analysis. The three major 16-oxygenated 3P-0H-A"* steroids were present in
sufficient quantity to be assayed and the results are given in Table 11.
These results are compared with the findings for normal infants in Fig. 25.
Although the amounts excreted were extremely low, they were within the
range found for normal infants as illustrated in Table 21 (in the Appendix).
The blue tetrazoliura reaction demonstrated the presence of a
relatively large amount of a compound of polarity intermediate between
16-oxo-androstenediol and 21-OH-pregnenolone (Fig. 31). This compound was
designated "Unknown BT" and its polarity was identical to a similar
compound found in urine collected from patient S.G., an infant with
congenital adrenal hyperplasia. Fig. 31 also illustrates the very small
amount of 16-oxo-androstenediol and 16a-0H-DHA that is present, since they
can hardly be seen when an amount of extract sufficient for the assay of
Unknown BT is separated on the plate. Unknown BT does not react with
either the antimony trichloride or the Zimmermann reagents. It is not
extracted by solvent, prior to hydrolysis of the urinary steroid
conjugates, so it is likely that it is present in urine as an enzyme
hydrolysable conjugate. An infra-red spectrum of the compound isolated
from the urine of infant B.O. is illustrated in Fig. 33. Unfortunately
there is insufficient evidence available for a structure to be assigned
to this compound.
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V. THE QUANTITATIVE ESTIMATION OF 30-OH-A5
STEROIDS IN PLASMA OBTAINED FROM THE UMBILICAL BLOOD
VESSELS.
Blood was collected from the umbilical blood vessels of infants
delivered by Caesarian section. It was considered that the quantity of
steroid present under these circumstances would indicate the normal
foetal production of steroids more closely than if the collection had
been made after the considerable stress of a normal birth. The venous
and arterial blood obtained from the umbilical blood vessels was
independently withdrawn through catheters by gently squeezing the umbilical
cord along its length. The blood was collected into heparinised
receptacles, and the plasma was separated as soon as possible. In most of
the cases studied it \?as possible to obtain sufficient plasma for duplicate
assays of venous and arterial plasma, but for some it was not possible to
obtain any arterial plasma, and in others amounts sufficient for only a
single assay were obtained.
Both DHA sulphate and 16a-0H~DHA sulphate are synthesised by the
foetus and are probably precursors of oestrogens. The oestrone, oestradiol
and oestriol were therefore determined in urine collected from the mother
during the x*eek prior to delivery. These assays were performed by Mrs.
E. A. Michie who used the method of Coyle and Brown (1963).
The results of all the assays are given in Table 25 in the Appendix.
This table also gives the arterio-venous gradient (arterial value in
jUg/100 ml. minus the venous value in /Jg/100 ml.) for each of the steroids
assayed, and this figure expressed as a percentage of the arterial assay.
Eleven of the fourteen cases studied (Table 25, Nos. 1-11) were
TABLE12
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considered normal; two of the other infants were in a weak state
immediately after birth (Table 25, Infants 12 and 13) and one of these
infants died on the second day of life (Infant 12). Infant 14 was
delivered from a woman who had been taking prednisolone during pregnancy.
The average values and the range for each of the compounds
measured in the eleven "normals" are given in Table 12. Although 16-oxo-
androstenediol and 16a-0H-DHA were determined independently in extracts
of urine collected from infants, only in the preliminary studies on plasma
was a thin-layer system used that was capable of separating the isomers.
It was found in these early experiments that 16-oxo-androstenediol was
present in the plasma at a level only about one-tenth that of 16a-0H-DHA,
and it was not considered necessary to assay this compound separately.
All the compounds determined were usually present in greater
concentration in plasma obtained from the arteries than in plasma
obtained from the vein; this indicates a net uptake of these steroids by
the placenta. The plasma levels of 16a-0H-DHA and DHA have been compared
individually with the corresponding results for oestrone and oestriol
obtained by assaying these compounds in urine collected from the mother
(Fig. 34). From the limited number of results available, there seemed to
be a slight correlatio between these findings. Little correlation was
apparent between the birth weight of the infants and the concentrations
of 16a-0H-DHA in the plasma samples (Fig. 35).
The infant born of the mother taking prednisolone (Table 25,
Infant 14) gave lower than normal results for all the 3p-0H-A^ steroids;
the concentration of DHA and pregnenolone was particularly low, the
remaining steroids being within the normal range. These low results
Fig.34
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Fig. 35. 16a-0H-DHA in Plasma Obtained from the Umbilical Blood Vessels,


































Infant birth weight (kg)
o Normal infants (arterial blood)
O This analysis was carried out on plasma obtained from an
infant whose mother had been taking prednisolone during pregnancy.
Prednisolone would be expected to suppress the production of
adrenhl steroids by the foetus.
A These infants were extremely weak at birth and one died
on ■ the-' second day of life.
* These assays were carried out on venous plasma; arterial
plasma was not available.
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indicated suppression of the "feed-back" mechanism in the foetus.
Insufficient plasma was obtained from the umbilical blood
vessels from infants 12 and 13 for accurate assay, but both showed a
relatively small concentration of 16a-0H-DHA compared to the normals.
In the method for the preliminary purification of steroid
conjugates by Sephadex column chromatography, unconjugated steroids
present in the first 100 ml. of the column eluant were normally
discarded. However, an experiment was carried out to determine how much,
if any, of the 3p-0H-AJ steroids assayed in the conjugated fraction were
also present as free steroids in plasma obtained from the umbilical vein.
It was not possible to measure directly the 3|3-OH-A"' steroids
present in the free steroid fraction, due to the presence of a large
amount of lipid material which interfered with the chromatography. It
was therefore necessary to remove as much of this material as possible
before the final TLC separation and quantitative measurement. This
purification was achieved by preparative TLC using system C (x 2). Since
all the known 3P-0H-<A~' steroids present in plasma obtained from the
umbilical blood vessels have mobilities between pregnenolone and
androstenetriol, all the silica gel between the positions of these two
steroids on the plate was removed and eluted with ether. This effectively
removed most of the non-polar and highly polar lipid, retaining only
compounds of polarity between pregnenolone and androstenetriol. The
eluate was dried and the residue was applied as a spot to a thin-layer
plate, which was developed three times in system C. After development
the plate was sprayed with antimony trichloride to detect the 3P-0H-A"*
compounds, if they were present. No spots corresponding to any 3P-0H-A"'
- 82 -
steroids could be detected, and it was estimated therefore that none of
these compounds could be present at a concentration greater than 5 jUg/
100 ml. plasma. The concentration of free 3p-0H-iA^ steroids in plasma
obtained from the umbilical blood vessels is therefore very low.
Apart from the 3P-0H-A"' steroids determined quantitatively in
plasma obtained from the umbilical blood vessels, three other compounds
were detected but not accurately measured. These were pregnenediol,
pregnenetriol and androstenetriol, Although they were assayed in a pool
of venous plasma obtained from several umbilical cords. The results
obtained were:-
Pregnenediol 50 jL(g./lOO ml.
Pregnenetriol 65 (Lfe./lOO ml.
Androstenetriol 68 /LIg./lOO ml.
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VI. THE CONJUGATION OF 30-OH-A5 STEROIDS PRESENT IN
URINE OBTAINED FROM INFANTS. AND IN PLASMA COLLECTED FROM
THE UMBILICAL BLOOD VESSELS.
The method used for the extraction and fractionation of plasma
steroid conjugates has been given in detail in Part I (p. 31). An
identical method was used for the preparation of the crude extract of
steroid conjugates obtained from urine collected from infants. After
applying this extract to the column of Sephadex LH 20, sequential 25 ml.
fractions of the eluting solvent (methanol:chloroform, 1:1; saturated with
sodium chloride) were collected, dried, dissolved in acetate buffer, and
were hydrolysed with Helix pomatia sulphatase and glucuronidase (Part 1,
sections 2.3, 2.4 amd 2.5). After extraction with solvent, a portion of
each fraction was separated by TLC to determine which contained steroids.
The fractions containing steroids were then pooled to form two fractions,
one containing the steroid monoconjugates, the other the steroid
diconjugates. For some unexplained reason the conjugates obtained from
urine were eluted from the column with a much smaller volume of eluting
solvent than was required for the plasma conjugates; a satisfactory
separation of steroid monoconjugates from free steroids and lipid
material was not obtained. The monoconjugates appeared in the eluant
after 50 ml. of solvent had passed through the column; no more monoconjugates
were obtained after 150 ml. had been collected. The diconjugates were eluted
between 250 ml. and 400 ml.
The steroids present in the monoconjugated and diconjugatecL
fractions of plasma and urine were assayed by TLC, and the percentage of
Fig. 36. The 33-OH-A^ Steroids Present in the Monoconjugated and
Piconjugated Fractions Prepared from Urine Collected from
Infants and Separated by Sephadix Chromatography
Solvent system C (x3)
(separates 16-oxo-androstenediol
from 16os-OH-DHA)

















S - Standard compounds
M - Monoconjugated derivatives
P - Piconjugated derivatives - the amounts applied to the
chromatograms was equivalent to twice the quantity of
extract used for the separation of the monoconjugated
derivatives.
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each steroid in each fraction was determined. The results of these
assays are given in Tables 13 and 14. Figure 36 illustrates the thin-
layer separation of the 3p-0H-A"^ steroids obtained from urine collected
from infants. Two different development systems were used; system C
(x 3) for resolving 16-oxo-androstenediol and 16a-0H-DHA, and system F
(x 2) for the separation of compound U-^ and 21-0H-pregnenolone. The
figure illustrates that most of the 16p-0H-DHA and all the
21-0H-pregnenolone, are present in the diconjugate fraction, the other
3p-0H-AJ steroids being mainly in the monoconjugate fraction. It can
be seen that almost all the uncharacterised polar compounds are excreted
as monoconjugates. It is likely that most of the Sp-OH-A"* steroids are
sulphated and that some, particularly I6p-0H-DHA and 21-0H-pregnenolone,
are predominantly disulphated. This study has demonstrated that the
Helix poraatia enzyme preparation has enzymes capable of hydrolysing the
16a-, 16p- and 21- esters of 3p-0H-A~* steroids. Androstenadiol and
pregnenetriol are present in the diconjugated fraction that can be
hydrolysed by solvolysis following enzymatic hydrolysis; it is probable
that these conjugates are disulphates, but that the 17a-sulphate and the
20a-sulphate are not hydrolysed by the enzymes present in the digestive
juices of Helix pomatia.
TABLE 13
The State of Con luxation of 38-QH-A"* Steroids Present in Urine
Collected from Infants
The steroid sulphates in urine were separated into a monosulphate
and a disulphate fraction by Sephadex LH 20 chromatography. After
hydrolysis of the steroid sulphates by Helix pomatia sulphatase, the
steroids in the monosulphate and disulphate fractions were separated by
TLC and assayed.
The percentage of each steroid present, as its monoconjugated and
diconjugated derivatives, is listed in the table.
Monoconjugates (%) Diconjugates (%)
Poox 1* Pool 2 Pool 1 Pool :
Compound 100 100 0 0
21-0H-pregnenolone 0 0 100 100
Androstenediol 0 0 100 100
16-oxo-androstenediol 78 80 22 20
16oc-OH-DHA 89 77 11 23
Compound Uh, 0 6p-QH-DHA) 34 42 66 58
16a-0H-pregnenolone 100 94 0 6
Androstenetriol 81 90 19 10
* Two samples of pooled uriiie were used for these analyses.
TABLE 14
5
The State of Conjugation of 3B-0H-A Steroids Present in Plasma Obtained
from the Umbilical Blood Vessels
The steroid sulphates in plasma samples were separated into a
monosulphate and a disulphate fraction by Sephadex LH 20 chromatography.
After hydrolysis of the steroid sulphates by Helix pomatia sulphatase,
the steroids in the monosulphate and disulphate fractions were separated
by TLC and assayed.
The percentage of each steroid, as monoconjugated and diconjugated
derivative, is listed in the table.
Monoconjugate (%) Diconjugate (%)
Pregnenolone 100 0
DHA 100 0
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ii METHODS USED IN THE IDENTIFICATION OF STEROIDS
1. Chemical methods for the formation of steroid derivatives
1,1 The separation of ketonic and non-»ketonic steroids
Steroids containing carbonyl groups (ketonic steroids) form water
soluble hydrazones when reacted with Girard's reagent T; this enables
them to be separated from steroids without carbonyl groups. After
formation of the hydrazones, the unreacted steroids(i.e. steroids without
any ketone groups) can be extracted from the aqueous phase with organic
solvents. Since steroid hydrazones are hydrolysed by acid, the ketonic
steroids may be recovered by acidification to pH 1 followed by extraction
into organic solvent.
Most steroid carbonyl groups form Girard hydrazones. An 11-ketone
group, however, will not form a derivative due to steric hindrance of this
position by the C-18 and C-19 methyl groups of the steroid molecule.
The formation of Girard hydrazones is often used to simplify the
purification of steroids from crude extracts of biological materials.
This reaction is also carried out to determine whether or not an unknown
steroid contains a carbonyl group.
Formation of Girard. hydrazones (Bush, 1961)
(i) The steroid (or steroid mixture) was dissolved in 0.1 ml of
glacial acetic acid.
(ii) Girard reagent T (10 mg) was added, and the mixture either
left overnight at room temperature or heated in a water bath at
90° for 20 minutes.
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(iii) Three ml. water and 0,7 ml. 10% sodium hydroxide (w/v)
was added. This mixture was extracted with three 10 ml. portions
of ether to obtain the non-lcetonic steroids.
(iv) Hydrochloric acid (50%, v/v) was added to the aqueous phase
to bring the solution to pH 1. This mixture was continuously
extracted for two hours with 10 ml. ether, and the extraction was
repeated twice with further portions of ether (10 ml.). The ether
extracts (containing the ketonic steroids) were combined and dried.
1.2 The reduction of carbonyl groups
Steroid carbonyl groups can be reduced to hydroxyl groups by sodium
borohydride. Ketone groups on almost every position of the steroid nucleus
Vkfl.
are reduced completely in two hours, but carbonyl group at position 11
A
requires about 16 hours before it is completely converted to an lip hydroxyl
group. A mixture of the two possible epimeric hydroxyl groups is normally
produced, but one of these epimers usually predominates.
Reduction with sodium borohydride (Bush, 1961):
(i) The steroid to be reduced was dissolved in 0.2 ml. of methanol.
(ii) Sodium borohydride (10 mg.) was added: this mixture was left at
room temperature for two hours.
(iii) Excess sodium borohydride was destroyed by the addition of
glacial acetic acid.
(iv) Distilled water (5 ml.) was added. This mixture was extracted
three times with 10 ml. ether. The ether extracts (containing the
reduced steroid) were combined and dried.
1.3 The formation of 0-methyloxime derivatives
Steroid 0-methyloxime derivatives are usually prepared in order to
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protect the C-20 carbonyl group } in steroids containing a dihydroxyacetone
side-chain, from destruction during gas chromatography. It is also useful
to prepare these compounds for thin-layer chromatographic analysis, since
steroid O-methyloxime derivatives are less polar than free steroids and it
is therefore simple to deduce whether or not a steroid contains a carbonyl
group.
Preparation of O-methyloxime derivatives (Brooks. 1966);
The steroid was dissolved in 0.2 M methoxamine hydrochloride
dissolved in dry pyridine, using a three to five-fold excess of reagent per
reactive carbonyl group. After four hours, portions of the mixture were
taken for analysis by thin-layer chromatography.
1*4 The preparation and purification of trlmethylsilyl ethers
Steroids are often polar, non-volatile compounds and before they are
analysed by gas chromatography it is usual to make them more volatile by
preparing derivatives of the hydroxyl groups. The derivatives most often
prepared are the trimethylsilyl ethers: under certain conditions, these can
be formed with all the steroid hydroxyl groups.
Formation of trimethylsilyl ethers
The method described by Vihko (1966) was used. This does not
normally effect the formation of trimethylsilyl ether derivatives of
tertiary hydroxyl groups.
X
A solution of hexamethyldisilazane;trimethylchorosilane:pyridine
(3:1:4) was prepared. 50 JLCL. of this solution was added to a vial
containing about 20 |Ug of steroid; this was then closed and left overnight.
The steroid trimethylsilyl ether was purified for gas chromatography-mass
spectrometry by preparative gas chromatography using a Perkin-Elmer 801
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gas chromatograph with an E 301 column. Either single peaks, or
i
alternatively the whole of the run, were collected into glass collection
tubes placed on the outlet pipe of the chromatograph (Sparagana, 1966).
The steroid trimethylsilyl ethers were then transferred with chloroform
into vials and dried under a stream of nitrogen. The steroid trimethyl¬




The advent of combined gas chromatography-mass spectrometry has
greatly simplified the problems involved in identifying small quantities
of steroid metabolites in urine and plasma since a mass-spectrum can be
obtained with as little as 0.06 jL(g. of the trimethylsilyl derivative
(Sjovall and Vihko, 1966). One of the major difficulties which hindered
the development of gas chromatography of steroids was the protection of
heat-labile compounds from destruction at the high temperatures required
for volatilisation. The formation of trimethylsilyl ethers is suitable
for the protection of hydroxyl groups in androstane and in polyhydroxy-
pregnane compounds lacking a C-20 carbonyl group (Rosenfeld, 1964), but
for the chromatography of steroids containing an oo-ketolic side chain it
is necessary to form a derivative of the C-20 carbonyl group. To protect
carbonyl groups, the formation of O-methyloxime or O-trimethylsilyloxime
derivatives is suitable (Gardiner and Homing, 1966). When mass-
spectrometry is combined with gas chromatography, these derivatives have
the added advantage of directing fragmentation in a recognisable manner
(Brooks £t_ a^., 1966). O-Methyloxime trimethylsilyl ethers have been used
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by Brooks and co-workers (1966) in the study of the excretion of
5
3P-0H-A steroids by newborn infants and triraethylsilyl ethers were
used by Sjovall and Vihko (1966, 1968) in their quantitative study of
the solvolysable steroids in peripheral blood.
The mass-spectrum of a steroid triraethylsilyl ether usually gives
fwvcL
the molecular weight (M)^ the number of trimethylsilyl groups in the
molecule; other detailed information about the structure can be obtained
from the fragmentation pattern (Budzikiewicz et al., 1964). Steroids
containing a 3j3-OH-A"^ group, for example, normally give an intense
M
fragment at m/e 129 and m/e-129; this fragmentation has been used by
A
Eneroth el: al^. (1964, 1965) to identify this type of steroid.
In this st dy combined gas chromatography-mass spectrometry has
been used to ide tify most of the compounds measured in the qua titative
method in order to evaluate i s specificity. The mass-spectrum fragmentation
patterns of several other reference compounds have also been determined, even
though these compounds have not been identified either in urine collected
from i ifants or plasma obtained from the umbilical blood vessels.
Method
The sample of trimethylsilyl ether was dissolved in chloroform and
a suitable amount was injected into the column of the LKB 9000 gas
chromatograph-mass spectrometer. For reference compounds, the mass-spectrum
was normally recorded at the centre of the peak, but for the identification
of urinary compounds a "scan" was taken on the ascending side of the peak
and also on the descending side (see Fig. 37) to determine whether the
peak was homogeneous or composed of more tha one compound. If two or
more compounds were present it was considered that these would probably













This method of fragmentation was
suggested by Eneroth e_t _al. (1964).
It has since been shown to be incorrect.
ila-OH-DHA trimethylsilyl ether
The mass-spectrum of this compound
(Fig. 58) shows a strong peak at m/e 217
but no peak at m/e 129. This indicates
that the fragment must contain carbon
atoms 1, 2 and 3. If the fragment formed
from the A ring had contained carbon
atoms 2, 3 and 4 (as suggested by Eneroth
et al., 1964), a strong m/e 129 peak would




The fragmentation of the A ring of
3P-0H-A steroids occurs as shown in this
figure.
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have slightly differing retention times, so differences might be detected
in the mass-spectra taken at each side of the peak. Occasionally three
scans were taken, the third being taken at the top of the peak.
Figure 37 shows the gas chromatograph record of 16a-0H-DHA (as its
trimethylsilyl ether) obtained after preparative TLC carried out on the
extract of urine collected from infants. There is one other maj:or peak
which is due to 16-oxo-androstenediol, a compound which is extremely
difficult to remove by the systems used for quantitative TLC.
After calculating the relative intensities of all the peaks in the
mass-spectrum, line-diagrams have been drawn for several of the compounds
analysed during this study. These line-diagrams are Illustrated in Figs.
55-68. Table 15 gives the relative retention times on gas chromatography
of all the steroids analysed.
5
Fragmentation of 38-QH-A ster ids
(a) Fragmentation peaks at m/e 129 and m/e M-129
5
The tendency of 3(3-trimethylsilyloxy-A" steroids to yield intense
fragments of m/e 129 and m/e M-129 has been used in the identification of
3P-0H-A steroids (Eneroth et_ al_., 1964, 1965). These workers originally
considered that this fragmentation was due to the splitting off of carbon
atoms 2, 3 and 4 of the steroid molecule (as illustrated in Fig. 38a) but
it now seems more probable that the fragment contains carbon atoms 1, 2 and
3 (Fig. 38d). Evidence to support this theory comes from the fragmentation
of la-OH-DHA trimethylsilyl ether (Fig. 58). This compound does not have a
major peak at m/e 129, although such a peak would have been expected if the
fragment had contained carbon atoms 2, 3 and 4 (Fig. 38c). Instead, it has
a base peak at m/e 217, which fits with a fragment containing carbon atoms
TABLE 15
Gas Chromatographic Retention Times of Steroid Trimethyl Silyl Ethers
(Relative to DHA trimethyl silyl ether)
Stationary phase 1% SE 30
Column temperature 220
Number of trimethyl Relative










16a-OH-DHA "2" " 1.63
16p-OH-DHA 2 1.80
17a androstenediol 2 1.04





Androst-5-ene-3p,15p,17p-triol (i) ** 3 1.69
Androst-5-ene-3p,15pjl7p-triol (ii) ' 3 1.83
Androst-5-ene-3p,lip,17p-triol 3 1.92
Compound 1 1.98
* The mass-spectrum did not give a peak corresponding to the
MW of the parent ion.
** Androst-5-ene-3p,15p,17p-triol gave two peaks which had similar
.. mass spectra.
Fig. 39. Fragmentation of DHA Trimethylsilyl Ether











1,2 and 3 (Fig. 38b); this would also explain the results given for the
fragmentation of 4-methyl- and 4,4-dimethyl-cholesteryl trimethylsilyl
ether (Brooks et al., 1966).
The peak at m/e 129 is frequently the base peak for trimethylsilyl
ethers of 3(3— CH-A"' steroids, but it has been shown that androstanes with
a 17-hydroxy group (but no 3{3-OIW group) also give intensive peaks at
m/e 129; for example, the epimeric androstane-3,17-diols (Vihko, 1966)
give such a fragment.
(b) Fragmentation peak at m/e M-15.
This fragment represents the loss of an angular methyl group
(Fig. 39).
(c) Fragmentation peak at m/e M-90.
This fragment is due to the loss of trimethylsilanol, and indicates
the number of esterifiable hydroxy1 groups. Dehydroepiandrosterone, for
example, gives only an M-90 peak, while in the spectrum of androstenediol
there are predominant peaks at ra/e M-90 and m/e M-£x9Q). Each of these
fragments can also be associated with the loss of an angular methyl group.
For each m/e x 90)peak (x = number of esterifiable hydroxyl groups),
therefore, there is a peak at M-(X x 90) + 15. This becomes clearer from
an examination of the fragmentation of mono-, di- and trihydroxy andros-
tenes (Figs. 40, 55, 63 and 67).
(d) Fragmentation peak at m/e .,-53.
Budzikiewicz and Djerassi (1962) showed that a peak at m/e M-56
(X
represented the splitting of the D ring of steroids containing carbonyl
A
group at positions 15, 16 or 17. This fragmentation is illustrated in
Fig. 39 for DHA trimethylsilyl ether (mass-spectra shown in Fig. 56).
Fig. 40. Fragmentation Peaks Expected for Mono-, Pi-, and Tri-Hydroxy
Androstenes.
(See Figures 55, 63 and 67).


























Fig. 41. Fragmentation of 16a-0H-DHA Trimethylsilyl Ether
(Mass-spectrum illustrated in Fig. 47)














The strong m/e M-144 (m/e 304) peak present in thespectma of 16a-0H-DHA
trimethylsilyl ether (Fig. 47) may also be related to the loss of the D ring
(Fig. 41).
(e) Unique features i: the fragmentation of some of the compounds analysed
The trimethylsilyl ethers of 30, 15a, 170-trihydroxyandrost-5-ene
(Fig. 66) and 30, 150, 170-trihydroxyandrost-5-ene did not give peaks
representing the parent ions (M+), but gave peaks at m/e M-15. However,
14a-0H-DHA trimethylsilyl ether (Fig. 61) did not give peaks at M, M-15,
M-90 or M-90+15, and this compound therefore appears to disintegrate
rapidly, giving little structural information apart from the presence of a
base peak at m/e 129 indicating that it is a 30-OH-AJ steroid.
With the exception of the androstenediol epimers, and la-OH-DHA, the
only steroid trimethylsilyl ether studied that failed to give a base peak
at m/e 129 was 7a-0H-DHA (Fig. 59). This compound has a base peak at m/e
M-90 (m/e 358) indicating the rapid removal of trimethylsila^ol at position 7.
Epimers frequently give almost identical mass-spectra. An example of
this is giver for 17a and 170 androstenediol; the mass-spectta of these
compounds are shown in Figs. 62 and 63.
3. Infra-red spectroscopy
A Unicam S.P. 200 spectrophotometer was used for analysis of steroids
by infra-red spectroscopy. This was a double beam instrument, one beam
being used for reference and one for the sample. By utilising a system of
mirrors, the sample beam was made to pass through a KRS 5 internal
reflectance plate (Fig. 42). The plate was made of a synthetic mixed
crystal of thallous brcmxide and thallous iodide, a strong resistant
Fig. 42. Internal Reflection Infra-Red Spectroscopy
By employing a reflection plate, the sample beam can be made to
reflect off the steroid many times as it travels to the detector; this









material which does not absorb in the infra-red region. The sample to
be analysed was dissolved in a small volume (200 (XL,) of a suitable
volatile solvent (acetone was used in this study) and the solution was
streaked on both sides of the plate, using a micropipette. Radiation frcra
the source is directed by the mirrors into the plate, where it reflects
internally many times as it trave s the length of the plate, penetrating
into the sample with each reflection. The additive effect of a large
nimber of internal reflections provides a reasonable spectrum on a small
amount of material. About 25 jJg. of steroid was found to be the smallest
amount that gave a satisfactory spectrum.
1
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II THE IDENTIFICATION (OR PARTIAL IDENTIFICATION) OF FOUR
STEROIDS PRESENT IN URINE COLLECTED FROM INFANTS
1. Partial identic' ation of compound
This steroid was excreted by infants as a conjugate which could be
hydrolysed by the ensymes present in the crop fluid of Helix .omatia.
Compound was not detected in extracts of urine collected from adults,
nor in plasma obtained from the umbilical blood vessels.
(a) Polarity:
Compound had a similar mobility to 21-OH-pregnenolone in all
the thin-layer solvent systems used (Table 20), but these two compounds
could be separated satisfactorily in systems based on chloroform, as
compound was slightly less polar. Its mobility with respect to a
5
3P-0H-A androstene was similar to 11-oxo-DHA; it was less polar than
androstenediol in systems C and F, but more polar in syste- H.
5
If compound is a 3p-0H-A pregnene, it is probable that it
either kas two hydroxyl groups, two hydroxyl groups and one ketone group
or one hydroxyl group and two ketone groups. If it is a 3p-0H~A^
androstene, it is most likely to contain two hydroxyl groups, or one
hydroxyl and two ketone groups, as it was found to be less polar than
all the androstene dihydroxy-monoketone standards available.
(b) Colour reactions:
Compound was detected on thin-layer chromatograms by the
antimony trichloride reaction, in which it produced the typical red
colour given by 3(3-OH-A^ steroids. The Zimmermann reaction was negative,
indicating the absence of a carbonyl group adjacent to an unsubstituted
Fig. 43. Infra-red Spectrum of Compound Unknown 1
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methyle e group. Compound did not react with blue tetrazolium, which
indicated that it did not contain an a-ketol group.
(c) Derivative formatiovi
Compound did not react with Girard's reagent T since it was
extracted with the non-ketonic fraction. No derivative was formed with
methoxamine hydrochloride, since the Rf value on thin-layer chromatography
remained uncha ged; steroid O-methyloxime derivatives are less polar tha
the free steroids. These findings are consistent with the steroid either
having no ketone group, or else a hindered one which does not readily form
derivatives, for example at position 11 of the steroid molecule.
Gas chromatography-mass spectrometry showed that the compound formed
a mono-trimethylsilyl ether, indicating the presence of at least one hydroxyl
group.
(d) Reduction
Two products were formed when compound was reduced with sodium
borohydride in methanol.
(e) Infra-red analysis
The infra-red spectrum of compound (Fig. 43) contained a large peak
at 1710 cm This is probably due to a ketone group, but the wavelength
-1V
is too low for the ketone to be in ring D (about 1720 - 1740 cm ), and
4 -1
too high for the carbonyl group of 3-oxo-A steroids (1660 - 1680 cm ).
Carbonyl groups at positions 11 and 20, however, absorb at this frequency.
Since there was only one peak in the part of the spectrum characteristic for




Compound did not absorb light of wavelength 240 mji, which
indicates that there is no a,(3 unsaturation.
(g) Mass-spectrometric analysis
The mass-spectrum of the steroid trimethylsilyl ether (Fig* 44)
showed that the base peak was at m/e 129, indicating the probable presence
of a 3(3-OH-A^ group, although 17-hydroxy androstanes without a 3p-0H-A^
group also give base peaks at m/e 129. The mass-spectrum indicated that
the molecular weight was 376, and the fragmentation pattern showed the
presence of one trimethylsilyl group, since there were peaks at m/e M-90
a id m/e M-90+15, but none at m/e M-^x90)nor at m/e M-(2x90) +15. A mono-
trimethylsilyl ether of molecular weight 376 indicated that the free compound
has a molecular weight of 304 since the formation of a trimethylsilyl ether
5
adds a mass of 72. These findings would be co .sistent with a 3|3-OH-A
androstene containing an additional hydroxyl group (which does not form a
trimethylsilyl ether) and a ketone group. There was a relatively strong
peak at m/e M-56, a fragment which ofte indicates the prese .ce of a
carbonyl group in the D ring (Fig. 39). However a ring D ketone is
inconsistent with the ketone frequency observed by infra-red analysis, and
with the lack of formation of O-methyloxime and Girard derivatives.
Analysis of the "free" expound by combined gas chromatography-mass
spectrometry resulted in the formation of two peaks, one of which was
compound and the other of which had a molecular weight of 286 (mass-
spectrum Fig. 44). It is probable that compound is heat labile, and
partially dehydrates immediately after injection into the column, due to
the removal of one of its hydroxyl groups. One of the reduction products
Fig. 44. Mass Spectra of Derivatives of Unlcnowni
MONO-TMSE - Mono-trimethylsilyl ether




of compound was also examined by gas chromatography-mass spectrometry
(Fig. 44). The molecular weight of this steroid was 450, and the
fragmentation pattern indicated the presence of two trimethylsilyl ether
groups. This mass-spectrum again indicated the probable presence of ai
unsubstituted hydroxyl group.
If this compound is a 3P-0H-A"* androstene, then it is likely that
the additional hydroxyl is at position 8, 9 or 14 since these are the only
tertiary carbon atoms that could support an additional group. It is also
most probable that only a tertiary hydroxyl group is unable to form a
trimethylsilyl ether. The carbonyl group must be unreactive and cannot be
in the D ring; it may therefore be at position 11.
More work will have to be carried out on this unknown steroid before
any definite structure can be assigned, since the available evidence is so
conflicting.
2. The identification of compound U„ (163-OH-DHA)
Compound was present in extracts of urine obtained after hydrolysis
with the Helix pomatia enzyme preparation and a similar compound was detected
in plasma obtained from the umbilical blood vessels. However compound was
not detected in extracts of urine collected from adults. Compound Ug gave
the antimony trichloride reaction characteristic of 3|3-OH-A"* steroids, a d
was slightly more polar than 16a-0H-DHA in all the TLC solvent systems used
(see Fig. 12). A strong reaction was given with the blue tetrazolium reagent,
similar to that given by 16-oxo-audrostenediol; the reaction given by
16a-0H-DHA is weak and slow to develop. Compound also gave a weak
reaction with the Zimmermann reagent. Because of the similar polarities
of compound t^, 16-oxo-androstenediol and 16a-0H-DHA, and their similar
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reactions with the blue tetrazolium and the Zimmermann reagents, it was
considered probable that compound U„ was another steroid with an a-ketolic
group in ring D.
Compound was purified by preparative thin-layer chromatography
(p. 45) in three solvent systems [system C (x3), H (x2) and F (xl)]. All
the solvent systems used were able to separate compound from 16a-0H-DHA
and 16-oxo-androstenediol, although all three compounds had similar
mobility. However, it proved impossible to remove all traces of a compound
with the same mobility as 16-oxo-androstenediol, although it was possible
to remove all l&a-OH-DHA. This finding was surprising since, in one of the
systems used for preparative chromatography (system C), compound U0 arid
16-oxo-androstenediol were separated by a considerable distance. In this
system I60-OH-DHA would have been the expected impurity, since it was of
polarity intermediate between 16-oxo-androstenediol and compound (Fig. 12).
It was apparent, therefore, that 16-oxo-androstenediol was being formed as
an artifact during the preparative procedure. The formation of 16-oxo-
androstenediol from compound suggested that this unknown steroid was in
fact 16(3-OH-DHA. 16(3-Hydroxydehydroepiandrosterone is the least stable of
the isomeric a-ketols, and would be expected to isomerise readily to the
a-ketol with the most stable configuration, namely 16-oxo-androstenediol.
The same difficulty with isomerisation was experienced by Layne and Marria 1
(1958) in the identification of 16p-0H-oestrone in urine.
The principal reduction product of compound had the mobility of
either 3(3,16a,17a-trihydroxyandrost-5-ene or 3|3,16p,17|3-trihydroxyandrost-
5-ene in solvent system G; these "cis" epimers could not be resolved in
this system, but were much less polar than the "tra s" epimers,
Fig. 45.
An androstenetriol with 16a and 17a hydroxyl groups cannot be formed




5-ene. Since carbonyl groups at positions 16 and 17 of the steroid
molecule reduce to "P" hydroxyl groups with sodium borohydride (Fig. 45),
the product formed by reduction of compound U^ cannot be 3P,16a,17a-
trihydroxyandrost-5-ene; the structure of the product must therefore be
3p,16p,17p-trihydroxyandrost-5-ene. Only 16-oxo-androste ediol (Fig. 45,
compound 2) or 16P-0H-DHA (Fig. 45, compound 3) could give this reduction
product, so reduction with sodium borohydride provides further evidence
for the structure of compound being 16P-0H-DHA.
On the asis of the evide .ce obtained, reference 16P-0H-DHA was
synthesised (this compound was prepared by Dr. R. W. Kelly). Synthetic
16P-0H-DHA was shown to have the same mobility as compound l^in all the
thin-layer solvent systems used, and it gave the same reactions as compound
with the a ;timony trichloride reagent, the blue tetrazolium reagent and
the Zimmermann reagent. Gas chromatography-mass spectrometry also
indicated that compound and 16P-0H-DHA were identical. Both compounds
had the same retention times on SE 30 stationary phase at 225° (Table 15),
and tare similar mass-spectra (Fig. 47). It was not possible to separate
16P-0H-DHA from 16-oxo-androstenediol under the conditions used, and the
major peak in the gas chromatographic tracing illustrated in Fig. 46 is a
mixture of these two compounds. This is particularly noticeable from an
examination of the fragmentation patterns (Fig. 47), since compound Ug
isolated from urine gives large peaks at M, M-15 and m/e 129; these peaks
are more important with 16-oxo-androstenediol than with 16|3-OH-DHA.
When the steroid conjugates present in urine collected from infants
were separated into monosulphates and disulphates by Sephadex chromatography,
Fig. 46 The Identification of Compound I)„ (163-OH-DHA) by Combined Gas Chromator
graphy-Mass Spectrometry
——i
Fig. 47. Mass Spectro£kgfc6metric Identification of Compound U?
This figure illustrates the mass-spectra of the trimethylsilyl
ethers of three ring D a-ketols and of compound













it was apparent that most of the compound U7 was present in the disulphate
fraction. It was also clear that this conjugate could be hydrolysed by
the enzymes present in the Helix poiuatia preparation. In the diconjugated
fraction, compound was present in large amount relative to 16a-0H-DHA
and 16-oxo-androstenediol (Fig. 36): by preparing compound from the
disulphate faction, therefore, it was obtained in sufficiently purr form
for infra-red spectroscopy. Earlier attempts to obtain compound
sufficiently pure for infra-red analysis had been unsuccessful. Figure 48
illustrates the infra-red spectra of compound and of synthetic 16(3-OH-
DHA. The two spectra are very similar, although there: i» some distortion
of the spectrum of compound U9 due to contaminants.
The evidence for the presence of 16P-0H-DHA in the diconjugated frac¬
tion of steroids obtained from urine excreted by infants is therefore
conclusive. It is not yet known, however, whether this compound is also
excreted as a monoconjugate.
3• The identification of 17a audrostenediol
After removing the steroids hydrolysed by the Helix poraatia enzyme
4
preparation, solvolysis of urine and olasma obtained from newborn infantsA
resulted in the extraction of more steroids. The principal steroid in this
solvolysis extract has been identified as 17a androstenediol (3p,17a-
dihydroxya drost-5-ene). This finding is of interest since the major
epimer of androstenediol produced by adults has a 17p hydroxyl group.
Since 17a androstenediol is not released from conjugation by the enzymes
present in the Helix poraatia preparation, it is probable that this steroid
is present in urine and in plasma as a diconjugate (probably disulphate).
17a Androstenediol obtained from urine was purified by two
Fig. 49. Identification of 17a Androstenediol by Infrared Spectroscopy












preparative TLC separations. The a drostenediol epimers were satisfac¬
torily separated from all other 3|3-OH-A"' steroids by two developments in
solvent system G. For the separation of 17a and 17p androstenediol,
however, it was necessary to use alumina (solvent system L), rather than
silica gel as the support: none of the solvent systems used for silica
gel chromatography was capable of resolving these epimers.
Following purification, part of the urinary 17a androstenediol
was transferred to an internal reflection plate for infra-red analysis.
It was found that the 17a androstenediol isolated from urine gave a
similar spectrum to reference 17a androstenediol (Fig. 49). There was,
however, a small peak in the carbonyl region of the spectrum due to an
impurity still prese t in the isolated compound.
A further portion of the purified steroid was analysed by gas
chromatography-mass spectrometry after formation of the trimethylsilyl
ether. The mass-spectrum recorded was identical to the spectrum of
standard 17a or 17p androstenediol trimethylsilyl ether (Figs. 62, 63),
since the fragmentation patterns of the two epimers could not be distin¬
guished. Gas chromatography on SE 30 stationary phase, however, resulted
in the separation of the two epimers, so a combination of the two
techniques in combined gas chromatography-mass spectrometry gave absolute
identification of both epimers. The retention times of 17a and 17p
androstenediol relative to DHA are given in Table 15*
17a Androstenediol extracted from urine collected from infants,
and from plasma obtained from the umbilical blood vessels, had Rf values
identical with standard 17a androstenediol in all the thin-layer solvent
systems used in this study. The isolated compound gave the same reaction
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with antimony trichloride as 17a androstenediol. 17(3 Androstenediol gave
a red-blue reaction with this reagent whereas 17a androstenediol produced
a grey-blue colour.
It has been suggested that the solvolysis of 17(3 androstenediol
disulphate may result in epimerisation of the 17p hydroxyl group to a 17a
hydroxyl group (Sjovall and Vihko, 1966). In order to show that 17a
androstenediol was not being formed as an artifact from 17p androstenediol
disulphate, a sample of the latter conjugate was prepared using the
technique of steroid sulphate formation described by Levitz (1963). The
product was purified by TLC using solvent system K. The formation of the
disulphate was indicated by the compound formed having an Rf value of 0.11,
compared with values of 0.79 for androstenediol and 0.42 for DHA sulphate.
In system K, free steroids, monosdphates and disulphates tend to run as
three groups with Rf. values similar to those indicated. After removal
from the plate, the silica gel containing the disulphate was eluted with
ethanol:water (50:50 v/v), the solvent was evaporated, and the residue was
hydrolysed by solvolysis for 24 hours. Subsequent chromatography on alumina
showed that only the 17p epimer of androstenediol was present so it can be
assumed that no epimerisation had taken place during solvolysis.
4. Identification of pregnenetriol
A substance of polarity similar to pregnenetriol was detected in
the solvolysis extract of urine obtained from infants. This steroid was
purified on a preparative scale by thin-layer chromatography in system C
(x3) and system H (x2). In these and other solvent systems, the compound
extracted from urine and standard pregnenetriol had identical Rf values.
Infra-red analysis of the purified steroid confirmed the identification,
Fig. 50. Infra-red Spectrum of Standard Pregnenetriol and of the




since the spectra of reference pregnenetriol and the steroid extracted
from urine were almost identical (Fig. 50). There was, however, a slight
impurity in the urinary steroid which absorbed at 1500 cm''.
Pregnenetriol was also detected in urine collected from adults,
although here it is probably present as a monoconjugate since it was
released from conjugation by the enzymes present in the Helix pomatia
preparation.
TABLE 16
The Identification of 3P-0H-A"* Steroids in Urine Samples
Obtained from Infants
5
The following 3p-0H-^A steroids have been sought, but have not
been found in an extract of pooled urine.
5 5















* Reference compounds for 15a-0H-DHA and 15P-0H-DHA were not
available. Since neither androst-5-ene-3p,15a,17p-triol nor
androst-5-ene-3p,15p,17p-triol could be detected in an extract
of urine which had been treated with sodium borohydride, it














III. THE ABSENCE OF CERTAIN 3P-OH-A5 STEROIDS FROM URINE
COLLECTED FROM INFANTS
Another approach to the characterisation of unknown steroids in
urine obtained from newborn infants has also been attempted. All the
3p-0H-A^ steroids listed in Table 16 have been sought in a pooled extract
of 200 ml. of urine collected from several infants. Although very many
unidentified steroids were detected when the extract was fractionated by
thin-layer chromatography, none of these unknown compounds had the same
mobility or gave quite the same colour with antimony trichloride as these
reference steroids. Although neither 3p,15a,17p-trihydroxyandrost-5-ene
nor 3p,15p,17p-trihydroxyandrost-5-ene could be detected, it was considered
that 15a-0H-DHA or ISp-OH-DHA might be present in the urinary extract;
however, no standards were available for these compounds. For this reason
a portion of the urinary extract was reduced with sodium borohydride so
that 15a-0H-DHA or 15P-0H-DHA, if present, would be reduced to 3p,15a,17p-
trihydroxyandrost-5-ene, and to 3p,15p,17p-trihydroxyandrost-5-ene. Neither
of these products could be detected.
The concentration of these 3P-0H-A"* steroids that would have been
detected in this analysis was of the order of 1/50 of the concentration of
the major 16-hydroxylated 3P-0H-A"* metabolites. The presence of these
compounds in urine collected from infants has therefore not been completely
excluded; if present, however, they are only present in small amount.
DISCUSSION
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1. The analysis of 33-OH-nA^ steroids in urine obtained from infants
Metabolites of DHA and pregnenolone with a carbonyl or hydroxyl
group at position 16 of the steroid nucleus were found to be quantitatively
the most important steroids in the urine samples collected from infants.
The presence in urine of a relatively large amount of these compounds,
together with the barely detectable amounts of DHA and pregnenolone can be
related to a high activity of 16a-hydroxylase and a low activity of 3(3-
hydroxy-dehydrogenase in foetal and infant tissues.
The major 16a-hydroxylated compound excreted by infants was
characterised as 16a-0H-pregnenolone, a steroid first identified by
Reynolds (1963). Other quantitatively important steroids that were
identified and measured included the three isomeric a-ketols, 16a-0H-DHA,
16-oxo-androstenediol and 16(3-OH-DHA. A reduction product of 16a-0H-DHA,
androstenetriol, was characterised during this study (Shackleton and
Mitchell, 1966) in extracts of urine obtained from infants and this compound
was simultaneously identified by other workers (Brooks _et aK, 1966;
Reynolds, 1966a). Although these 3p-0H-A^ steroids are so important, only
three quantitative studies have been made of their excretion by newborn
infants. For this reason Table 17 gives the mean results for the daily
excretion of the 16-oxygenated 3(3-OH-A~' steroids observed during the present
study, and in the studies of Reynolds (1965a,b, 1966a,b) and of Cleary and
Pion (1968). Considering the different methods used for the analysis of
tKese steroids — Reynolds used a method based on paper chromatography,
whereas Cleary and Pion used gas-chromatography and the great variation

























































between the results obtained in these studies is considered reasonable.
No relationship could be established between the weight of the
babies and the excretion of the 16-oxygenated steroids; there was, however,
a greater excretion of these compounds in thc9e infants studied who were
under a stress for which treatment with adrenocorticotrophin was to be given.
In the infants whose steroid excretion was determined for the first six
days of life, no constant pattern of daily excretion of steroids was
observed; there was considerable day to day fluctuation, an observation
also reported by Cleary and Pion (1968), who determined the excretion of
16a-0H-DHA and 16-oxo-androstenediol by individual infants during the
first three days of life.
The urinary 16-hydroxylated steroids arise principally by
hydroxylation of DHA and pregnenolone in the adrenal glands and liver of
the foetus and the newborn infant. The 16a-hydroxylase enzymes present in
each of these organs have different substrate specificity. From perfusion
experiments carried out with foetuses under conditions obtaining _in vivo,
4
it has been shown that 3-oxo-A steroids cannot be hydroxylated at position
16 by foetal liver, and that 3p-0H-A^ steroids do not act as substrates for
adrenal 16ot-hydroxylase (Solomon, 1966; Dell'Acqua et al., 1966). The
foetal liver will, therefore, only hydroxylate 3p-0H-A^ steroids in the
4
16a-position, and the adrenal glands will only act similarly on 3-oxo-A
steroids. The conversion of labelled pregnenolone to 16a-0H-pregnenolone
by foetal liver in vivo has been shown to occur at mid-pregnancy; it is,
therefore, probable that 16o-0H-DHA and 16a-0H-pregnenolone are formed
by foetal liver from DHA and pregnenolone supplied by the adrenal glands.
5
Although the formation of 16a-hydroxylated 30-OH-A steroids by foetal
Fig. 51. Possible Routes for the Synthesis of 16a-0H-DHA from
Pregnenolone by Pathways in which 16a-Hydroxylation Precedes
Cleavage of the Side-Chain.
These reactions may take place with the steroids either in the free







adrenal tissue has not been demonstrated under in vivo conditions, they
can be formed by foetal adrenal glands and newborn anencephalic adrenal
tissue in vitro (Villee and Loring, 1965; Shahwan et al., 1968).
Although 16a-OH-pregnenolone is produced in large amounts by the
foetus and by the newborn infant, this compound has no known function in
utero and it is generally accepted that 16a-0H-pregnenolone is merely
formed due to the high activity of 16a-hydroxylase in foetal liver. It
is possible, however, that 16a-OH-pregnenolone could be an intermediate
in the conversion of pregnenolone to 16o-0H-DHA by a pathway not involving
DHA as an intermediate (Fig. 51). Shahwan et al. (1968) have demonstrated
14
the conversion of C pregnenolone to 16o-0H-DHA by adrenal cortex t is*sua
from anencephalic foetuses. These workers did not, however, find any
conversion of pregnenolone to 3(3,16a,17a-trihydroxypregn-5-en-2O-one,
although this is presumably an essential intermediate in the process
leading to 16o-0H-DHA. There is evidence that such a pathway may be
important since Villee et al. (1967) have demonstrated by studies
conducted in vitro with foetal adrenal glands that pregnenolone is a
better precursor of 16a-0H-DHA than 17a^0H-pregnenolone, the classical
precursor of DHA. Slaunwhite and co-workers (1966) studied the conversion
3
in vitro of H 17a-OH-pregnenolone to 16a-OH-DHA by liver tissue obtained
from adults, and found no tritium associated with either DHA or
androstenediol. It was therefore concluded that 16o-hydroxylation must
precede cleavage of the side-chain, and that an intermediate such as
3(3,16a, 17a-trihydroxypregn-5-en-20-one must be involved. Villee and
Villee (1964) have demonstrated the formation of 16a,17a-dihydroxypregn-
4-ene-3,20-dione from progesterone during incubation studies with foetal
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adrenal tissue. It is therefore possible that the analogous 3p-0H-A^
steroid, 3p,16a,17o-trihydroxypregn-5-en-20-one is formed during synthesis
of I60&-OH-DHA, but is an exceptionally short-lived intermediate. This
compound was not detected in urine obtained from newborn infants.
Slaunwhite et al. (1965) demonstrated that foetal liver (in vitro)
could hydroxylate DHA both in the 16a and the 16(3 positions, but the
identification in the present study of 16P-0H-DHA in urine obtained from
infants provides the first evidence that 16p-hydroxylation does occur under
in vivo conditions. 16p-0H-DHA was found to be one of the major steroids
present in urine collected from infants, and this compound was often excreted
in larger quantity than I6a-0H-DHA. It is surprising, therefore, that
16P-0H-DHA had not been detected previously by other workers. Two isomers
of 16p-0H-DHA, 16-oxo-androstenediol and 1Co-OH-DHA, have been assayed in
urine obtained from infants (Reynolds, 1965a; Cleary and Pion, 1968) and
it is particularly difficult to separate 16p-0H-DHA from these compounds
by chromatographic techniques. It seems likely that the method used by
Reynolds (1965a) and by Cleary and Pion (1968) for extracting steroid
conjugates prior to solvolysis is unable to extract disulphated steroids
efficiently. Hydrolysis of the steroid conjugates by enzymes is probably
necessary for the analysis of 16P-0H-DHA in plasma and urine. Other 16p-
hydroxylated steroids have been isolated from several sources. A reduced
metabolite of 16P-0H-DHA, 3P,16p,17p-trihydroxyandrost-5-ene, was identified
in urine obtained from adults by Fotherby (1957) and it is significant that
none of this androstenetriol was detected in urine collected from infants,
even though some might be expected to be present as a reduction product of
16P-0H-DHA or 16-oxo-androstenediol. It is possible that the 16-carbonyl
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group of 16-oxo-androstenediol cannot be reduced enzymatically, or that
rapid disulpliation of 16(3-OH-DHA by the foetus prevents any further
metabolism by reduction of the ketone group at position 17. It is well
established that 16a-0H-DHA sulphate, elaborated by the foetal adrenal
glands and by foetal liver, is an important precursor of the oestriol
produced during pregnancy (see p. 11 )(Magendantz and Ryan, 1964; CoTSs
et al., 1964; Dell'Acqua et al., 1966), but it is not known whether
16P-0H-DHA is a precursor of the two 16f3-hydroxylated oestrogens, 16-
epioestriol and 16p-0H- >estrone, excreted by pregnant women. These
oestrogens have been assayed by Breuer (1964) in urine obtained from
pregnant women, and it is likely that these steroids are formed by pathways
similar to those utilised in the synthesis of oestriol, i.e. both by aroma-
tisation of 16p-0H-DHA and by 16p-hydroxylation of oestrone and oestradiol.
16-Qxo-androstenediol is another steroid which has no known function.
Reynolds (1964) considered that it was formed in the adrenal glands, but it
is possible that much of this 16-oxo-androstenediol assayed in urine
obtained from infants arises by isomerisation of 16p-0H-DHA during the
procedures of hydrolysis and extraction. It is therefore difficult to
determine how much has been formed enzymatically in foetal and newborn
infants tissues. Recently it has been shown that 16-oxo-testosterone can
be formed by perfusion of placentas with 16-oxo-androstenediol (Reynolds
et al., 1968), but it was not stated in this report whether there had been
any conversion to 16-oxo-oestradiol, a steroid found in urine obtained from
pregnant women (Breuer, 1964).
Dehydroepiandrosterone is the principal 3p-0H-A^ steroid excreted by
adults, but the amount of this compound excreted by infants is very low.
- 110 -
Nevertheless, an attempt was made to measure DHA in some of the samples
of urine collected from infants. The levels found during this study were
much lower than those reported by Lauritzen and Lehmann (1965, 1967), who
used the technique of Fotherby (1959). No explanation can be given for
the high results of these workers, but is is thought that their methods
were unreliable. Urine samples collected from five ii'ints (four samples
supplied by Dr. Lauritzen, and one provided from this study) were assayed
for DHA by Dr. Fotherby, and were found to contain between 2.5 and 7.5
/jfe/20 ml. urine, indicating a total daily excretion of about 6-15 /^g. It
is difficult to reconcile these results with those obtained by Dr. Lauritzen
who found normal values for daily excretion ranging between 70 and 250 /Hg./
24 hours. The finding in this study of only a small amount of DHA in the
urine collected from newborn infants is in agreeme it with the results
reported by Birchall et al. (1961), Cathro et al. (1963) and Paulsen et al.
(1966).
2. Control of the production of steroids by the foetus and by the newborn
infant.
Many of the 3P-0H-A"* steroids which form such a quantitatively
important group of steroids produced during pregnancy are probably precursors
of the oestroge s, progesterone and the corticosteroids. Although these
3P-OH-A*5 steroids are so important, relatively little is known of the
factors which control their production. If it is assumed that the level of
excretion of 3p-0H-A^ steroids by infants during the first few days of life
is proportional to their production, then a study of the effect of adreno¬
corticotropic and gonadotropic hormones upon their rates of excretion
should yield useful information, providing that it can be assumed that the
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production of these steroids still proceeds by the same mechanisms as were
used during pregnancy. As in later life, adrenocorticotrophin produced by
the foetal pituitary gland is of major importance in the regulation of
foetal corticosteroid synthesis. It is, however, likely that human
chorionic gonadotrophin secreted by the placenta also exerts some control
over steroid formation by the foetus.
Lauritzen and Lehmann (1965, 1967) showed that the administration
of adrenocorticotrophin to infants during the first xveek of life caused a
significant increase in the excretion of DHA, a precursor of oestrogen, but
the effect of stimulation by adrenocorticotrophin on the production of other
3(3-OH-A^ steroids by the foetus and newborn infant has not previously been
determined. In view of the relative unimportance of DHA in urine obtained
from newborn infants, measurement of this steroid was only attempted for
two of the infants studied, and the quantities found were very low even
during stimulation of the adrenals by adrenocorticotrophic hormone. Since
5
adrenocorticotrophin did have an effect on the excretion of all the 3p-0H-A
steroids measured, it is probable that adrenocorticotrophic hormone in foetal
4
blood has some influence on the production of oestrogens and 3-oxo-A
5
pregnenes (e.g. progesterone), since the 3p-0H-A steroids are almost
certainly precursors of these two groups of steroids. Further evidence
supporting this theory has been provided by Dassler (1966), who reported
that excretion of oestriol by women in late pregnancy was increased following
the infusion of adrenocorticotrophin; no such increase was obtained when
intra-uterine foetal death had occurred. These findings suggest that the
administration of adrenocorticotrophin stimulated the foetal adrenal glands
to produce more DHA; after 16a-hydroxylation in the foetal liver, the
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16a-0H-DHA was then converted by the placenta to oestriol.
The great Increase found in the excretion of Cortisol and its
metabolites by infants during treatment with adrenocorticotrophin agreed
with the increases in b .ood Cortisol in infants reported by Bertrand ejt al.
(1962) and Hillman and Giroud (1965). It is difficult to find an
explanation for the greater stimulation of Cortisol pro luction, as
compared with 3P-0H-A"* steroid production, but the following alternatives
exist
1. It is possible that adrenocorticotrophin specifically stimulates
steroid production by the cells of the adrenal cortex; these cells
are designed primarily to produce corticosteroids. This hormone may
have little effect on the synthesis of 3p-0H-A^ steroids by the foetal
zone of the foetal adrenal glands. If this is the case, there m-;st
5
be another hormone which controls the formation of the 3p~QII-A
steroids, the precursors of oestrogen.
2. Adrenocorticotrophin may stimulate steroid synthesis by the whole
adrenal gland. However, the potential of the cortical zone (a
developing tissue) for steroid synthesis may be greater than that of
the foetal zone (a degenerating tissue). Adrenocorticotrophin may
therefore be able to stimulate Cortisol synthesis to a greater extent.
The effect of human chorionic gonadotrophin on the production of
steroids by the newborn infant is even more complex than the effect of
adrenocorticotrophin. Lauritzen and Lehmann (1965, 1967) have shown that
DHA excretion by newborn infants is very significantly increased following
intramuscular administration of human chorionic gonadotrophin. These
workers were not able to measure the excretion of other 3(3-OH-A5 steroids,
TABLE 18
The Specificity of Action of Human Chorionic Gonadotroph!!! and
of Adrenocorticotrophin on Steroid Excretion by Newborn Infants
This table gives the mean factor by which the excretion of
individual steroids is increased as a result of administration of human
chorionic gonadotrophin or of adrenocorticotrophin to newborn infants.
These factors have been obtained by comparing the average excretion for
the three days when no treatment was given with the amounts excreted
for the three days when treatment was being given. The figures for the
infants treated with human chorionic gonadotrophin represent only the
average change in steroid production for the two infants who showed a




DHA >x 34 x 2
16a-OH-DHA x 1*04 x 2
Cortis >1 No increase >x 7
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but they did report that, in contrast to the action of adrenocorticotropic,
the 17-hydroxycorticosteroid excretion was not increased following
administration of human chorionic gonadotropic.
In this study the effect of htanan chorionic gonadotropic on the
5
production of all the major 3P-0H-A steroids was examined. Of the five
infants studied, none showed a significant increase in the excretion of
the 16-hydroxylated metabolites of DHA, but two of the infants showed a
considerable increase in the excretion of DHA. Findings for the excretion
of 17-hydroxycorticosteroids were in agreement with those of Lauritzen and
Lehmann (1967), as no increased excretion of Cortisol or of its reduced
metabolites was found. It appeared, therefore, that human chorionic
gonadotropic stimulated solely the excretion of DHA.
It may be significant that the two infants that showed an increased
excretion of DHA were premature (35 and 36 weeks gestation), as Lauritzen
and Lehmann (1967) demonstrated that premature infants responded to human
chorionic gonadotrophin to a greater extent than did infants born at term.
The extent to which the excretion of the three important steroids (DHA,
16o-0H-DHA and Cortisol) are increased by human chorionic gonadotrophin
and by adrenocorticotropic are given in Table 18. Average values have
been calculated for the increase in steroid production by adrenocortico¬
tropic, but for stimulation by human chorionic gonadotrophin only the
figures representing the two infants who showed an increased DHA excretion
have been included.
The origin of the large amounts of DHA produced during stimulation
with human chorionic gonadotrophin is unknown. It is likely that it is
formed in the adrenal glands, since this tissue normally produces large
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amounts of DHAj most of the DHA is further metabolised before being
excreted, for example, by 16-hydroxylation. Human chorionic gonadotrophin
may have more effect on the metabolism of DHA prior to excretion, than on
the synthesis of DHA by the adrenals. There is no direct evidence, that
human chorionic gonadotrophin can control steroid biosynthesis in the
foetal adrenal glands, but it has been shown that administration of this
hormone produces marked histological changes in the foetal adrenal glands
(Johannisson, 1968). Possibly the DHA formed during stimulation by human
chorionic gonadotrophin is synthesised in other foetal tissues, for example
by the foetal testes. However, for the purpose of this discussion, it will
be assumed that the excess DHA produced is synthesised in the adrenal
glands.
Since stimulation of steroid synthesis by human chorionic
gonadotrophin gives rise to an increase in the ratio of DHA to 16a-0H-DHA,
it could be argued that the 16-hydroxylating enzymes are saturated with the
excess of DHA produced. This seems unlikely, however, since the production
of 16-hydroxylated compounds is increased considerably by adrenocortico-
tr ?phin to levels about twice as high as those found in infants treated with
human chorionic gonadotrophin, and it is also unlikely therefore that the
16-hydroxylating enzymes are working at full capacity. It it also possible
that human chorionic gonadotrophin increases the excretion of DHA by
inhibiting the 16-hydroxylating systems in foetal tissue and tissues from
newborn infants. Thus human chorionic gonadotrophin may be concerned with
regulating the supply of DHA and 16a-0H-DHA to the placenta, where these
steroids serve as precursors for placental oestrone, oestradiol and oestriol.
If, as is suggested, human chorionic gonadotrophin acts in the foetus by
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increasing the ratio of DHA to 16oc-OH-BHA, an increase in the ratio of
oestrone and oestradiol to oestriol (i.e. 16-deoxy-oestrogen to 16-hydroxy-
oestrogen) would be the result of Luv action of human chorionic gonadotrophin.
This hormone would then directly control the ratio of "active" oestrogen
(oestradiol) to "inactive" oestrogen (oestriol) produced during pregnancy.
Adrenocorticotrophin may act to a limited extent as an antagonist of human
chorionic gonadotrophin, since it gives rise to a considerable increase in
the production of 16oc-OH-DHA which would in turn lead to an increased
synthesis of oestriol. This scheme is supported by the work of Dassler
(1966), who has shown that excretion of oestriol by pregnant women is
increased considerably following administration of adrenocorticotrophin.
In summary, it seems probable that both adrenocorticotrophin and
himan chorionic gonadotrophin are important for controlling steroid synthesis
by the foeto-placental unit. Adrenocorticotrophin has been shown to be
primarily involved in the control of Cortisol production, and to a more
limited extent in the control of oestrogen synthesis. The true role of
human chorionic gonadotrophin is still obscure, but it has been suggested
above that human chorionic gonadotrophin is probably concerned with
regulating the formation of oestrogens by the placenta, by controlling the
synthesis and metabolism of DHA in the foetus.
3. The excretion of steroids by infants with congenital adrenal hyperplasia
During the course of this study an extensive analysis was made of the
steroids excreted by an infant with congenital adrenal hyperplasia. This
disorder is normally related to a reduced production of Cortisol by the adrenal
glands since deficiency of Cortisol leads to an excessive secretion of
adrenocorticotrophin by the pituitary gland, and this in turn causes
Fig.52
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3(3,17a,21-trihydroxypregn-DHA 5-en-20-one 3(3,17a,20a,21-tetra- hydroxypregn-5-ene
16a-OH-DHA
(InsufficientCortisolipr ducedt suppresstheformationofadrenocortico¬ trophinbythepituitary)
Pregnenetriol
Major alternative pathways followed when
there is a deficiency of either enzyme
Major alternative pathways followed when
there is a deficiency of 3(3-hydroxy-
dehydrogenase
Major alternative pathways followed when
there is a deficiency of 21-hydroxylase
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continuous adrenal stimulation. The abnormally low production of Cortisol
is due to a defect in one of the enzyme systems required for the synthesis
of this compound; this defect leads to an increased production of those
steroids whose synthesis is not affected by the enzyme block. Since the
3p-0H-A^ steroids are precursors of all other types of steroid, a defect
in most of the enzyme systems required for Cortisol synthesis leads to an
increased production and excretion of compounds with this structure.
Three forms of congenital adrenal hyperplasia are associated with
an increased production of 3p-0H-A"* steroids due to inadequate adrenal
suppression. These are (a) a deficiency (or inactivity) of 21-hydroxylase
(the most common form of the disorder); (b) a deficiency (or inactivity)
of 3p-hydroxydehydrogenase; and (c) a deficiency of lip-hydroxylase. Since
the infant studied (patient S.G.) excreted large amounts of the 11-oxo-
17-oxosteroids, inactivity of one of the enzymes required for lip-hydroxy-
lation is unlikely. This discussion of the results will therefore be
limited to a consideration of the means of distinguishing a defect in
21-hydroxylase from a deficiency of 3p-hydroxy-dehydrogenase. Figure 52
illustrates the enzymic defects present in these forms of the disorder,
and the major metabolic pathways for steroids utilised as a result of these
defects.
Eberlein (1966) and Reynolds (1965b) showed that congenital
adrenal hyperplasia due to a 21-hydroxylase defect was associated with a
5
greatly increased excretion of the 3p-0H-A steroids normally excreted by
newborn infants. Bongiovanni (1962) reported two cases of congenital
adrenal hyperplasia due to a deficiency of 3p-hydroxy-dehydrogenase, the
diagnosis being based on the large amounts of 3p-0H-A"^ steroids which were
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excreted. Since both a lack of 21-hydroxylase and of 3(3-hydroxy-
dehydrogenase results in increased production of 3(3-OH-A~' steroids, the
position of the metabolic block is often difficult to ascertain.
The most marked abnormality of steroid metabolism in patient S.G. on
the seventh day of life (the first day when urine was collected) was the
excretion of a much larger amount of 3P-0H-A"* steroids than is normally
excreted by infants. There appeared to be no abnormality of a qualitative
nature; all the usual 3P-OH-A"3 steroids were present in the urine in
approximately the normal proportions, and there was no evidence of an
increased amount of any unusual 3(3-OH-A^ steroids (e.g. DHA or pregnenetriol)
or pregnanetriol. However, 21-hydroxylase deficiency in the first few days
of life is not always associated with an increased excretion of pregnanetriol
(Eberlein, 1966). Because of the difficulty of measuring urinary
pregnanetriol during the first few days of life (Eberlein, 1966), and the
abnormally high urinary levels of 3(3-OH-A^ steroids present both in the
3(3-hydroxy-dehydrogenase and the 21-hydroxylase types of the disorder, it
is useful to study the excretion of a 21-hydroxylated steroid, e.g. 21-0H-
pregnenolone.
Cathro et al. (1965) described a three day old infant suspected of
having a deficiency of 3p-hydroxy-dehydrogenase and who excreted an
excessive amount of 21-OH-pregnenolone; these workers used this finding as
a means of diagnosing 3p-hydroxy-dehydrogenase deficiency. Reynolds (1965b)
found that the ratio of 16a-OH-pregnenolone excretion to 16a-0H-DHA
excretion was greater for infants with 21-hydroxylase deficiency than for
normal infants. However, for the diagnosis of a 21-hydroxylase block, it
would be more valuable to measure the ratio of 16a-0H-pregnenolone to
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21-OH-pregnenolone since this ratio would presumably be very much higher
than normal when deficiency of this enzyme existed. This is only true
providing it is assumed that a single hydroxylating system catalyses the
21-hydroxylation of all steroids. A large amount of 21-OH-pregnenolone was
detected in the urine of patient S.G. on the seventh day of life, but the
ratio of 16a-OH-pregnenolone to 21-OH-pregnenolone was within the normal
range, although it was slightly low compared to the average values for
normal infants. Initially, it was concluded that the patient did not have
21-hydroxylase deficiency, but that there was a congenital deficiency of
3|3-hydroxy-dehydrogenase. There were several important differences, however,
when the steroid excretion of patient S.G. was compared with earlier cases
studied by other workers. Bongiovanni (1962) found that the steroids mainly
excreted by patients wi :h this disorder were DHA, pregnenetriol, and 30,17a,
20a,21-tetrahydraxypregn-5-ene; these steroids were only excreted in small
quantity by patient S.G.. According to Bongiovanni (1966), DHA is the major
17-oxosteroid excreted in this form of adrenal hyperplasia, whereas a high
excretion of 11-oxygenated 17-oxosteroids is more usual for 21-hydroxylase
deficiency. Therefore, from a study of the steroids excreted by patient
S.G. on the seventh day of life, the results obtained were ambiguous and no
definite metabolic defect could be ascertained.
A more typical pattern emerged with the second collection, when a
fall in the excretion of 21-OH-pregnenolone was associated with the
appearance of relatively large quantities of pregnanetriol in the urine.
The ratio of 16a-0H-pregnenolone to 21-OH-pregnenolone (30/1) was now above
normal for an infant of this age; it therefore appeared that the patient had
a partial deficiency of 21-hydroxylase.
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Cathro ej; al. (1965) give as evidence for 30-hydroxy-dehydrogenase
deficiency the large amount of 21-OH-pregnenolone present in urine obtained
from an infant with congenital adrenal hyperplasia, but the assay of this
steroid alone amongst the 3P-OH-A5 steroids is inadequate for diagnosis
since this finding does not exclude a detect in 21-hydroxylase. The
excretion of 21-OH-pregnenolone by patient S.G., who had 21-hydroxylase
deficiency, was seven times greater than the average value for newborn
infants. This study demonstrated, therefore, the difficulty in identifying
positively the enzyme deficient in newborn infants with congenital adrenal
hyperplasia solely by the assay of the major urinary steroids. The
investigation of the urinary steroids of patient S.G. also emphasised the
need to study the excretion of steroids on more than one day, since a very
significant change (both qualitative and quantitative) occurred between the
st /enth and eighth days of life.
4. The assay of steroids in plasma obtained from the umbilical cord.
The assay of steroids present in venous and arterial plasma obtained
from the umbilical blood vessels showed that the 3p-0H-A^ steroids were
almost invariably present in greater concentration in arterial plasma than
in venous plasma. This finding indicates that they are synthesised by the
foetus and agree with the recent findings of other workers in respect of
pregnenolone, DHA and 16<*»0H-DHA (Colas £t al., 1964; Simmer et al., 1966;
Conrad et al., 1567). It is well established that DHA sulphate and
I600-GH-DHA sulphate are precursors of oestrogens, and two infants studied
who were born to mothers having low urinary oestriol excretion (one due
to corticosteroid therapy) gave low values for DHA and 16a-0H-DHA in plasma.
This agrees with the findings of Simmer and Easterling and their co-workers
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(Simmer et al.. 1966; Easterling et al., 1966).
There was only a slight degree of correlation between normal levels
of the oestrogens excreted by the mother, and DHA and 16a-0H-DHA assayed
in plasma obtained frcm the umbilical blood vessels. This is partly due
to the fact that DHA sulphate produced by the mother is also an important
precursor of oestrogen (Kirschner et al., 1966). The results given for
the plasma levels of pregnenolone, DHA and 1C j£-0H-DHA are similar to those
reported by other workers; the comparative results of four studies are
presented in Table 19.
The level of androstenetriol sulphate in plasma obtained from the
umbilical cord, although only accurately determined in a sample of pooled
venous plasma, was very snail compared to the concentration of 16o-0E-DHA
sulphate (about 1/20). It is therefore unlikely that this steroid is a
significant precursor of oestriol even though it is more similar in
structure to oestriol than 16a-0H-DHA. Thus, it is almost certain that
reduction of the 17-carbonyl group occurs after aromatisation of the
neutral steroid by the placenta.
Dell'Acqua et al. (1966) have demonstrated by perfusion of
placentas in situ that 16oc-OH-DHA is a better precursor of oestriol than
is androstenetriol. By employing similar techniques it was shown that
16oc-OH-androstenedione was a better precursor of oestriol than is 16a-0H-
testosterone. These workers suggested that the vicinyl 16a,17p-hydroxyl
groups of androstenetriol and of 16a-0H-testosterone interfered with the
removal of the angular methyl group at position C-10 of the steroid
molecule.
Pregnenolone sulphate was first detected in plasma obtained from
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the umbilical blood vessels by Eberleii (1965b) and it has been determined
in arterial and venous plasma obtained from the umbilical cord by Conrad
et al. (1967) who found it to be in considerably greater concentration in
the arterial samples. The determinations reported in this thesis agree
with this finding; it therefore seems likely that a considerable amount of
pregnenolone sulphate is synthesised by the foetus and taken up by the
placenta. Solomon (1966), however, consider^ that the foetus is not an
important producer of pregnenolone because acetate and cholesterol are
poor precursors of neutral steroids in the adrenal glands of the foetus,
although acetate and cholesterol are active precursors of pregnenolone in
the placenta. From the results reported here, and from the work of
Conrad et al. (1967), it is clear that relatively large amounts of
pregnenolone sulphate i ust be synthesised by the foetus. The pregnenolone
sulphate present in the umbilical circulation must arise solely from the
foetus, since the level of this compound is higher in the umbilical
arteries than in the vein. Pregnenolone may be produced in greater amount
by the placenta than by the foetus but little, if any, escapes into the
umbilical circulation. Pion et al. (1966) demonstrated that pregnenolone
was an extremely efficient precursor of progesterone in the placenta and
it is likely that some of the progesterone elaborated during pregnancy is
formed from pregnenolone sulphate synthesis, d by the foetus. Host however
is, or can be, synthesised from pregnenolone produced in the placenta from
maternal cholesterol since death of the foetus does not result in a marked
reduction of pregnanediol excretion by the mother.
The steroid assays carried out on plasma obtained from the umbilical
cord have also indicated that pregnenolone or pregnenolone sulphate is
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metabolised by the foetus into 17a-OH-pregnenolone sulphate, 21-0H-
pregnenolone disulphate, pregnenediol sulphate and pregnenetriol
disulphate. Diczfalusy (1966) considers that pregnenolone metabolites
4
such as these produced by the foetus could be converted into 3-oxo-A
steroids on reaching the placenta, these steroids then being recirculated
to the foetus. If this scheme is at all important in corticosteroid
synthesis, then it will only be possible to form corticosterone sulphate
(and not free corticosterone) since 21-OH-pregnenolone is present as a
disulphate, and the placenta has little or no 21-sulphatase activity
(Pasqualini and Diczfalusy, 1966). It is more likely that 17os-OH-
pregnenolone are intermediates in the synthesis of corticosteroids in the
foetus and only "escape" Into the foeto-placental circulation.
Pasqualini et ai_. (1968) have demonstrated the formation of
labelled Cortisol by foetuses perfused with blood containing labelled
3f3,17a,21-trihydroxypregn-5- en -20-one. This study indicated that the
foetus has a 3p-hydroxy-dehydrogenase capable of performing this conversion
even in the absence of an enzyme for the conversion of pregnenolone to
progesterone. It is therefore probable that the foetus has 3(3-hydroxy-
dehydrogenase enzymes capable of converting 17a-0H-pregnenolone and 21-0H-
4
pregnenolone into the analogous 3-oxo-A steroids.
The hydroxylated pregnenolone derivatives detected and assayed in
this study have all been previously characterised in plasma obtained from
the umbilical blood vessels (Eberlein, 1965b), but none have been previously
measured quantitatively.
Plasma obtained from the umbilical cord and urine collected from
infants have also been shown in this study to contain a relatively large
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amount of 17a androstenediol disulphate, a steroid conjugate which has
recently been detected in small quantity in peripheral plasma obtained from
adults by Sjovall a id Vihko (1966, 1968). These workers demonstrated that
the major conjugate of androstenediol present in plasma obtained from
adults was 17(3 androstenediol monosulphate. Eberlein (1965b) detected
17(3 androstenediol in the sulphate fraction prepared from blood samples
collected from the umbilical cord at a concentration of about 5jhg./l00 ml.,
although this compound was possibly not distinguished from its 17a epimer.
It is surprising, however, that Eberlein (1965b) did not detect the large
quantity of androstenediol reported in the present study; this may have
been due to an inadequate recovery of disulphated steroids by the method
used in his analyses.
Bolte jet al. (1966) isolated 17(3 androstenediol monosulphate after
perfusion of the foeto-placental unit (in vivo) with DHA and DI1A sulphate.
The monosulphated steroids from this experiment were separated by paper
chromatography and were identified after hydrolysis. No attempt was made
to isolate any disulphated steroids, and this may be a reason way Bolte
et al. (1966) did not find any conversion to 17a androstenediol monosulphate
as it was possibly formed but immediately converted to the disulphate.
Since these experiments were carried out at mid-pregnancy, the development
of 17a-dehydrogenase activity later in pregnancy cannot be excluded. These
workers found that 170-dehydrogenase activity was located principally in
the adrenal glands and liver and it seems probable that the 17a-dehydro-
genase will also be located in these tissues. Foetal tissue is capable of
forming 170-sulphate esters of steroids at mid-pregnancy, since Mancuso e£ al.
(1967) have reported the formation of testosterone sulphate by foetal









The probable biosynthetic pathway for the formation of 17a
androstenediol disulphate is illustrated in Fig. 53. Baulieu and Dray
(1963) have demonstrated the formation of 170 androstenediol monosulphate
from DHA sulphate under in vitro conditions by experiments employing
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doubly labelled steroid sulphates ( C and S). These experiments proved
that 170 androstenediol monosulphate could be formed from DHA sulphate
without hydrolysis of the sulphate esters. The reverse reaction has been
demonstrated by Baulieu et al. (1963), a finding also reported by Roberts
et al. (1964). Assuming that 17a androstenediol disulphate is formed
from DHA sulphate, the difference between the reduction products of DHA
produced by infants and by adults is particularly interesting, since the
major metabolite in infants and in the foetus is 17a androstenediol
disulphate whereas the major metabolite formed by adults is 170 androstene¬
diol monosulphate. The reason for this difference in metabolism is not
known. 17a-Hydroxy-Cl9-steroids are hormonally inactive so the preferential
formation of this epimer by the foetus and by the newborn infant is unusual.
•re.
Not all 17-oxo-C19 steroids produced by the foetus are prefentially
reduced to 17a-hydroxy steroids. 30,16a,170-trihydroxyandrost-5-ene
(androstenetriol) is the major metabolite of l6a-0H-DHA; no 30,16a,17a-
trihydroxyandrost-5-ene has yet been detected in extracts of plasma or urine.
It is possible that only a small amount of 17a androstenediol is actually
formed compared to 17(3 androstenediol, but the 17a epimer may not be so
extensively metabolised as the 170 epimer (e.g. by I6a-nydroxylation).
The metabolism of 17a androstenediol disulphate by the foeto-placental
unit is not known but it is possible that this compound could be metabolised
to cis-testosterone sulphate by the placenta (Fig. 54); cis-testosterone
Fig. 54. Possible Pathway for the Formation of 17a Oestradiol
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sulphate has recently been identified in adult peripheral blood by Dray et
al. (1967). Cis-testosterone sulphate could in turn be aromatised to 17a
oestradiol sulphate, a compound which has been identified by Schott and
Katzmann (1964) in urine obtained from pregnant women. However, this is
unlikely since testosterone sulphate cannot be aromatised by the placenta
under in vitro conditions (Baulieu et al., 1965) and this would indicate
that hydrolysis of the sulphate group must occur before aromatisation can
take place. It is not yet known whether the placenta has the necessary
sulphatase for the removal of a 17a-sulphate group, but French and Warren
(1966) have shown that this tissue has no 17p-sulphatase activity. Mancuso
et al. (1967) demonstrated that testosterone sulphate was formed by foetuses
perfused with testosterone, and suggested that this compound accumulated in
the foeto-placental unit due to the relative lack of any further metabolism,
and to the difficulty that steroid conjugates have in crossing the placental
barrier into the mother. If accumulation of this type is possible, 17a-
androstenediol disulphate could also share the same fate, and the level of
this compound in the foeto-placental circulation may not be directly related
to the actual production by the foetus. In this scheme, 17a-androstenediol
disulphate has no role to play in the biosynthesis of steroids by the
foeto-placental unit, but is merely an end product of the metabolism of
DHA sulphate. It will be necessary to study further the biosynthesis of
this compound by the foetus and its metabolism by the foeto-placental unit
before its importance can be properly assessed.
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5. The characterisation of unknown steroid metabolites present in urine
obtained from newborn Infants
It is evident that many of the unknown steroids present in urine
collected from infants have hydroxyl or ketone groups at unusual positions
in the steroid molecule. For this reason, several steroids were synthesised
during the course of this study (Tasle 16) for reference purposes, but none
of these has been detected yet in extracts of urine.
Several workers in recent years have demonstrated that steroids can
be hydroxylated by mammalian enzyme systems in positions other than the
classical ones. Knuppen et al. (1966) demo strated the formation by foetal
tissue in vivo and in vitro of oestrogens hydroxylated at the 2, 6a, 15a,
16a and 16p positions* In addition, these workers identified 15P-GH-
oe3trone and 15f3-OH-oestradiol in urine obtained from pregnant women, and
Lisboa e_t aK (1967) identified 15a-0H-oestradiol from the same source.
Zucconi et al. (1967) identified 15oc-OH-oestriol in urine obtained from
newborn infants and pregnant women; this was the first report of a naturally
occurring human steroid with three functional groups in the D ring.
Studies on the aromatisation of androstenedione and of testosterone
by foetuses at midpregnancy showed that 15a-hydroxylated phenolic
metabolites were formed by the foetal liver (Mancuso et al.. 1968). However,
these workers could not isolate any 15a (or 16a)-0H-androstenedione or
15a (or 16a)-0H-testosterone from the foetal livers. This suggested that
15a-hydroxylation only occurred with oestrogens. Since 16a-hydroxylation
by liver enzymes occurs both with oestrogens and with 3p-0H-A^ steroids, it
was considered that the foetal liver might also be capable of effecting the
15a-hydroxylation of 3p-0H-A~' steroids because it could hydroxylate oestrogens
- 127
in the 15 position. In this study, standard 3p,15oc,17p-trihydroxyandrost-
5-ene and 3p,15p,17p-trihydroxyandrost-5-ene were synthesised, but no
evidence was found for the presence of either of these two compounds (or
of 15a-0H-DHA) in urine collected from newborn infants. It is therefore
likely that 15ac-hydroxylated oestrogens are formed by direct hydroxylation,
in contrast to the formation of 16a-hydroxylated oestrogens (e.g. oestriol)
which are principally formed from neutral 16a-hydroxylated compounds
(e.g. 16O-0H-DHA).
No evidence has been found for the presence of 18-OH-DHA or of
3p,17|3,18-trihydroxyandros t-5-ene, although 18-OH-oestrone has been detected
by Loke et al, (1957) in urine collected from pregnant women, and 18-0H-
androsterone and 18-OH-aetiocholanolone have been identified in urine
collected from adults (Fukushima et al.. 1962).
11-Oxygenated 3P-9H-A"' steroids were not detected in urine or plasma,
although two compounds (3p,17o,21-trihydroxypregn-5-ene-ll,20-dione and
3p,lip,17a,21-tetrahydroxypregn-5- en-20-one) have been provisionally
identified by Eberlein (1965b) in plasma obtained from the umbilical blood
vessels. Another of the steroids sought, 3p,lip,16a-trihydroxyandrost-5-en -
17-one, was a steroid which had previously been tentatively identified by
Brooks et al. (1966) in urine obtained from infants. However, thin-layer
chromatography did not reveal the presence in urinary extracts of any steroid
with mobility similar to this compound.
14a-0H-oestrone has recently been shown to be a major metabolite of
oestrone in bovine adrenal tissue (Knuppen et al., 1967) but it was not
found by these workers in urine obtained from pregnant women. No 14a-0H-DHA
was detected in urine collected from infants.
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Evidence has been presented by O'Kelly and Grant (1967) and by
Fahmy £t al. (1967) for the formation of 19-OH-DHA as an intermediate in
the synthesis of oestrogens. It will be of interest to examine extracts
of urine for the presence of this compound and its 16a-hydroxy metabolite
(3|3,16a,19-trihydroxyandrost-5- en -17-one).
6. Concluding remarks
Analysis of the steroids excreted in urine by infants has revealed
the presence of many compounds which are absent from urine collected from
adults. Several of the quantitatively important steroids have been
characterised, but there are many more of which the structures are still
unknown.
Three populations of steroids may be considered to be formed and/or
metabolised by the foetus and newborn infant. These steroids may be
expected to be constituents of urine collected from infants and of plasma
obtained from the umbilical blood vessels.
1. Steroids arising from the metabolism of the large quantities of
oestrogen and of progesterone received from the placenta.
2. Metabolites of 3(3-OH-A"^ steroids produced by the foetus for
conversion by the placenta into oestrogens and progesterone (e.g.
16a-0H-DHA and 16a-OH-pregnenolone). Steroids used by the foetus in
the biosynthesis of corticosteroids may also be considered in this
group (e.g. 21-0H-pregnenolone and 17a-0H-pregnenolone).
3. Metabolites of androgens, Cortisol and other corticosteroids
(corticosteroid and androstane derivatives containing a 3a-OH-5a
(or 5(3) group).
Steroids with a 3(3-OH^A"* group form quantitatively the most important
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group of steroids found in urine excreted by infants. This indicates that
the foetus produces much more of these "precursor steroids" than is ever
converted into active hormones. The situation in adults is very different
since the steroids mainly present in urine are 3a-OH-5|3 (or 5a) metabolites
of the androgens or of the corticosteroids. The cause of this difference
in the pattern of excretion is a continuation into extrauterine life of
synthetic systems for steroids developed for use jja utero. The relatively
small proportion of Cortisol metabolites in urine obtained from infants
renders their investigation, and therefore the investigation of Cortisol
production, difficult. It was found impossible in the present study to
determine the production of Cortisol by an infant with congenital adrenal
hyperplasia. For this reason diagnosis of a 21-hydroxylase defect was based
on the excessive excretion of 3|3-(ffl-A^ steroids, the high ratio of 16a-0H-
pregnenolone to 21-OH-pregnenolone and the presence of pregnanetriol in the
urine.
The results reported in this study suggest that human chorionic
gonadotrophin and adrenocorticotrophin play an important part in the control
of steroid formation during pregnancy. Both hormones are available to the
foetus (human chorionic gonadotrophin from the placenta, adrenocorticotrophin
from the foetal pituitary) and it is suggested that adrenocorticotrophin
controls Cortisol synthesis whereas human chorionic gonadotrophin controls
the synthesis of foetal precursors of oestrogen. It is possible that human
chorionic gonadotrophin increases DBA (and oestrone) synthesis by inhibiting
foetal 16a-hydroxylase.
Many steroid-like compounds present in urine obtained from infants
have still to be identified, and it may be several years before the metabolism
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of steroids by the foetus and newborn infant has been fully elucidated.
A complete understanding of the metabolism of steroids will only be
obtained by gathering together information obtained by perfusion studies,
incubation experiments, and the analysis of steroids in urine, amniotic
fluid, plasma and foetal tissue.
- 131 -
BIBLIOGRAPHY
Allen, W, H, (1953), In discussion of Hunt, A. B., and McConthey, W. M.
Arner.J.Obstet.Gynecol., j66, 970,
Appleby, J. I, and Norymberski, J. K. (1957). J.Endocrinol., 15, 310.
Baulieu, E.-E., and Dray, F. (1S63). J.Clin.Endocrinol.Metab., 23, 1298.
Baulieu, E.-E., Corpechot, C. and Emiliozzi, R. (1963). Steroids, 2, 429.
Baulieu, E.-E., Corpechot, C., Dray, F., Emiliozzi, R., Lebeau, M.-C. and
Mauvais-Jarvis, P. (1965). Recent Progr. Hormone Res., 21, 411.
Bengtsson, G., Ullberg, S., Wiqvist, N., and Diczfalusy, E. (1964).
Acta Endocrinol., 46, 544.
Bertrand, J., Gilly, R., and Loras, B., (1962). In: "The Human Adrenal
Cortex" (A. R. Currie, T. Symington and J. K. Grant, eds.),
p. 608. Livingstone, Edinburgh and Lon ' ;.
Bertrand, J., Loras, B., Gilly, R., and Cautenet, B. (1963).
Pathol. Biol., JJL, 997.
Birchall, K., Cathro, D. M., Forsyth, C. C., and Mitchell, F. L. (190").
Lancet, JL, 26,
Birchall, K., Cathro, D. M., Forsyth, C. C., and Mitchell, F. L. (1963).
J. Endocrinol., 27, 31.
Birchall, K., and Mitchell, F. L. (1965). Steroids, _6, 427.
Bloch, E. (1966). Excerpta Med. Int. Congr. Ser., 132, 64.
Bloch, E., and Benirschke, K. (1959). J.Biol.Chem., 234, 1085.
Bloch, E., Romney, S.L., Klein, M., Lipiello, L., Cooper, P., and
Goldring, I.P. (1965). Proc. Soc. Exp. Biol. Med., 119, 449.
Bolte, E., Mancuso, S., Eriksson, G., Wiqvist, N., and Diczfalusy, E.
(1964). Acta Endocrinol., 45, 535.
- 132
BoltfT, E,, Wiqvist, N., and Diczfalusy, E. (1966). Acta Endocrinol.,
52, 583.
Bongiovanni, A. M., (1962). J.CIin.Invest., 41, 2086.
Bongiovanni, A. M. (1966). Excerpta Med. Int. Congr. Ser., Ill. 96.
Bongiovanni, A. M., Eberlein, V. R., Westphal, M., and Boggs, T. (1958).
J. Clin. Endocrinol. Metab., 18^, 1127.
Breuer, II. (1964). In: "Research on Steroids', (C. Cassano, Ed.),
vol. 1, p.133. Il. Pensiero Scientifico, Rome.
Brooks, C. J. W. (1966). Personal communication.
Brooks, C. J. W., Chambaz, E. M., Gardiner, W. L., and Horning, E. C.
(1966). Excerpta Med. Int. Congr. Ser., 132, 366.
Bud^ikiewicz, H., and Djerassi, C. (1962). J. Amer.Chem.Soc., 84, 1430.
Budzikiewicz, H., Ijerassi, C., and Williams, D. H. (1964). "Structure
Elucidation of Natural Products by Mass Spectrometry", vol. 2,
Holden Day, Inc., San Francisco.
Burstein, S., and Lieberman, S. (1958). J.Biol.Chem., 233, 331.
Bush, I.E. (1961). "The Chromatography of Steroids", p. 358. Pergamon
Press, London.
Cathro, D. M., Birchall, K., Mitchell, F. L., and Forsyth, C. C. (1963).
J. Endocrinol., 27, 53.
Cathro, D. M., Birchall, K., Mitchell, F. L., and Forsyth, C. C. (1965).
Arch. Dis. Childhood, 40, 251.
Cleary, R. E., and Pion, R. J. (1968). J. Clin. Endocrinol. Metab.,
28, 372.
Colas, A., and Heinrichs, W. L. (1965). Steroids, jj, 753.
- 133
Colls, A., Heinrichs, W. L., and Tatum, H. J. (1964). Steroids, J3, 417.
Conrad, S. H., Pion, R. J., and KitchiJ. D. (1967). J. Clin.
Endocrinol. Metab., _27, 114.
Coyle, M. G., and Brown, J. B. (1963). J. Obstet. Gynaecol. Brit. Cwlth.,
20, 225.
Dassler, C.-G. (1966). Acta Endocrinol., 52i, 401.
Dell'Acqua, S., Mancuso, S., Benagiano, G., Wiqvist, N., and Diczfalusy, E.
(1966). Excerpta Med. Int. Congr. Ser., 132, 639.
Diczfalusy, E. (1966). Excerpta Med. Int. Congr. Ser., "132, 82.
Diczfalusy, E. (1968). Personal communication.
Diczfalusy, E,, and Troen, P. (1961). Vitamins Hormones, 19, 229.
Diczfalusy, E,, Pion, R., and Schwers, J. (1965), Arch. Anat. Microsc.
Morphol, Exp,, _54, 67,
Dohmann, K, (1965), Laboratory Practice, L4, 808,
Doisy, E. A., Veler, C. D., and Thayer, S, A. (1929). Amer. J. Physiol .,
20, 329.
Dray, F., Mowszowicz, I., and Ledru, M.-J. (1967). Steroids, 10, 501.
Easterling, W. E., Simmer, H. H., Dignam, W. J., Frankland, M. V., and
Naftolin, F. (1966). Steroids, _8> 157.
Eberlein, W. R. (1962). J. Clin. Endocrinol. Metab., _22, 963.
Eberlein, W. R. (1965a). J, Clin. Endocrinol. Metab., _25, 288.
Eberlein, W. R. (1965b). J. Clin. Endocrinol. Metab., _25, 1101.
Eberlein, W. R. (1966). Excerpta Med. Int. Congr. Ser., 132 , 687.
Ekholm, E., and Niemineva, K. (1950). Acta Paediat. Scand., 2£» 67.
Eneroth, P., Hellstrom, K., and Ryhage, R. (1964). J. Lipid Res., 2» 245.
Eneroth, P., Hellstrom, K., and Ryhage, R. (1965). Steroids, j6> 707.
- 134 -
Fahmy, D., Griffiths, K., and Turnbull, A. C. (1967). Eur. J. Steroids,
2, 483.
Flood, C., Layne, D. S., Ramchara, S., Rossipal, E., Tait, J. F., and
Tait, S. A. S. (1961). Acta Endocrinol., J36, 237.
Fotherby, K. (1957). Biochem. J., 61[, 25p.
Fotherby, K. (1958). Biochem. J., j>9, 596.
Fotherby, K. (1959). Biochem. J., _73, 339.
Fotherby, K., James, F., Kamyab, S., Klopper, A. I., and Wilson, G. R.
(1965). J. Endocrinol., 33, 133.
Frandsen, V. A., and Stakemann, G. (1961). Acta Endocrinol., 38, 383.
Frandsen, V. A., and Srakemann, G. (1963). Acta Endocrinol., 44, 183.
French, A. P., and Warren, J. C. (1966). Steroids, jJ, 79.
Fukushima, D. K., Bradlow, H. L., Hellman, L., and Gallagher, T. F. (1962),
J. Biol.Chem., 237, 3359.
Gardiner, W. L., and Horning, E. C. (1966). Biochim. Biophys. Acta, 115, 524.
Hamman, B. L., and Martin, M. M. (1964). J. Clin. Endocrinol. Metab.,
24, 1195.
Henry, R., and Thevenet, M. (1952). Bull. Soc. Chira. Biol. (Paris),
34, 886.
Hillman, D. A., and Giroud, C. J. P. (1965). J. Clin. Endocrinol.
Metab., _25, 243.
Hillman, D. A., Stachenko, J., and Giroud, C. J. P. (1962). In: "The Human
Adrenal Cortex", (A. R. Currie, T. Symington, and J. K. Grant, Eds.),
p. 596. Livingstone, Edinburgh and London.
Hobkirk, R., and Cohen, J. J. (I960). Can. J. Biochem., ^8, 769. ,
- 135 -
Horning, E. C., Gardiner, W. L., and Brooks, C. J. W. (1966). Excerpta
Med. Int. Congr. Ser., 132, 197.
Huffman, M. N., MacCorquodale, D. W., Thayer, S. A., Doisy, E. A., Smith,
G. V., and Smith, 0. W. (1946). J. Biol. Chem., 143, 591.
Hughes, E. R., Seely, J. &., Kelly, V. C., and Ely, R. S. (1962).
Amer. J. Dis. Child., 104, 605.
Iwamiya, M., Tweedie, F. J., and Solomon, S. (1966). Quoted by
Solomon (1966).
James, A. T., Ravenhill, J. R., and Scott, R. P. W. (1964). Chem. Ind.
(London), 746.
Jarrige, P. and Henry, R. (1952). Bull. Soc. Chira. Biol. (Paris),
34, 972.
Johannisson, E. (1968). Acta Endocrinol., Suppl. 130.
Jayle, M. F., and Baulieu, E.-E. (1954). Bull. Soc. Chim. Biol. (Paris),
36, 1391.
Kirschner, M. A., Wiqvist, N., and Diczfalusy, E. (1966). Acta Endocrinol.,
53, 584.
Kliman, B., and Peterson, R. E. (1960). J. Biol. Chem., 235,1639.
Klopper, A., MacNaughton, M. A., and Michie, E. A. (1961). J. Endocrinol.,
22, 14.
Knuppen, R., Breuer, H., and Diczfalusy, E. (1966). Excerpta Med. Int.
Congr. Ser., Ill, 171.
Knuppen, R., Haupt, 0., and Breuer, H. (1967). Biochetn. J., 105, 971.
Lanman, J. T. (1953). Medicine (Baltimore), 32, 389.
Lanman, J. T. (1957). Endocrinology, 81, 684.
Lauritzen, C., and Lehmann, W.-D. (1965). Arch. Gynaekol., 200, 699.
- 136 -
Lauritzen, C., and Lehmann, W.-D. (1967). J. Endocrinol., 39, 173.
Layne, D. S,, and Marrian, G. F. (1958). Biochem. J., _70> 244.
Leon, Y. A., Bulbrook, R. D., and Corner, E. D. S. (I960). Biochem. J.,
75, 612.
Levitz, M. (1963). Steroids, JL, 117.
Levitz, N., Emerman, S., and Dancis, J. (1962). Excerpta Med. Int.
Congr. Ser., 51, 266.
Lisboa, B. P. (1965). J. Chromatog., lj), 333.
Lisboa, B. P., Goebelsmann, U., and Diczfalusy, E. (1967). Acta
Endocrinol., _54, 467.
Loke, K. H., Watson, E. J. D., and Marrian, G. F. (1957). Biochim.
Biophys. Acta, 26, 230.
Magendantz, H. G. and Ryan, K. J. (1964). J. Clin. Endocrinol. Metab.,
24, 1155.
Mancuso, S., Dell'Acqua, S., Eriksson, G., Wiqvist, N., and Diczfalusy, E.
(1965). S eroids, _5, 183.
Mancuso, S., Benagiano, G., Froysa, B., and Diczfalusy, E. (1967).
Biochim. Biophys. Acta, 144, 183.
Mancuso, S., Benagiano, G., Dell'Acqua, S., Shapiro, M., Wiqvist, N., and
Diczfalusy, E, (1968). Acta Endocrinol., j>7, 208.
Maner, F. D., Saffan, B. D., Wiggins, R. A. Thompson, J. D. and Preedy,
J. R. K. (1963). J. Clin. Endocrinol. Metab., 23, 445.
Marrian, G. F. (1930). Biochem. J., 2A, 435.
Marsh, C. A. (1962). Nature, 194, 974.
Menini, E. (1966). Biochem. J., 9^9, 747.
Migeon, C. J. (1959). J. :ediat., 55, 280.
- 137 -
Migeon, C. J., Bertrand, J., and Gemzell, C. A. (1961). Recent Progr.
Hormone Res., 1_7> 207.
Mills, I. H. (1967). In Discussion of Forsham, P. H., Ciba Foundation
Study Group No. 27, p. 48.
Mitchell, F. L. (1967). Vitamins Hormones, 25, 191.
Morrison, G., Meigs, R. A., and Ryan, K. J. (1965). Steroids, J5,
(Suppl. II), 177.
McKenna, J., and Norymberski, J. K. (i960). Biochem. J., _76, 60P.
McKenna, J., and Rippon, A. E. (1965). Biochem. J., 95, 107.
Natoli, A., Nicolosi, G., and Magliocca, R. (1957). Quaderni Clin.
Ostet. Ginecol., 12, 31.
Neher, R. (1964). "Steroid Chromatography", Elsevier, New York.
Nielsen, M. D. (1966). Excerpta Med. Int. Congr. Ser., Ill, 241.
Oertel, G. W., and Eik-Nes, K. B. (1959). Anal. Chem., 31, 98.
O'Kelly, D. A. and Grant, J. K. (1967). Eur. J. Steroids, 2, 209.
Palmer, R., Eriksson, G., Wiqvist, N., and Diczfalusy, E. (1966). Acta
<
Endocrinol., J52, 598.
Pasqualini, J. R., and Diczfalusy, E. (1966). Excerpta Med. Int. Congr
Ser., 111., 288.
Pasqualini, J. R., Wiqvist, N., and Diczfalusy, E. (1966). Biochim.
Biophys. Acta, 121, 430.
Pasqualini, J. R., Lowy, J., Wiqvist, N., and Diczfalusy, E. (1968).
Biochim. Biophys. Acta, 152, 648.
Paulsen, E. P., Sobel, E. H., and Shafran, M. S. (1966). J. Clin.
Endocrinol. Me tab., j?6, 329.
Pearlman, W. H. (1957). Biochem. J., £7, 1.
138 -
Pion, R. J., Jaffe, R., Eriksson, G., Wiqvist, N., and Diczfalusy, E.
(1965a). Acta Endocrinol., 48, 234.
Pion, R. J., Jaffe, R., and Diczfalusy, E. (1965b). Excerpta Med. Int.
Congr. Ser., _99, 185.
Pion, R. J., Conrad, S. H., and Wolf, B. J. (1966). J. Clin. Endocrinol.
Metab., _26, 225.
Reynolds, J. W. (1963). Proc. Soc. Exp. Biol. Med., 113, 980.
Reynolds, J. W. (1964). Steroids, ^3, 77.
Reynolds, J. W. (1965a). J. Clin. Endocrinol. Metab., 25, 416.
Reynolds, J. W. (1965b). Pediatrics, ^6, 583.
Reynolds, J. W. (1966a). Steroids, 8, 719.
Reynolds, J. W. (1966b). J. Clin. Endocrinol. Metab., _26, 1251.
Reynolds, J. W., Colle, E., and Ulstrom, R. A. (1962). J. Clin.
Endocrinol. Metab., _22, 245.
Reynolds, J. W., Mancuso, S., and Diczfalusy, E. (1968). Biochim.
Biophys. Acta, 152, 438.
Riondel, A., Tait, J. F., Gut, J. F., Fait, M., Joachim, E., and Little, B.
(1963). J. Clin. Endocrinol. Metab., 23, 620.
Roberts, K. D., Bandi, L., Calvin, H. I., Drucker, W. D., and Lieberman, S.
(1964). Biochemistry, _3, 1983.
Rosenfeld, R. S. (1964). StAroids, 4, 147.
Roy, A. B. (1956). Biochem. J., j62, 41.
Schott, E. W., and Katzman, P. A. (1964). Endocrinology, 74, 870.
Schwers, J., Eriksson, G., and Diczfalusy, E. (1965a). Acta Endocrinol.,
49, 65.
- 139 -
Schwers, J., Govaerts-Videtzky, M., Wiqvist, N., and Diczfalusy, E.
(1965b). Acta Endocrinol., j>0, 597.
Shackleton, C. H. L., and Mitchell, F. L. (1966). Reported at the
international congress on hormonal steroids, Milan 1966.
Excerpta Med, Int, Congr. Ser., Ill, 176.
Shackleton, C. H. L., and Mitchell, F. L. (1967). Steroids, 10, 359.
Shahwan, M. M., Oakey, R. E., and Stitch, S. R. (1968). J. Endocrinol.,
40, 29.
Simmer, H. H., Easterling, W. E., Pion, R. J., and Dignam, W. J. (1964).
Steroids, 4, 125.
Simmer, H. H., Dignam, W. J., Easterling, W. E., Frankland, M. J., and
Naftolin, F. (1966). Steroids, 8, 179.
Sjovall, J., and Vihko, R. (1966). Steroids, 2> 447.
Sjovall, J., and Vihko, R. (1968). Acta Endocrinol., 52, 247.
Slaunwhite, W, R., Karsay, M. A., Hollmer, A., Sandberg, A. A. and
Niswander, K. (1965). Steroids, j>, (Suppl. II), 211.
Slaunwhite, W. R., Karsay, M. A., and Sandberg, A. A. (1966). Excerpta
Med. Int. Congr. Ser., Ill, 172.
Solomon, S. (1960). In: "The Placenta and Foetal Membranes", (C. A. Villee,
ed,), p. 200. Williams and Wilkins Company, Baltimore.
Solomon, S, (1966). J. Clin. Endocrinol. Metab., 26, 762.
Solomon, S., Lanman, J. T., Lind, J., and Lieberman, S. (1958).
J. Biol. Chera., 233, 1084.
Solomon, S., Bird, C. E., Ling, W., Iwamiya, M., and Young, P. C. M.
(1967). Recent Progr. Hormone Res., 23, 297.
Sparagana, M. (1966), Steroids, 8, 219.
- 140 -
Stitch, S. R., Halkerston, I. D. K., and Hillman, J. (1956). Biochem.
J., 63, 705.
Ten Berge, B. S. (1958). Geburtsh. Frauenheilk., L8, 323.
Ulstrom, R. A., Colle, E., Burley, J., Gunville, R., and Reynolds, J. W.
(1959). Med. Bull. Univ. Minnesota, 30, 495.
Ulstrom, R. A., Colle, E., Reynolds, J. W., and Burley, J. (1961).
J. Clin. Endocrinol. Metab., _21, 414.
Van Leusden, H. and Villee, C. A. (1965). Steroids, j3, 31.
Vihko, R. (1966). Acta Endocrinol., Suppl. 109.
Villee, C. A., and Loring, J. M. (1965). J. Clin. Endocrinol. Metab.,
25, 307.
Villee, D. B., and Driscoll, S. G. (1965). Endocrinology, _77, 602.
Villee, D. B., and Villee, C. A. (1964). Excerpta Med. Int. Congr. Ser.,
83, 709.
Villee, D. B., Rotner, H., Kliman, B., Briefer, C., and Federman, D. D.
(1967). J. Clin. Endocrinol. Metab., ,27, 1112.
Williams, K. I. H., and Layne, D. S. (1967). J. Clin. Endocrinol. Metab.,
27, 159.
Wilson, R., Bird, C. E., Wiqvist, N., Solomon, S., and Diczfalusy, E. (1966).
J. Clin. Endocrinol. Metab., _26, 1155.
Winslow, M. (1766). "Exposition Anatomique de la Structure du Corps
Humain". Revised Edn., vol. 3, p. 216, Paris.
Zander, J. (1961). Ciba Foundation Study Group, No. 9, p. 32.
Zollner, N., Wolfram, G., and Amin, G. (1962). Klin. Wochenschr., 40, 273.
Zucconi, G,, Lisboa, B. P., Simonicsch, E., Roth, L., Hagen, A. A., and
Diczfalusy, E. (1967). Acta Endocrinol., J56, 413.
APPENDIX
TABLE 20
Rf Values (x 100) of 3g-0H-A^ Steroids on rain-Layer Chromatography
These results represent the mobilities of steroids on chromatograms
developed once in some of the solvent systems listed in Table 5. The figures
represent the arithmetic mean of four determinations.
Medium polarity steroids
System:- H C F
Aadrost-5,16-diei-3p- ol 54 44 55
DHA 40 34 51
11-0X0-DHA 24 27 45
la-OH-DHA 4,5 7.0 14
7a-OH-DHA 3.5 6.5 14
7p-OH-DHA 5.5 7.0 15
lip-OH-DHA 24 17 29
14a-OH-DHA 20 14 27
14P-0H-DHA 17 13 25
16a-OH-DHA 22 16 34
16p-OH-DHA 20 15 30
i 8-OH-DHA 12 11 24
droste lediol 33 19 37
11-oxo-audroste ediol 14 19 21
16-oxo-androste:iediol 22 11 34
3p,16a-dihydroxyaadrost-5-en-ll,17-dio ie 11 13 24
3p,lip,l6a-trihydroxyandrost-5-en-17-o .e 12 10 16
[ Compound U_^ 23 26 45]
Pregnenolone 44 36 51
16a-OH-pregnenolone 16 13 26
17a-0H-pregnenolo te 36 27 42
18-OH-pregnenolone 38 34 48
21- OH- pregneriol one 24 27 43
Pregnenediol 32 19 37
Pregnenetriol 17 13 22







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(a)Av-Averagedailyxcretionforthr edayp riod. (b)A"lessthan"symbol̂)indicatest.i tthsteroidwasn tccuratelyas ay d,w s presentatconcentra ionle sthant efiguregiv n.
TABLE 25
Quantitative Results for tne Determination of 33-OH-A^ Steroids in Plasma
Obtained from the Umbilical Blood Vessels and the Corresponding Figures
for Oestrogens in Urine Collected from tie Mother
A - Arterial result
V - venous result
A—V - arterio-venous difference
% - arterio-venous difference as percentage of
arterial result.
Plasma 3P-0H-A"* steroids Urinary oestrogen
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1. 3465 39 A 108 83 47 53 386 17 142 107 0.62 0.12 24.3
V 41 74 37 46 327 16 125 96
A-V 67 9 10 7 59 1 17 11
% 62 11 21 13 15 6 12 10
2. 4402 39 A 56 65 30 45 200 20 100 160 0.85 0.57 16.9
V 33 42 16 30 180 16 80 76
A-V 23 23 14 15 20 4 20 84
7. 41 35 47 33 10 20 20 52
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12 . 2850 38 A •» —- —~ — » — •«•
(see note 1) V 117 105 92 42 131 - 202 100
A-V
% - .. -
13. 3250 40 A* 14 14 - - 90 - 40 111
(see note 1) V - -• -- —■ - *- - -
A-V - ' - - . -■ ~
% - «,
14*- 2300 39 A - - - - - - - - 0.163 0.074 8.4
(see note 2) V 11 11 20 53 2)0 10 90 80
A-V ~ ----- -
* Assay on a specimen (total volume 2.8 ml.) consisting of plasma obtained
from both arterial ad venous sources (0.8 ml. and 1.5 ml. volumes
respectively).
Notes:
1-. Infants 12 and 13 were in a distressed condition at birth. Infant
13 died the following day.
2. The mother of this infant was taking prednisolone during pregnancy.
This steroid may be expected to suppress indirectly the production
of steroids by the adrenal glands of the foetus.
Figures 55 - 68.
Mass-Spectra of 33-OH-A"1 Steroids
These figures illustrate the mass-spectra obtained for several
5
reference 3p-0H-A steroids. Some of these steroids were identified in
urine obtained from infants, i.e. the mass-spectrum of a reference
compound and a steroid isolated from urine were virtually identical.
The heights of each peak (relative intensity) were measured
relative to the "base-peak", i.e. the highest peak in the spectrum.
Several of the spectra contain very large peaks at m/e 73 and 75 but these
are due to impurities and should not be confused with the base-peak.
M+ represents the molecular ion
M - x represents a loss of x mass units from the molecular ion
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C. H. L. Shackleton and F. L. Mitchell
University Department of Clinical Chemistry, The Royal Infirmary, Edinburgh
Steroid metabolism in utero and in the newborn
period has recently been shown to be different in
many ways from that found in the adult (Cathro,
Birchall, Mitchell and Forsyth, 1963), and up to
two years may elapse before the infant's steroid
metabolism is completely replaced by the adult
mechanism (Barr, Diczfalusy and Tillingen,
1961). One of the main differences appears to be
due to a relative deficiency or inactivity in the
infant of the steroid enzyme 3 P-hydroxydehydr-
ogenase which catalyses the dehydrogenation
and isomerisation of a 3 p-OH- a 5-steriod to
a 3-oxo- A-4steroid: e.g. pregnenolone con¬
verted to progesterone and dehydroepiandro-
sterone (DHA) to androstenedione.
Inability to carry out this conversion com¬
pletely, results in a build up of pregnenolone
which then appears to be acted upon by enzymes






produce corticoids. For instance, instead of
forming deoxycorticosterone from progester¬
one, 21-hydroxylase would produce 21-hydroxy-
pregnenolone, a steroid found in significant
quantity in urine from infants but not normally
detectable in adults (Cathro, Birchall, Mitchell
and Forsyth, 1965). A large number of com¬
pounds showing many of the chemical properties
of A6-steroids are present in infant urine, cord
blood, amniotic fluid, etc. and have not yet been
identified but could be produced by enzymes such
as 11 P or 17 a-hydroxylase, and 17 P (acting on
17 oxosteroids) or 20 a-reductase, acting upon
A5 instead of A4-steroids.
A further major difference in metabolism
results from the foetus and infant having a high
activity of the enzyme 16 a-hydroxylase, and
where one would expect from the above a
relatively high excretion of a ^pregnenolone
and DHA, this does not in fact occur, but further
metabolism to the 16-hydroxy compounds
causes the excretion of a relatively large quantity
of 16 OH-pregnenolone and 16 OH-DHA
(Reynolds, 1965). These compounds are
undetectable in normal adult urine. The reason
for this high activity of 16 a-hydroxylase is not
known.
Many of the metabolites of pregnenolone and
DHA so far remain uncharacterised, but it is
thought that they may be hydroxylated in any of
the following positions: 11, 16, 17, 20 or 21.
Little is known about the importance of these
compounds in the overall metabolism of the
foeto-placental unit and, to make investigation
possible, a method has had to be devised for
their separation and quantitation.
After hydrolysis of urine, plasma or amniotic
Progesterone
fluid by P-glucuronidase and steroid sulphatases,
the free compounds are extracted with ether:
ethyl acetate 2:1 (v/v) and then separated into
ketonic and non-ketonic fractions by Girard
Reagent T. Thin-layer chromatography is then
carried out on each fraction, using the following
systems.
System C (Lisboa, 1965)
ethyl acetate: cyclohexane 50:50 (v/v).
System L (Lisboa, 1965)
chloroform: ethanol 95:5 (v/v).
System D (Lisboa, 1965)
chloroform: ethanol 90:10 (v/v).
System C is suitable for relatively non-polar
steroids, system L for steroids of all polarities
and system D for relatively polar steroids.
Heating, after spraying with a saturated solution
of antimony-trichloride in chloroform gives a
reasonably specific red colour with 3 P-OH A5-
steroids. By running suitable standards on the
same plate an approximate quantitative assay
may be obtained by the visual comparison of
spot intensity. The use of the thin-layer attach¬
ment to a Chromoscan (Joyce, Loebl & Co.,
Princesway, Gateshead-on-Tyne) gives consider¬
able improvement in quantitative accuracy.
It has been possible, by using this technique,
to demonstrate in addition to those already
specifically mentioned by name, at least 8 a5-
steroid-like compounds which are present in
relatively large quantity in the infant but not
demonstrable in the normal adult. It will be
interesting to discover whether these compounds
are produced by processes present in the infant
purely for detoxication purposes, or whether
their production and subsequent use is an
essential part of foetal life and growth. Whatever
43
the reason, the fact that they form a large
proportion of the steroid excretion of the new¬
born must be borne in mind in the interpretation
of any conventional steroid assay which may be
carried out on infant urine.
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ABSTRACT
A relatively simple new technique is reported for the
separation and measurement of the following A^ steroids in human
fetal blood, amniotic fluid and infant and adult urine: 3(3-
hydroxypregn-5-en-20-one, 3[3-hydroxyandrost-5-en-17-one, 3(3,21,-
dihydroxypregn-5-en-20-one, 3(3,17cx(and 17(3 )-dihydroxyandrost-5-ene,
3(3, 17[3-dihydroxyandrost-5-en- 16-one, 3(3, 16<x-dihydroxyandrost-5-
en-17-one, 3(3,16oc-dihydroxypregn-5-en-20-one, 3(3,16a, 17p-trihydroxy¬
andro st-5-ens and two unidentified compounds. After enzyme hydrolysis
and solvolysis the steroids are extracted from the biological
material and separated on thin-layer silica-gel chromatograms. Assay
is by direct photo-electric scanning of the coloured bands developed
on the chromatograms by an antimony trichloride reagent. The identity
of the compounds has been checked by gas chromatography-macs spectro¬
scopy and further thin-layer chromatography. The accuracy, specificity
and precision of the method have been evaluated. The t^tal urinary
excretion of the compounds when expressed in /7g/24 hr/m body area is
approximately 10 times that of the adult. The 2 unknown compounds,
21-hydroxypregnenolone and 16-hydroxypregnenolone are undetectable in
adult urine. In cases of the adrenogenital syndrome the excretion of
16-hydroxypregnenolone was markedly increased.
INTRODUCTION
Steroids with the A^-3(3-hydroxy configuration predominate
quantitatively and qualitatively over all other steroids (cholesterol
apart) in"fetal blood and infant urine. In adults the quantitative
importance of such steroids is largely limited to dehydroepiandros-
terone (DHA)''', but in the fetus and in infants a large number of
other A^ steroids and A^ steroid-like compounds are present, some
in considerable quantity (1 - 3).
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Easterling et al. (4) have shown that the concentration of
DHA-sulfate and 16a-hydroxy~DHA-sulfate in fetal blood totals 200 -
300 Hg/100 ml. and Reynolds (5) has recorded a total urinary
excretion of 16a-hydroxypregnenolone (16-OH-Preg.), 16a-hydroxy-DHA
(16-OH-DHA) and androstenetriol (AT) of 14 mg./24 hr. in a 3 week
old premature infant and of over 8 mg./24 hr. in 6 similar infants
aged up to 5 weeks.
It is only comparatively recently that the importance of the
A~* steroids in early life has been appreciated and the techniques of
assay so far used have been tedious, most of them having been
designed more to achieve the isolation of pure compounds rather than
for assay purposes (1,3-8). It is apparent that much is to be gained
from a quantitative study of the individual A"* steroids circulating
in the feto-placental unit and excreted by the infant during the first
few months of independent life (9); also there is an immediate
clinical application in that an early diagnosis of any dysfunction in
adrenocortical steroid synthesis may depend upon an ability to measure
*
Abbreviations for compounds used throughout the text are shown
in Table 1.
accurately the A^ steroids in day-old infant urine (10). In
adults it is not usually considered worthwhile to investigate the
3p-hydroxy-A~' steroids as a group but as they constitute by far the
most abundant group in infants, it is of considerable importance that
more should be known of their excretion in the normal and abnormal
infant.
During the development of a suitable technique, an attempt has
been made to balance specificity, sensitivity and reliability against
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ease of operation and the possibility of measuring the individual
steroids in a urine sample from a day-old infant, and in the small
samples of arterial and venous cord blood which can be obtained from
single umbilical cords. The compounds chosen for assay are shown in
Table 1 and include two chromatographic bands of material staining
with antimony trichloride which have not been identified, but they
are probably steroidal and if so, are of considerable quantitative
significance.
The technique has been used to measure the excretion of
urinary steroids during the first few days of infant life, and
the rates of excretion are compared with those found in adults.
Findings in 2 cases of the adrenogenital syndrome are also reported.
MATERIALS
All the reagents used were of analytical grade unless other¬
wise specified. Other material used was obtained as follows
Succus entericus from the snail Helix pomatia - L'Industrie
Biologique S.A., Gennevilliers, France.
Silica-gel, grade Hf 254 - Merck A.G., Darmstadt, Germany.
Thin-layer chromatography spreader - Quickfit and Quartz Ltd.,
Stone, England.
Thin-layer chromatography tanks - Shandon Scientific Co. Ltd.,
London, England.
Thin-layer chromatogram scanner - Joyce, Loebl and Co. Ltd.,
Gateshead 11-, England.
Gas chromatograph-mass spectrograph - LKB 9000. LKB Produkter AB,
Stockholm, Sweden.
The source of steroids used as authentic standards is indicated
in Table 1.
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Complete 24 hr. specimens of urine were collected from different
normal infants on each day for the first 6 days of life, and also from
normal adult males. Preservation was by storage at 4° followed by
freezing at -24° as soon as possible. Umbilical cord blood was hepar-
inized and the plasma separated as soon as possible. Plasma and
amniotic fluid were stored at -24°.
METHOD
Choice of Technique
To ensure the extraction and measurement of as much steroid
material as possible a comprehensive hydrolysis procedure was chosen,
and for separating the steroids in the extract, thin-layer was
decided upon in preference to column, paper or gas-liquid chromato¬
graphy. The quantities of steroid being dealt with, particularly
in blood, were small and the assay of bands of material on paper
or thin-layer chromatograms was preferred to the use of column
chromatography involving the collection of many eluate fractions.
Paper chromatography was found to necessitate a complex preliminary
purification stage (6), long development periods were required and
the spots or bands of steroid formed tended to be more diffuse than
those obtained using thin-layer chromatography. Many of the compounds
were found to be unstable when subjected to gas-liquid chromatography.
Elution of the bands of material from the thin-layer plates,
with subsequent colorimetric assay did not prove practicable because
many were too close together for accurate detection and delineation
using a parallel run of standards.- Assay was therefore achieved by
direct staining and quantitative scanning.
Preliminary studies
Hydrolysis. Leon et al. (11) have shown that the crop fluid of the
snail Helix pomatia contains both p-gluc^ronidase and sulfatases.
Eberlein (l) has demonstrated that the A -3P-0H steroids are present
in cord blood mainly in sulfated form,and it was found that the use
of the Helix pomatia enzyme alone did not achieve complete hydrolysis
of the A^ steroids present in the biological fluids studied. A second
stage involving a solvolytic procedure (12) was essential.
To test the completeness of hydrolysis by the two-stage
process, the residual hydrolysate after extraction with ether:ethyl-
acetate was further extracted with butanol to remove any material
still conjugated. The butanol extract was evaporated to dryness,
taken up in water and the two stage hydrolysis repeated. This
procedure was carried out 6 times on infant urine and no detectable




Compounds assayed, together with their abbreviations,
trivial names and the source of origin of the standards





































Koch-Light Laboratories Ltd., Colnbrook, England.
Medical Research Council Reference Collection.
( C )
Synthesized by P.J. Sykes and R.W. Kelly.
Drs. D. Fukushima, P.J. Sykes and R.W. Kelly.
Preliminary purification. With the thin-layer chromatography systems
used, it was found that the ether:ethyl acetate extract of urine and
the ethanol:ether (see later) extracts of amniotic fluid and blood,
needed only alkali, mild acid and water washes.
Thin-layer Chromatography. In order to achieve adequate separation
of the antimony trichloride (see later) staining compounds which
appear to be important in the biological materials studied, a
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procedure of chromatogram development using multiple solvent runs
was designed using the same or different solvent systems. Multiple
running with systems giving low Rf values was found to give better
separations than the more normally used single stage development
procedure. In all cases plates were prepared using silica-gel and
the following solvent systems were selected for user-
System A - Chloroform
System B - Chloroform : absolute ethanol (95:5 v/v)
System C - Chloroform: absolute ethanol (90:10 v/v)
System D - Benzene : absolute ethanol (96:4 v/v)
Sys tem E - Cyclohexaner ethyl acetate (50:50 v/v)
Compounds which proved difficult to separate either from each other
or from interfering chromatogenic material were:-
1. DHA from Preg
2. U-i from 21-OIi-Preg
3. 16-0-AD from 16-OH-DHA
4. AT
The use of System D will satisfactorily separate the substances
listed under 1 and 3 but not those under 2, separation of these may
however be achieved by using System A. The desired properties of the
two systems may be combined by running the plates three times in
Sys tem A then three times in System D; the resulting separation then
produced for infant urine is shown in Fig. 1.
Since AT is considerable more polar than the other compounds to
be assayed, when adequate distribution of the main group is obtained
AT moves only a short distance from the origin and is poorly separated
from neighbouring substances. A second chromatogram must therefore be
prepared and run in the more polar solvent system C.
Fig. 2 shows the separation achieved for infant urine after two
runs in this system. It will be seen that pregnanetriol is also
separated, staining as a yellow band. Quantitative information on the
content of this steroid in infant urine can be of considerable diagnostic
importance in addition to the measurement of the A"* steroids, in cases of
the adrenogenital syndrome.
In adult urine there is qualitatively and quantitatively less
steroid present, and unlike infant urine, pregnenetriol assumes quantit¬
ative importance, but in the systems designed for infants an unidentified
band staining with antimony trichloride is not separated from pregnene¬
triol. For adults therefore, the problems of separation are different but
less complex and a procedure utilizing a single chromatogram has been
chosen.
The plates are run once in System E, then twice in System B and
it will be seen in Fig. 3 that AT and pregnanetriol move sufficiently
far from the origin to be separated and measured, but 16-0H-DHA and
16-0-AD are not separated. This disadvantage may easily be overcome if
necessary, by carrying out additional runs in the systems designed for
infants.

















Figure 1. A typical 20 x 20 cm. thin-layer chromatography plate
for the assay of the following compounds in infant urine:
A, pregnenolone; B, DHA; C, unknown 1; D, 21-0H-pregnenolone;
E, androstenediol; F, 16-oxo-androstenediol; G, 16-0H-DHA;
H, unknown 2; I, 16-0H-pregnenolone. The position of andros-
tenetriol (not assayed) is shown at J. Samples of 16-0H-DHA were
run in positions 1 (1.25 Hg)> 5 (3.75 /Jg) and 7 (5.0 jJg). Samples
(2.5 /Jg) of all the steroids measured (unknown compounds apart)
were run in position 3. Duplicate extracts of urines collected
from the same baby orr days 1, 2, 3, 4, 5 and 6 of life were run
in positions 2, 4, 6, 8, 9 and 10. The plate was sprayed with
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gure 2. A typical 20 x 20 cm. thin-layer chromatography plate
for the assay of androstenetriol (X) in infant urine. The
position of pregnanetriol, if present^is shown at Y. Standard
samples of androstenetriol were run in positions 1 (1.25 pg),
3 (2.50 pg), 6 (3.75 pg) and 9 (5.0 pg). Urine extracts run
in duplicate in positions 2, 4, 5, 7,8 and 10 were the same as
shown in Fig. 1. The plate was sprayed with antimony tri¬
chloride followed by heating.
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Figure 3. (Above). Part of a typical thin-layer chromatography
plate for the assay of the following compounds in adult urine:
A, DHA; B, androstenediol; C, 16-OH-DHA and 16-oxo-androstene-
diol; D, pregnenetriol; E, pregnanetriol; F, androstenetriol.
Standard steroids were run in positions 1 (1.25 pg), 3 (2.50 pg),
5 (3.75 pg) and 7 (5.0 pg). Duplicate extracts of urines from 3
different adults were run in positions 2, 4 and 6. The plate was
sprayed with antimony trichloride followed by heating.
(Below). The recording produced by run 4 when scanned in a photo¬
electric reflectance densitometer.
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Staining technique. Spraying the thin-layer chromatograms with
antimony trichloride in chloroform solution followed by heating
at 110° for 5 min. produces a red colour with A->-3|3-hydroxysteroids
(13). This reaction was selected as being the most suitable both
with regard to specificity and quantitation of the compounds to be
investigated. It has previously been used for the quantitative
assay of cholesteryl esters on silica-gel plates (14).




(i) See Table 2 for the volumes to be taken.
(ii) Adjust to pH 11.5 with 4N HaOH.
(iii) To precipitate sulfate ions which may interfere with
enzyme action add 10% BaCl2 (w/v) until no further
precipitation is obtained.
(iv) Adjust to pH 5 with 50% HC1 (v/v).
(v) Add 10% of the volume of 5N acetate buffer (5N acetic
acid, 5N sodium acetate, 2:3, v/v).
(vi) Add 0.1 ml. of the succus entericus of Helix pomatia
per 20 ml. urine. Incubate at 37° for 24 hr.
(vii) Repeat (vi).
(b) Extraction
(i) Extract twice with 2 volumes of ether:ethyl acetate
(2:1, v/v).
(ii) Wash the extract repeatedly with 10% of the volume of
N NaOH until the washings are clear.
(iii) Wash once with 10% of the volume of water with 2-3 drops
of acetic acid added.
(iv) Wash once with 10% of the volume of water.
(v) Evaporate to dryness on a rotary evaporator at 45°.
(vi) Transfer the extract with chloroform into a small tube,
dry down under nitrogen.
(c) Solvolysis
(i) Bring the aqueous phase from b (i) to pH 1 with 50%
H2S04 (v/V).
(ii) Saturate with ammonium sulfate.
(iii) Extract twice with 1 volume of ethyl acetate, incubate
the extract at 38° for 24 hr.
(iv) Repeat b (ii to vi). The solvolysis extract is combined
with the enzyme freed extract in the same tube.
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TABLE 2
Volumes of urine-, extract etc. required





































































Amniotic Fluid and Umbilical Cord Plasma
(i) See Table 2 for the volumes to be taken
(ii) Precipitate proteins with 4 volumes of ethanol, centrifuge,
(iii) Extract the precipitate with 100 ml. of 807« ethanol (v/v),
centrifuge.
(iv) Combine the ethanolic solutions and evaporate to dryness
on a rotary evaporator at 45°.
(v) Add 30 ml. of distilled water and extract twice with 30 mTi
ether.
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(vi) The extract contains the free steroids and because of
fatty impurities it is not suitable for thin-layer
chromatography and is normally discarded. If required for
other purposes it may be further treated as under lb (ii-vi).
(vii) Hydrolyse and extract the aqueous fraction from (v) as for
urine. The final extract will contain the conjugated
steroids.
Thin-layer Chromatography. Silica-gel is spread onto 20 x 20 cm plates
to a thickness of 0.25 mm. No activation is required but the plates
are allowed to stand for at least 24 hr. at room temperature before use.
Extracts are "spotted" onto two prepared plates in the amounts shown in
Table 2. Duplicate extracts of up to 6 urines may be run on each plate
(see Figs. 1 - 3). Care must be taken to ensure that all the spots are
as nearly as possible 0.5 cm diameter. The spot pairs are interspersed
with spots containing 1.25, 2.50, 3.75 and 5.0 pg of 16-0H-DHA (for
infant medium polarity compounds), AT (for infant high polarity compounds)
and DHA and 16-0H-DHA (for adult compounds), to be used for
quantitative calibration. One spot containing 2.5 /Jg of each steroid
to be assayed is also prepared to check the quantitation of each steroid.
The plates thus prepared are placed momentarily in a highly
polar development system (ethyl acetate:methanol, 3:1 v/v) to "run up"
the spots approximately 0.5 cm, so that bands are produced instead of
circles. This procedure is repeated a second time, allowing the plate
to dry in between. Very narrow bands of material are thus produced,
making it possible to achieve maximal chromatographic separation.
The solvent systems used for development have been described in
a previous section. Multiple runs are carried out by drying the plates
in air after development in one 'system, then immediately placing them
for a further run either in the same or in another system. Details of





Colour Development. The fully developed plates are sprayed evenly
with a saturated solution of antimony trichloride in chloroform and
heated for 5 min. in an oven with an even temperature of 110 . The
colours formed will fade after several hours in the open air but if
the chromatograms are covered with a glass plate they may be kept
successfully in the refrigerator for several days. It is however
recommended that they be scanned as soon as possible.
Quantitation. Each developed chromatogram spot is scanned in succession
in the thin-layer scanner using reflectance, a slitr 1 x 7 mm and the
no. 490 filter (max. transmission 490 m/i.). The base-line is drawn in
for medium polarity compounds (3 X System A
(3 X System D
for AT 2 X System C
(1 X System E
(2 X System B
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Figure 4. Calibration graphs for standard steroids run on thin-
layer chromatograms, stain.ed with antimony trichloride, scanned
by a reflecting densitometer and the areas under the peaks
measured by planimetry.
on the resulting recorder trace (Fig. 3) and perpendicular lines are
inserted to divide each peak, areas are measured by planimetry. The
integrator on the scanner is not used because no correction can then
be made for a base-line which is often slightly sloping. A standard
curve is constructed from the areas under the standard 16-OH-DHA peaks
and similar graphs based on the single multistandard run are drawn for
the other compounds assayed (Fig. 4). The graphs are then used for
quantitation of the compounds in the extracts. (Greater precision may
-be obtained by using 4 multistandard runs but the above scheme is





Accuracy and Specificity. As a measure of accuracy (the concordance
between the determination and the true value of the quantity measured),
the recovery of DHA from DHA sulfate has been determined. DHA sulfate
(250 pig) was added to 10 ml. of pooled 1-3 day old infant urine and
after hydrolysis and extraction l/50th of the extract was chromato-
graphed and assayed. The average recovery for 6 experiments was
807. + 6.2 (S.D.).
The antimony trichloride reaction used for colour development
was thoroughly investigated to determine its specificity (the ability
of a technique to determine solely the compound it purports to
measure). The preliminary purification and separation stages of the
method were chosen purposely for their simplicity and ease of opera¬
tion, and consequently the substances to be assayed are not obtained
on the chromatograms in pure form; the specificity of the colour
reaction is therefore important.
The fluorescence producing reactions of antimony trichloride
are very unspecific (15) but the reaction considered here produces in
normal light, specific colours for certain groups of steroids when the
amount of each steroid on the chromatogram is less than 10 pig.
Table 3 indicates the various colours which were found to be
produced; some others have been reported previously (13, 16, 17).
With the exception of the estrogens (removed in the preliminary
alkali wash) most of the major biologically common groups of steroids
are represented and it will be seen that all the 3P-0H-A"' steroids
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give a strong colour except when a 7-oxo group is present. Compounds
with a 7-0H group are readily distinguished by their producing an
4
immediate turquoise colour without heating. None of the 3-oxo-A
steroids listed gives a colour except epitestosteroneC 17a-hydroxyandrost-
4-en-3-one) which produces a blue colour, and a yellow colour is
1 4
produced by a A 1 steroid. Amongst the saturated steroids, only a
6cc-0H steroid gave an orange colour, all others tested produce either
a weak yellow colour or no colour at all. Pregnanetriol gives an
intense yellow colour by which it may be assayed. If careful
consideration is given to the data in Table 3 and chromatogram
development systems are carefully chosen, the antimony trichloride
reaction on thin-layer chromatograms can in practice be very specific.
Extracts from the biological materials under investigation
were run firstly in one direction using the systems normally used,
and then a second development was carried out at 90° to the first
using the following thin-layer chromatography solvent systems:
chloroform: absolute ethanol (95:5, v/v)
ethyl acetate: water saturated with n-hexane:
glacial acetic acid: absolute ethanol (72:13.5:10:4.5, by vol
cyclohexane: ethyl acetate (50:50, v/v)
cyclohexane: ethyl acetate: absolute ethanol (45:45:10, by
vol.)
In no case could an interfering chromogen be separated from a
spot normally assayed. In addition, after completing "standard" runs
of extracts, the separated spots were acetylated by spraying the plates
with acetic anhydride: pyridine (50:50, v/v); after standing for 2 hr.
they were then "run up" at 90° to the line of the first development,
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thus forming new origins for a second development carried out using
ethanol: benzene (2:98, v/v). For the compounds normally assayed no
additional antimony trichloride staining spots could be separated.
Identification of Compounds. From extracts of infant urine, 50 to
100 ptg. of AD, 16-0-AD, 16-OH-DHA, 16-OH-Preg and AT were prepared as
follows: the extract was streaked along the origin of thin-layer
chromatography plates which were then developed in the normal
systems; the antimony trichloride reaction was carried out only on
the two outer edges of the plates and the bands of material in the
centre, thus delineated,were eluted from the silica-gel with ether,
the silica-gel having first been deactivated with a drop of water.
The compounds were converted to their trimethylsilyl ethers and sub¬
jected to gas-liquid chromatography using an E30L column. In each
case they had the same retention times as the corresponding authentic
standards treated in the same way.
The trimethylsilyl ether of each eluate was then subjected to
gas chromatography-mass spectroscopy, and mass spectra were produced
on the beginning, centre and end of each gas chromatography peak. In
each case all three spectra were identical with each other and with
similar spectra produced by the authentic standard steroids (the
identification of steroids using gas chromatography-mass spectros¬
copy will be the subject to a later publication with Dr. C. J. W.
Brooks).
Precision. The precision of the method (the concordance of measurements
of the same quantity) has been determined by calculating the standard
deviation from the differences between the chromatogram peak areas of
duplicate extracts (duplicated through the whole procedure) of the
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urinary assays reported in this paper. Table 4 shows the results
obtained.
TABLE 4
Precision, as shown by the concordance of areas
under the peaks of chromatogram scans.
Compound No. of duplicate Average area Standard deviation
assayed assays (planimeter of the area (7.)*
readings)
U1 22 81 7.3
21-OH-Preg 22 43 8.9
AD 11 95 8.5
16-0-AD 22 252 4.5
16-0H-DHA 22 211 7.6
U2 17 85 7.0
16-OH-Preg 22 245 4.4
AT 22 162 5.7
* The standard deviation has been calculated from the
/Sfd 2formulwhere d = % difference between duplicate
areas and N = no. of duplicate assays.
Labour involved. Working a normal 8 hr. day, it is possible for one
reasonably skilled technician to assay 6 specimens each.week.
Findings in normal individuals
2
Table 3 compares the excretion (in /Jg/24 hr/m ) of the major
identified A~* steroids and two unknown steroid-like compounds
(measured in terms of the chromogenicity of the A^ steroid nearest in
polarity,^21-OH-Preg and 16-O-AD) in the day-old infant with that found
in normal adult males. AD, 16-0-AD, 16-0H-DHA, 16-0H-Preg and AT have
TABLE5̂























































































TABLE6.URINARYEXCRETIONOFA5ST R IDSNE RLYIN A CY(/Jg/24hr.) AGEINDAYS()=no.ofinfants. 1( 1)2(1 )3( 1)4(5-5( )6(5) Averageexcretionwi hrange 4835556166834295036-2,35785-1, 08374-1,2210-1,690212-8 515-75
21-Hydroxypregnen-210236279111 365olone(21-0H-Preg)5-4710-492128-5901 4-64-358-20/5 Androstenediol172191,2081444737w(17a+(3)(AD<20-84<20-80-880<20-<20-1 0-14&
o




(16-OH-DHA)72"2,24017"2,5604 "3,18039,5659 ~,14024"1,8 0
1
UNKNOWN26668087807194604 694-1,52020-1, 4420-1,7 035-1,393176-8 81 0-8 16-Hydroxypregnenolone8279001,1671,2981,0371,114(16-OH-Preg)52-1,52080-2, 603, 2091-,4246-, 808-,680 Androstenetriol64062696899675921(AT)84-1,62012-1,2 025-1,6 08 -,3 0383-1,1 04 4-82 Totalfaverages4,8635,4026,8246,726,7264,547
©
0^
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been identified by comparison with authentic standards during thin-
layer chromatography in several systems and also by gas-liquid chromato¬
graphy of their trimethylsilyl ethers followed by mass spectroscopy.
DHA, 21-OH-Preg and pregnenetriol have only been partially identified
from their Rf values in several thin-layer chromatography systems and
the specificity of the antimony trichloride staining bands.
Table 6 shows the excretion during the first few days of life of
the 8 compounds shown in Table 5 to be prominent in infant urine. There
was a considerable variation in the excretion of each compound by
separate individuals.
The excretion in 2 cases of the adrenogenital syndrome is shown
in Table 7.
TABLE 7
URINARY EXCRETION OF A5 STEROIDS IN TWO CASES OF
THE ADRENOGENITAL SYNDROME
(pg/24 hr)
pifflrnnm CASE 1 CASE 2STEROID i o J a i Aaged 2 days aged 7 days
UNKNOWN 1 150 1,350
21-Hydroxypregnenolone (21-OH-Preg) not assayed 1,350
Androstenediol (17a and 17(3) (AD) 150 638
16-oxoandrostenediol (16-0-AD) 100 6,750
16-Hydroxydehydroepiandrosterone (16-OH-DHA) 100 7,425
UNKNOWN 2 <20 995
16-Hydroxypregnenolone (16-OH-Preg) 1,550 14,925
Androstenetrlol (AT) 200 1,460
Total 2,250 ' 34,893
DISCUSSION
The relatively large number of steroids present in the
>iological material being assayed and the small quantity of original
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material available, led to the choice of a single technique which
j
would maintain a reasonable degree of reproducibility while measuring
all the compounds required, with a fairly high degree of specificity.
The chromatograms produced also give a comprehensive indication of the
amounts of other A^ steroid-like compounds present, and this feature
is important in view of the large number of these compounds and the
present lack of knowledge as to their identity and importance.
All the steroids on the chromatograms which have been referred
to by name have been identified before either in infant urine or fetal
blood or tissue:
Preg (1,18), DHA (3,7), 21-OH-Preg (1,19), AD (1,2,9,20).
16-0-AD (9,21,22), 16-0H-DHA (2,3,7,8,9,23,24,25),
16-OH-Preg (1,2,5,8,9,24), AT (2,5,9,20,25,26). The bands labelled
and U2 together with the other unlabelled bands shown in Figs. 1 and 2
remain to be identified. In the present investigation only the last
five compounds mentioned by name above (the major identified A"' steroids
in infant urine) have been fully characterised. AD includes both 17a
and 17p androstenediol, separation of the epimers only being possible
after further chromatography.
The precision obtainable is adequate for the purposes for which
the technique is designed. The standard deviations shown in Table 4 are
true for single assays, when in practice the average of duplicate
measurements is used the precision is considerably increased.
The excretion of such a large quantity and variety of A^ steroids
in early life is undoubtedly related to the low activity of 3fl-hydroxy
steroid dehydrogenase which is known to obtain in the fetus and which
must persist during early childhood. Similarly the high rate of
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excretion of 16-OH-DIIA in the absence of barely detectable amounts of
•DHA must be related to the known high activity of 16a-hydroxylase in
the fetus and infant and not in the adult.
The results shown in Table 6 indicate that on the whole the
compounds measured are being synthesized by the infant in fairly constant
amount during the first 6 days Of life. The normal newborn infant may
be considered, because of its deficiency in 3(3-hydroxy dehydrogenase,
to possess a mild form of the congenital adrenal hyperplasia due to
severe congenital deficiency of 3(3-hydroxy dehydrogenase first described
Ay Bongiovanni (27). In babies with this disorder, large quantities of
5
-Ik steroids are produced (10, 27), presumably by overactivity of an
idrenal under the stimulus of excessive corticotrophin from a pituitary
mdeavouring to maintain an adequate level of blood Cortisol.
It is probable that the normal fetus and infant synthesize
:ortisol and corticosterone differently from the major route used by
idults, the limited activity of 3(3-hydroxy dehydrogenase acting subsequent
:o 17a, 21- and ll(3-hydroxylase (9,10). This would account for the
iresence of 3(3,21-dihydroxypregn-5-en-20-one in infant urine (19) and
:ord blood (l) and 3(3, 17a,21-trihydroxypregn-5-en-20-one and 3(3,11(3,17a,
1-tetrahydroxypregn-5-en-20-one in cord blood (l). If, in the normal
nfant, excess corticotrophin is being produced to stimulate normal
—ortisol production in'the face of a lack of 3(3-hydroxy dehydrogenase,
=he C-19 A5 steroids (DHA, 16-0H-DHA etc) would be incidentally
increased in' the same way that 17 oxosteroids are over-produced in the...
/ -
=ore common forms of congenital adrenal hyperplasia due to deficiency
—f lip- and 21-hydroxylase. As with increasing age the deficiency of
p-hydroxy dehydrogenase is rectified, Cortisol production becomes more
fficient and the "by-products" are no longer formed in quantity.
Of the compounds measured, AD, 16-0-AD, 16-OH-DHA and AT may be
onsidered to be estrogen precursors (or their metabolites) produced
jy the fetus for aroraatization in the placenta. 16-OH-Preg however is
■4,ot an immediate precursor of estrogen but is possibly derived, as is
■16-OH-DHA, by 16 hydroxylation in the liver of the parent compound
oroduced by the adrenal (20), The reported levels of pregnenolone in
■fetal blood vary considerably (23 /ig/100 ml., (l); 43 jJg/100 ml., (18);
!00 Jig/100 ml., (28)). It can be utilized by the placenta for progest-
•rone production (29) and by the fetal adrenal for DHA production (30).
'urther work is required to elucidate the reason for its considerable
-quantitative significance as indicated by the large amount of 16-OH-Preg
:xcreted in infant urine.
In 2 cases of the adrenogenital syndrome whose results are shown
n Table 7, there is a selective increase in the excretion of 16-OH-Preg.
lase 1 shows a reduction in the excretion of the other compounds measured
■but Case 2 shows a considerable increase in all compounds. Reynolds
-(31) has measured 16-OH-Preg and 16-OH-DHA excretion in cases with 21-
-hydroxylase deficiency and has shown that during the first few months
of life the ratio of 16-0H-Preg/l6-0H-DHA is increased from a normal
average of 3:2 to 10:1 in the adrenogenital group'. As for normal
infants he found that both steroids were almost undetectable in the
urine of patients aged over 5 months. The marked increase in 16-OH-
Preg excretion in the cases reported here, together with the findings
of Reynolds would seem to indicate that in the patients studied there
was for some reaaon a. relative inactivity of 17-20 desmolaoe. It is
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difficult to suggest a reason for this and further study is required.
The considerable difference from normal in the excretion of A~* steroids
by cases of the adrenogenital syndrome indicates the importance of
their assay in the investigation of such disorders.
Work carried out in recent years has uncovered the existence
of complex interrelationships in the steroid metabolism of the mother,
the fetus and the placenta (9), but much of this work has so far only
„been qualitative. The A"* steroids certainly play a major role and the
use of the technique described, should expedite work on the quantitative
relationships of these steroids in the feto-placental unit and in the
newborn, and facilitate the isolation and identification of more
compounds. As thin-layer chromatography forms the basis of the
separations, the chances of transformation, destruction or artifact
formation taking place are considerably less than would be likely with
the alternative gas-liquid chromatography.
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ABSTRACT
The 17a and 17(3 epimers of androstenediol (3(3,17-dihydroxy-
androst-5-ene) have been separated in umbilical cord venous plasma
and infant and adult urine and the 17a epimer isolated and identified
in infant urine. The ratio of 17a- to 17p~androstenediol is at least
9 to 1 in both media, and is the opposite ratio to that found in adult
urine. It is suggested that the predominance of the 17cs epimer in the
fetus and in infants is due to a preferential 16a hydroxylation of 17p—
androstenediol by the high activity of 16a hydroxylase in early life,
coupled in the fetus by possible preferential placental aromatization
of the 17p epimer to form estradiol. Androstenediol is one of the
major components of umbilical cord plasma, the approximate levels are:
arterial plasma 126 pg/100 ml., venous plasma 94 pg/100 ml. The 17a-
epimer is present in infant urine as the disulfate.
INTRODUCTION
The 17p~hydroxy epimer of androstenediol was first isolated
from male urine by Fotherby (l) and identified in adrenal vein blood
by Hirschmann et a]. (2) and Wieland et al. (3). It has been detected
(although possibly not distinguished from the 17a epimer) and measured
(3 pg/100 ml) in the sulfate fraction from umbilical cord plasma (4)
and isolated from fetal tissue after perfusion with DHA and D: sulfate
(5). It has been identified and measured in adult human peripheral
blood by Vihko (6) who reported levels of between 0 and 90 pg'iOO ml
(with one of 160 pg/100 ml) in the solvolysable steroid tion.
Sjovall and Vihko (7) have recently rhnwn that some af i east of the
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measured in human biological fluids but has been demonstrated in the
urine of a boy with adrenocortical carcinoma (8) and small quantities
have been reported in the di-sulfate fraction of adult peripheral
blood (7),
Steroids with the 3p-hydroxy-A^ configuration predominate
quantitatively in infant urine and androstenediol is one of the major
components of the group. When a method was being developed for their
assay (9), it became evident that the majority of the androstenediol
present had the 17a configuration, furthermore, unlike the other 3p-
hydroxy-A"* steroids measured, it was not hydrolysed by the Helix
pomatia enzyme but only by solvolysis. It was decided to identify the
17a epimer fully and to investigate its relative importance and mode of
conjugation in infant urine and umbilical cord plasma.
EXPERIMENTAL
Abbreviations











Complete 24 hr. specimens of urine were collected from normal
male infants during the first 6 days of life and also from adult males
and females. Preservation was by storing at 4° followed by freezing at
-24° as soon as possible. Umbilical cord venous plasma was obtained by
gently withdrawing the venous blood in cords from normal babies into
receptacles containing sufficient heparin to prevent clotting, separating
the plasma as soon as possible and storing at -24°.
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Hydrolysis and extraction
The basic quantitative technique used has been described previously
(9). For urine, this was unaltered but recent experience has shown that
for plasma the extract occasionally contains sufficient fatty material to
prevent chromatographic separation. This fatty impurity proved to be
difficult to remove since its polarity was very similar to that of the
group of steroids being separated. Removal was finally achieved by
performing the separation while the steroids were still in conjugated
form, and to this end the following additional procedure has been
included for plasma specimens only. Plasma (5 ml.) was dripped into 4
vol. ethanol:acetone (50:50 v/v) to precipitate protein, the precipitate
was washed with one vol. ethanol:acetone and the combined extracts were
evaporated to dryness on a rotary evaporator at 45°. The dried extract
was dissolved in 10 ml methanol:chloroform (50:50 v/v) saturated with
NaCl and the whole applied to a Sephadex column (prepared by standing
17 g. of Sephadex LH 20 (Pharmacia, Uppsala, Sweden) in methanol:
chloroform (50:50 v/v) saturated with NaCl for 1 hr, pouring into a 2 cm
column and passing further solvent through for 6 hr before use). Fatty
impurities and the free steroids were eluted with a further 100 ml of
NaCl saturated methanol-chloroform and finally the conjugated steroids
were eluted with 200 ml methanol. This was evaporated to dryness and the
residue dissolved in 5 ml acetate buffer (0.5 N acetic acid: 0.5 N sodium
acetate 2:3 v/v); after hydrolysis with a Helix pomatia enzyme preparation
and extraction (to free other plasma steroids), the androstenediol was
obtained by solvolytic extraction (9) with ethyl acetate. Separation and
assay was as previously described (9). The technique for urine briefly
consisted of an initial hydrolysis with Helix pomatia enzyme followed by
extraction with ether:ethyl acetate (2:1 v/v). The aqueous phase was
further subjected to solvolysis and the extracts combined.
Thin-layer chromatography and quantitation
Plates (20 x 20 cm) were spread with silica-gel or alumina (both
from Merck A.G., Darmstadt, Germany) to a thickness of 0.25 mm. The
silica-gel plates were left to stand at least 24 hr. before use but
those prepared with alumina were used immediately they were dry. The
solvent systems referred to later were as follows:-
Silica-gel
System A - Cyclohexane:ethyl acetate (50:50 v/v)
System B - Benzene:acetone:ethanol:wate» (30:30:30:10 v/v)
Alumina
System C - Methylene dichloride:ether (90:10 v/v)
Colour development was by spray inf with a satui.i'd ut:' or- of
antimony trichloride in chloroform fo11o\ d by heating fo- 5 min
110". The bands produced vn-.rt d by dens! to ui. -
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RESULTS
Identification of androstenediol-17a In Infant urine
The 17-hydroxy epimers of androstenediol are not separated in
the thin-layer silica-gel chromatographic systems previously described
(9) and to achieve an adequate separation it was found necessary to use
alumina. A sample of the major epimer in infant urine was prepared for
identification as follows:- 500 ml. 1-6 day old infant urine were
treated as described, and the extracts streaked onto almost the full
width of a 20 x 20 cm silica-gel thin-layer chromatography plate which
was developed by 2 runs in System A. With the rest of the chromatogram
masked, the edges were sprayed with antimony trichloride and the band of
silica-gel containing the androstenediol thus located in the unsprayed
portion was removed from the glass and eluted with absolute ethanol.
The material obtained was streaked onto an alumina thin-layer plate
later developed by 2 runs in System C (Fig. 1 shows the separation of the
epimers obtained in this system). The band containing the 17a epimer
was located and eluted as before and the material obtained after
pr~ ! •»
1 2 3
Figure 1. Thin layer alumina chromatography of 1, androstenediol
(17a); 2, the androstenediol (17a and (3) fraction from infant, urine;
and 3, androstenediol ]7('., The separation was achieved by 2 runs in
System C, and colour development was by antimony trichloride. A part
only, of the chromatography plate is shown.
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evaporation of the ethanol transferred to a 1 mm germanium internal
reflector plate with acetone. The infrared spectrum produced with a
Unicam SP 200 spectrophotometer is shown in Fig. 2. It is practically
identical to the spectrum for authentic 17a androstenediol produced
under similar conditions and also shown in Fig. 2. The spectrum of
17p-androstenediol is also shown for comparison.
Gas chromatography-mass spectroscopy was carried out on the
unseparated epimers from the silica_gel chromatography of infant
urine (9) and the spectrum was, for practical purposes, identical to
that of either epimer. The fragmentation patterns of the epimers
cannot be distinguished (6).
The mode of conjugation of androstenediol in infant urine and cord
plasma
When the 3p-hydroxy~A"* steroids freed by the Helix pomatia
enzyme hydrolysis of infant urine are compared with those freed by
the further action of solvolysis, it is evident (Fig. 3) that
androstenediol in infant urine is unique in being freed practically
entirely by solvolysis only. The bulk of the known steroid material
shown in Fig. 3 to be freed by the enzyme is made up of 16-oxo-androst-
enediol, 16a-0H-DHA, 21-0H-pregnenolone, I6a-0H-pregnenolone and
* androstenetriol. Very little material other than androstenediol is freed
by the solvolysis.
Androstenediol also behaves uniquely together with 21~0H-
pregnenolone when the steroid conjugate extract of cord plasma is .
subjected to Sephadex chromatography. Chromatography was carried out
as described excepf that the eluting solvent was not saturated with NaCl
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Figure 2. Infrared spectra of (top) androstenedio] (l7a) .fraction
from infant urine, (centre) authentic androstenediol (17a),
and (bottom) authentic androstenediol (17p).
and the eluate was collected in 10 ml. fractions. All fractions were
then subjected to hydrolysis with Helix pomatia and the extracts of
freed steroids were separated by thin-layer chromatography in System A
anc shown up by antimony trichloride staining. The steroids listed















Figure 3. Thin-layer silica-gel chromatography of 1, 3p-hydroxy-A^
steroids freed from infant urine by Helix pomatia enzyme hydrolysis
and 2, those freed by subsequent solvolysis. Standards have been run
as shown. Separation was by 2 runs in System A and colour development
was by antimony trichloride. Run 1 has purposely been overloaded to
allow a demonstrable amount of androstenediol in run 2. A part only
of the chromatography plate is shown.
above together with other unidentified material were present in the 140
to 190 ml of eluate, with the exception of 21~hydroxypregnenolone which
was shown to be in the fraction 350-380 ml. The eluate fractions were
further subjected to solvolysis and the extracts again separated by thin-
layer chromatography. Androstenediol now appeared in the extracts from
350-380 ml, and was the only detectable spot on all the chromatograms.
The relative elution volume of androstenediol and 21-hydroxypregnenolone
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to the other 3p-hydro'xy-A"' steroids (^*65 = 2.27) is consistent with
their being disulfated compared with the more usual monoconjugation of
the other 3p-hydroxy-A^ steroids (10).
It was thought possible that 17a-androstenediol was being formed
as an artifact during the hydrolysis of 17p~androstenediol disulfate.
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To discount this, a sample of the 17p-epimer disulfate was prepared
using the technique of steroid sulfate formation described by Levitz
(11). The product was purified by thin-layer silica-gel chromatography
using System B. The formation of the disulfate was indicated by the
compound having an Rf of 0.11 compared with values of 0.79 for andros-
tenediol and 0.42 for DHA sulfate. In System B, free steroids, mono-
sulfates and disulfates tend to run as three groups with Rf values
similar to those indicated. After removal from the plate the silica-
gel containing the disulfate was eluted with ethanol:water (50:50 v/v),
the solvent evaporated and the residue hydrolysed by solvolysis for
24 hr. Subsequent chromatography in System C showed that only 17(3-
androstenediol was present.
Quantitative assay
Infant urine. The levels of 17p-androstenediol in infant urine are
too small for accurate assay by the techniques used but it can be seen
from Fig. 1 that the ratio of the 17p to the 17a epimer is low
(allowing for the decreased chromogenicity of 17a-androstenediol, see
Fig. 4). It has been estimated from many similar separations on
different urines to be less than 1 to 9. The urinary excretion of both
epiraers measured together during the first 6 days of life has been
previously reported (11) and was found to vary from less than 20 to
880 /LIg/24 hr.
Adult urine. The 24 hr. urine specimens from 4 male and 4 female
adults were pooled and portions subjected to Helix pomatia hydrolysis
with extraction followed by solvolysis, and to solvolysis alone. The
two epitners of androstenediol were then separated and measured in each
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extract. Fig. 4 shows the resulting chromatograms. The following
percentages of each isomer in each extract were obtained:
17a 17(3
enzyme hydrolysis (1) 38 62
solvolysis after enzyme hydrolysis (2) 25 75
[(1) + (2) 34 66]
solvolysis alone 50 50




1 2 3 4 5
Figure 4. Thin-layer alumina chromatography of 1, 2/Jg each of
androstenediol (17a) and (17(3); 2, the enzyme hydrolysable androst¬
enediol fraction from adult urine, previously purified on thin-layer
silica-gel; 3, the solvolysable fraction remaining after enzyme
hydrolysis; 4, the fraction obtained from adult urine after solvolysis
alone; 5, 4 /Jg each of androstenediol (17a) and (17p). The separation
was achieved by 2 runs in System C, and colour development was by
antimony trichloride. Each extract was obtained from approximately
the same quantity of urine. A part only of the chromatography plate
is shown.
The average total excretion of both epimers of androstenediol
in 4 adult males was 560 (range 150 - 830) JUg/24 hr.
From Fig. 4 it is evident that adults differ from infants in
having a considerable proportion of both 17a and 17(3 androstenediol
which is hydrolysable by Helix pomatia (17a, 83%; 17(3, 89%; total 87%)
and a relatively small portion (17a, 17%; 17(3, 33%; total 27%) which ran
STEROIDS 11:3
i freed by solvolysis. This could be accounted for by a major quantity
E the androstenediol being present as glucosiduronate.
abilical cord plasma. The ratio of the 170 to the 17a epimer was
^proximately the same as in infant urine. The concentration of both
timers in a 70 ml pool of venous cord plasma was 190 /Ig/100 ml.
jasurements in arterial and venous cord plasma (-{Jg/100 ml) from 3
ifants were as follows:
Arterial plasma Venous plasma
Infant 1 160 76
n 2 107 96
" 3 110 110
DISCUSSION
In infants and _in utero the 17a epimer of androstenediol
redominates approximately 9 times over its 170 counterpart whereas
n adults the 170 epimer is dominant. Furthermore the 17a-androstene-
iol in infants would appear to be in disulfate form with at least one
f the ester sulfate groups not hydrolysable by the Helix pomatia
nzyme preparation (the. title of "sulfate" has been given to
olvolysable compounds with the retention volumes of sulfates on
ephadex LH-20). The difficulty with enzyme•hydrolysis may account
or Bolte et al. (5) isolating only the 170 epimer after perfusion of
fetus with DHA and DHA sulfate. 17a Androstenediol appears to be
he only 30-hydroxy-A^ steroid present in any quantity in cord blood and
ot completely hydrolysed by the Helix pomatia enzyme. It is the only
0, 17a hydroxy steroid detected in cord blood and is apparently
he sole 30-hydroxy-A^ ^ steroid excreted by infants in any quantity
s the di-sulf'te. 21-Hydro y..■>egnenclone, the only other 30-hydroxy-
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A steroid present as the disulfate, has been shown by Pasqualini (12)
to be present exclusively as such in adults. It is hydrolysed by
enzyme hydi'olysis.
The reason why the 17a epimer predominates in the fetus and
in infancy is not readily apparent. One possibility is that both
epimers are produced (perhaps 17p-androstenediol in greater quantity
as found in adult urine) and 16a hydroxylase [abundant in the fetus and
infant and not in adults (13)], selectively acts on 17p-androstenediol
producing androstenetriol. This compound is present in considerable
amount in infant urine (9) and 16a,17p-dihydroxy~androst-4-en-3-one
has been identified as a major steroid component of placental tissue
(14). 17a Androstenetriol is undetectable in infant urine by the
techniques used.
This selective removal of the 17p epimer would not operate in
the adult because of the low level of activity of 16a-hydroxylase.
The possibility of an enhancement of the effect _in utero by the
placenta selectively aromatizing the 17p epimer to form estradiol,
cannot be discounted.
It is possible that an equilibrium exists ijt vivo between DHA
and androstenediol since Baulieu et al. (15) has shown that 17p andros-
tenediol sulfate can be converted in humans to DHA sulfate and the
reverse conversion has been indicated in adults by Roberts et al. (16)
and in the fetus by Bolte et al. (5). It is not known what would be
the ratio of 17a- to 17p- androstenediol in such an equilibrium, or how
much, if any, androstenediol is produced as such by the adrenal.
An important aspect of the relative amounts of circulating 17a
and 17p epimers arises if androstenediol is an important intermediate
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in the synthesis of testosterone as has been suggested may be the case
(17,18), An excessive amount of 17ct-androstenediol may conceivably
lead to an excessive production of epitestosterone relative to
testosterone.
ACKNOWLEDGEMENTS
The authors wish to thank Profess'or W, Klyne (Medical
Research Council Steroid Reference Collection) for samples of
steroids, Dr. C. J. W. Brooks for helpful collaboration with gas
chromatography-mass spectroscopy, Mrs. E. A. Michie and Sisters
M. Barr and C. Wilson for baby urine collections, Miss C, A. Chitty
and Miss R. Leask for technical assistance and the Medical Research
Council for financial assistance.
REFERENCES
1. Fotherby, K., BIOCHEM.J. _69, 596 (1958).
2. Hirschmann, H., de Courcy, C., Levy, R.P., and Miller, K.L.,
J. BIOL. CHEM. _235, PC 48 (i960).
3. Wieland, RcG0j de Courcy, C., Levy, R.P., Zala, A,P., and
Hirschmann, H. J. CLIN. INVEST. 44, 159 (1965).
4. Eberlein, W.R., J. CLIN. ENDOCRINOL. & METAB. _25, 1101 (1965).
5. Bolte, E., Wiqvist, N., and Diczfalusy, E., ACTA ENDOCRINOL,
52, 583 (1966).
6. Vihko, R., ACTA ENDOCRINOL. SUPPL. L09, 51 (1966).
7. Sjovall, J., and Vihko, R., EXCERPTA MEDICA INTERNATIONAL
CONGRESS SERIES, 132, 210 (1967).
8. Hirschmann, H., and Hirschmann, F.B. J. BIOL, CHEM. 157, 601
(1945).
9. Shackleton, C.H.L., and Mitchell, F.L., STEROIDS, 10 *359 (1967).
10. Sjovall, J., and Vihko, R., ACTA CHEM. SCAND. 20, 1419 (1966).
11. Nevitz, M., STEROIDS JL, 117 (1963).
12. Pasqualini, J.R., Dutter, F., and Jayle, M.F. BIOCHIM. BIOPHYS.
ACTA, 69, 331 (1963).
13. Mitchell, F.L., VITAMINS HORMONES, 25, 191 (1967).
14. Neher, R., and Stark, G., EXPERIENTIA, 1510 (1961).
15. Baulieu, E.-E.,nCorpechot, C., and Emiliozzi, R., STEROIDS, _2,
429 (1963).
■[arch 1968 STEROIDS 311
16. Robei'ts, K.D., Bandi, L., Calvin, H„I», Drucker, W.D., and
Lieberman, S., BIOCHEMISTRY, 3, 1983 (1964).
17. Hagen, A.A., and Eik-Nes, K.B. BIOCHIM. BIOPHYS. ACTA, 90^. 593
(1964).
18. Baulieu, E.-E., and Robel, P., STEROIDS 2, 111 (1963).
Reprinted from Excerpta Medica International Congress Series No. 170
containing abstracts of papers read at the
INTERNATIONAL SYMPOSIUM ON FOETO-PLACENTAL UNIT
Milan, September 4-6, 1968
62. Arterio-venous blood and amniotic fluid levels of individual 3(5-hydroxy-As-steroids
C. H. L. SHACKLETON, J. R. B. LIVINGSTONE, E. A. MICHIE and F. L.
MITCHELL, Clinical Research Centre at Medical Research Council, Clinical
Endocrinology Research Unit and Department of Obstetrics and Gynaecology,
University of Edinburgh, Edinburgh, United Kingdom
The concentration of many of the 3p-hydroxy-A5 steroids in umbilical cord blood is
higher than that of any other known steroid (cholesterol apart) in human blood at any
time, and the measurement of the differences in concentration between the arterial and
venous blood in the cord can give an indication of their production or utilization by the
foetus or placenta. The following known steroids have been measured in cord arterial
and venous blood: dehydroepiandrosterone, pregnenolone, 17a-hydroxypregnenolone,
16a-hydroxypregnenolone, 21 -hydroxypregnenolone, 16a-hydroxydehydroepiandrostero-
ne, and androstenetriol. In addition, two new steroids, 16|3-hydroxydehydroepiandroste-
rone and androstenediol (17a) have been identified and measured. In general the con¬
centration of all compounds is greater in arterial than in venous blood. By the methods
used, none of the steroids were detectable in the free form and all were present as
mono-conjugates except for the di-conjugation of androstenediol (17a), 16fS-hydroxyde-
hydroepiandrosterone and some of the 16a epimer, 21-hydroxypregnenolone, and some
of the androstenetriol. The di-sulphate of androstenediol (17a) could not be completely
hydrolysed by sulphatases present in placental tissue and as they are absent in foetal
tissue this may be one reason why such di-conjugates build up in the circulation, since
if they cannot be hydrolysed they may not readily be removed.
The steroids mentioned have also been assayed in amniotic fluid where their profile
resembles that in neonatal urine more than in cord blood. Negligible quantities were
found in cases with anencephalic foetuses presumably due to their low synthesis and
excretion by these infants.
[Reprinted prom the Proceedings of the Society for Endocrinology, 10-12 September 1968.]
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The identification and importance of new steroids in the foeto-placental unit.
By R. W. Kelly, C. H. L. Shackleton* and F. L. Mitchell*. Medical Research
Council Clinical Endocrinology Research Unit, 2 Forrest Road, Edinburgh, 1
Until recently it was believed that the placenta, acting as a single endocrine organ,
was responsible for the production of the large quantity of the steroids associated with
pregnancy, but it is now known that the foetus itself plays a major role in their syn¬
thesis and probably also in the control of their production. Diczfalusy has suggested
the term foeto-placental unit to describe the complete endocrine organ responsible.
If it is accepted that a high level of oestrogen and progesterone is necessary for a
successful pregnancy, then the involvement of the foetus in their production means
that in some respects it is responsible for its own future and any fault which develops
in its steroid synthesis may have serious repercussions for its well-being. Study of
steroid metabolism in the intact foetus is not easy, but the mechanisms of steroid
production by the foetus are still functional at birth, and it may be assumed that the
steroids in newborn urine are indicative of production in utero. Many new steroids
have recently been discovered both in foetal blood and in infant urine and undoubtedly
many more remain to be identified; other already known steroids have been shown
to be present in considerable quantity. It is not known what role many of these
compounds play with regard to the overall requirement for steroids in pregnancy
and certainly the control of their production is not understood.
The majority of the compounds involved have the 3/?-hydroxy-A5 configuration
and the chemical synthesis of model compounds for identification purposes presents
problems in introducing functional groups, sensitive and otherwise, in the presence
of the 3/?-hydroxy-A5 structure.
The excretion of variously hydroxylated oestrogens in pregnancy urine has raised
the question as to whether the correspondingly hydroxylated dehydroepiandro-
sterone derivatives are precursors. In an endeavour to answer this, model compounds
oxygenated at positions 14, 15, 16 and 18 have had to be synthesized. Most of these
have not been found in infant urine, but two have been identified which are excreted
by the newborn infant in quantity and are present in high concentration in cord
blood, 3/?,17a-dihydroxyandrost-5-ene and 3/?, 16/?-dihydroxyandrost-5-en-17-one.
Both these compounds are the epimers (at C-17 and C-16 respectively) of steroids
previously identified in adult urine and, in greater quantity, in infant urine. If they
are aromatized in the placenta they should form 17a-oestradiol and 16/?-hydroxy-
oestrone (leading to 16-epioestriol) respectively. These oestrogens are only excreted
by the mother in very small quantity. Possible factors limiting their aromatization
will be discussed.
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THE EFFECT OF EXOGENOUS CORTICOTROPHIN ON
STEROID EXCRETION IN THE NEWBORN
By
C. Lauritzen, C. H. L. Shackleton
and F. L. Mitchell
ABSTRACT
The urinary excretion of the individual 3/5-hydroxy-d5 steroids together
with Cortisol and the chromatographic bands of material containing its
tetrahydrometabolites, have been studied in early infancy before and after
stimulation by exogenous corticotrophin (ACTH). The average increase
in the excretion of the A5 steroids after stimulation is relatively small
(less than 185%) compared with the increase in Cortisol and its meta¬
bolites (greater than 600 %) and it is suggested that ACTH stimulation
cannot be solely responsible for the formation of the considerable quan¬
tities of A5 steroids in early infancy and the high A5 steroid/cortisol
production ratio in utero.
Steroid metabolism in early infancy differs markedly from that in adults
(.Mitchell 1967). Factors are still in operation which presumably were designed
to meet circumstances prevailing in utero. These include the production of
oestrogen and possibly progesterone precursors, 3/5-hydroxy-zl5 steroids, which
in utero would be converted by the placenta into the active hormones but
in early independent life are excreted in the urine either unchanged, 16a
hydroxylated or otherwise metabolized. They make up by far the largest
fraction of the total steroid content in infant urine during the few weeks
immediately following birth.
The control of oestrogen and progesterone production in pregnancy is not
understood, but if it is assumed that the production of their precursors in early




certain agents upon their rates of production should yield useful information.
Lauritzen & Lehmann (1965) and Lauritzen (1966) have shown that the ad¬
ministration of corticotrophin (ACTH) and human chorionic gonadotrophin
(HCG) to infants during the first week of life, causes a statistically significant
increase in the excretion of the oestrogen precursor dehydroe/handrosterone
(DHA). A study has now been made of the effect of ACTH on the urinary
excretion of the major 3/5-hydroxy-z(5 steroids found in infant urine and this is
compared to the effect on urinary Cortisol and its tetrahydro metabolites.
MATERIAL AND METHODS
Abbreviations
PREG: pregnenolone (3/?-hydroxy-pregn-5-en-20-one); DHA: dehydroe/u'androste-
rone (3/?-hydroxy-androst-5-en-17-one); 21-OH-PREG: 21-hydroxypregnenolone (3/5,
21-dihydroxy-pregn-5-en-20-one); AD: androstenediol (3/3,17a (and 17/?)-dihydroxy •
androst-5-en); 16-O-AD: 16-oxoandrostenediol (3/?,17/?-dihydroxy-androst-5-en-16-
one); 16-OH-DHA: 16a-hydroxydehydroe/u'androsterone (3/?,16a-dihydroxy-androst-
5-en-17-one); 16-OH-PREG: 16a-hydroxypregnenolone (3/?,16a-dihydroxy-pregn-5-en-
20-one); AT: androstenetriol (3/?,16a,17/?-trihydroxy-androst-5-en); Cortisol: 11/5,17a,-
21-trihydroxy-pregn-4-ene-3,20-dione; THE: tetrahydrocortisone (3a, 17a,21-trihydroxy-
5/?-pregnane-ll,20-dione); THF: tetrahydrocortisol (3a,ll/?,17a,21-tetrahydroxy-5/?-
pregnan-20-one).
Subjects
Infants used for the study were all male and were being treated with ACTH for
either prematurity, hyperbilirubinaemia, anorexia with dyspepsia leading to an-
hydraemic shock or laryngitis subglottica (pseudokrup). It was considered that in all
cases the disorders were of non-endocrine origin and the results found should not
differ markedly from those to be expected in normal individuals. ACTH (Cortico-
trophine-Z, Organon, Oss) was administered intramuscularly twice daily at the rate
of 8 units per day for 3 successive days. Urine was collected from these infants during
treatment and for the 3 days previously. Collections of 24 h urines were also made
from 4 normal infants during the first 6 days of life.
Urine was collected in plastic bags attached to the infant, refrigerated as soon as
possible and stored at —20° C until processed.
Extraction, chromatography and assay
The basic method was that reported previously for the 3/?-hydroxy-zl5 steroids
(Shackleton S: Mitchell 1967), modified to include Cortisol and its tetrahydro meta¬
bolites. These required a longer period of enzyme hydrolysis, and to achieve this,
penicillin (500 IU/ml urine) and streptomycin calcium chloride B. P. (0.625 mg/ml
urine) were added to the urine before the addition of 750 units per ml of /5-glucu-
ronidase from Helix pomatia. Hydrolysis was allowed to proceed for 48 h at 37° C,
a further 750 units of enzyme being added after 24 h. Extraction by ethyl acetate,
solvolysis, chromatography on thin-layer silica-gel and quantitation by direct scanning
of the chromatogram after colour development by antimony trichloride reagent was
then done for 3/5-hydroxy-d5 steroids as previously described.
656
For Cortisol and its metabolites, thin-layer chromatography was done by running
twice in the system, chloroform:absolute ethanol (90:10 v/v) and colour development
for the tetrahydro compounds was by spraying the plates, until they were uniformly
soaked, with a blue tetrazolium reagent (1 °/'o blue tetrazolium chloride in absolute
ethanol w/v: 3.5 N KOH in absolute ethanohwater, 2:5:3) and drying with a domestic
hair dryer held at a distance of approximately 30 cm. Only the bands of material
containing THE and THF were quantitatively measured; this was done by densito¬
metry comparison with standard runs of Cortisol. Cortisol was assayed by visually
comparing the absorption of its chromatographic band in ultraviolet light of wave¬
length 254 nut with standards, using the precautions for visual assessment described
for fluorescent spots by Bush & Mahesh (1959).
Identification
The 3^-hydroxy-d5 steroids AD, 16-O-AD, 16-OH-DHA, 16-OH-PREG and AT
were identified by methods including gas chromatography-mass spectroscopy as pre¬
viously described (Shackleton Sc Mitchell 1967). The Cortisol band was eluted from
the silica-gel with absolute ethanol and subjected to two dimensional thin-layer
chromatography in the systems: a) two runs in ethyl acetate:cyclohexane:absolute
ethanol (45:45:10), b) one run in ethyl acetate:water saturated n-hexane:acetic acid:
absolute ethanol (72:13.5:10:4.5). No other ultraviolet light absorbing spot could be
separated. The Cortisol spot was eluted with absolute ethanol and the residue after
evaporation to dryness dissolved in acetone and transferred to a 2 mm germanium
internal reflector plate for infra-red spectroscopy. The spectrum showed major peaks
at 1060, 1135, 1240, 1280, 1460, 1660 and 1710 wavenumbers and agreed well with
the spectrum of authentic Cortisol prepared in a similar way.
The pattern of reducing steroids in infant urine is complex (Cathro et al. 1963) and
the chromatographic bands of material containing THE and THF undoubtedly con¬
tain other compounds which have not been identified. A full investigation of the
material in these bands has not been attempted.
RESULTS
In Table 1 the results obtained in /zg/24 h have been averaged for the 3 days
prior to treatment and for the 3 days during the administration of ACTH.
Table 2 shows findings over a similar period for 4 normal untreated individuals
and Table 3 gives the average excretion for the 5 ACTH treated infants on
the first, second and third days of treatment.
DISCUSSION
Of the major 3/3-hydroxy-zl5 steroids studied, DHA (Ryan 1959), 16a-OH-DHA
(Colds et al. 1964) and androstenetriol (Ryan 1958) have been shown to act in
the placenta as precursors of oestrogens, and 16-oxoandrostenediol is possibly
implicated also {Dell'Acqua et al. 1967). Pregnenolone has been found to be
converted to progesterone in high yield when perfused through placentas in situ
{Palmer et al. 1966), though it is not known how this pathway of synthesis
657
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using circulating pregnenolone compares quantitatively with the use of cir¬
culating cholesterol which can also act as a precursor (Solomon et al. 1960).
Both DHA and PREG are present in considerable quantity in foetal blood
(iSimmer et al. 1964; Conrad et al. 1967) and their low rate of excretion in
infant urine together with the high excretion of their 16a-hydroxylated deri¬
vatives may be explained by the considerable activity of 16a-hydroxylase in
the liver at this time (Reynolds 1966). On the whole the 3/7-hydroxy-zl5
steroids measured are being excreted by the infant in fairly constant amount
during the first 6 days of life (Table 2 and Shackleton 8c Mitchell 1967) and
without ACTH stimulation no significant increase would be expected.
In view of the relative quantitative unimportance of DHA and PREG in
infant urine, measurement has only been attempted for 2 of the infants studied.
The use of different methodology would account for the somewhat higher
values for DHA excretion found by Lauritzen 8c Lehmann (1965). The un¬
detectable or very small amounts indicated by the present technique agree with
the findings of Birchall et al. (1961) and Paulsen et al. (1966). The increase in
urinary Cortisol after ACTH may be compared with the increases found by
Bertrand et al. (1962) and Hillman 8c Giroud (1965) in blood Cortisol in infants
(average increases 170% and 340 %) after ACTH stimulation.
It is of interest to compare the increases in the major 3/?-hydroxy-z(5 steroids
(16-OH-DHA and 16-OH-PREG) under ACTH stimulation with those found
by other workers for the major group of urinary steroids not emanating to any
extent from Cortisol, i. e. the 17-oxosteroids. For androsterone, aetiocholanolone
and DHA in adults, Jungmann et al. (1967) have listed the findings of 7
laboratories and though the results for individuals vary considerably, the
average overall increase is 120 %• For 12 children between the ages of 3 and
14 years, Paidsen et al. (1966) showed an average increase in total 17-oxo¬
steroids of 35 % and the average increase in 30 children aged from 5 months
to 14 years, with 3 days stimulation, investigated by Clayton et al. (1963) was
350 %. A direct comparison in infants, of the effects of ACTH on the 3/3-
hydroxy-A5 steroids and upon the adult type 17-oxosteroids, cannot be made
because of the virtual absence of the latter from infant urine (Birchall et al.
1961).
If the rate of excretion can be taken as a measure of production, it appears
that the 3/7-hydroxy-,d5 steroids in infancy are about as sensitive to ACTPI
stimulation as are the 17-oxosteroids later in life, and it is thus possible that
ACTH in foetal blood has some influence on the production of oestrogens and
possibly progesterone in pregnancy. Dossier (1966) has reported a considerable
increase in the urinary excretion of oestriol by women in late pregnancy after
the infusion of ACTH; no such increase was obtained in cases of intrauterine
foetal death.
The relatively small increase (occasionally a decrease) in the 3/?-hydroxy-zls
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steroids, however, has been produced together with a very considerable increase
in Cortisol and its metabolites, and if urinary excretion is taken as a measure
of production it is evident that to produce the opposite effect in utero of a
considerable production of 3/?-hydroxy steroids with an apparently fairly nor¬
mal, compared proportionately with adults (Mitchell 1967), production of
Cortisol, a different or more complex mechanism of control must obtain. The
qualitative difference in steroid production is so great that it cannot be ex¬
plained by peculiarities in the catabolism of Cortisol which undoubtedly obtain
in the newborn (Mitchell 1967). It has been suggested (Shackleton 8c Mitchell
1967) that the explanation for the large quantity of 3/3-hydroxy-d5 steroids
produced after birth lies in their incidental formation by ACTH stimulation,
during a somewhat inefficient synthesis of Cortisol via hydroxylated A5 inter¬
mediates. It now appears that some other reason for their presence must be
found since under exogenous ACTH stimulation the efficiency of Cortisol,
relative to A5 steroid production, is apparently considerably improved.
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ABSTRACT
The urinary excretion of a range of steroids and steroid-like compounds,
including the major compounds with the 3/?-hydroxy-d5 configuration,
have been studied in early infancy before and after the administration
of human chorionic gonadotrophin. The only compound which showed any
increase in excretion was dehydroe/u'androsterone which was increased in
four out of seven cases studied.
In a previous communication (Lauritzen et al. 1968) we described the effect of
corticotrophin on the urinary excretion, in the first few days of life, of the
individual 3/3-hydroxy-zl3 steroids together with Cortisol and the chromato¬
graphic bands of material containing its tetrahydro metabolites. It was then
found that though Cortisol and its metabolites were increased over 600 per
cent, the increase in the 3/?-hydroxy-zl5 compounds was very variable but
averaged approximately 60 per cent, indicating that other factors must nor¬
mally be operating in utero and after birth, to produce the opposite effect of
a considerable production of 3/?-hydroxy-/)3 steroids with a very much smaller
amount of Cortisol and its metabolites.
It has been shown that human chorionic gonadotrophin (HCG) can stimulate
the excretion of dehydroe/uandrosterone in newborn infants (Lauritzen 8c Leh¬
man 1965, 1967). In order to compare fully the effect of the two stimulatory
* Staff of the M. R. C. Clinical Research Centre, to be at Northwick Park, London.
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21 -OH-PREG: 21 -hydroxypregnenolone (3/9,21 -dihydroxy-pregn-5-en-20-one;
AD: androstenediol (3/9,17a (and 17/3)-dihydroxy-androst-5-en);
16-0-AD: 16-oxoandrostenediol (3/9,17/9-dihydroxy-androst-5-en-16-one);






Only male infants were used in the study and all were being treated with HCG for
undescended testicles. It was considered that this disorder would not markedly alter the
results from those to be expected in normal infants. HCG (Predalon®, Organon, Oss)
was administered intramuscularly twice daily at the rate of 5000 IU per day on the
4th, 5th and 6th day of life. Urine was collected for the first three days of life and also
on the three days during treatment, by attaching plastic bags to the infant. It was re¬
frigerated as soon as possible and stored at -20° C until processed.
Assay technique
The method was the same as that used for the study with corticotrophin stimulation
[Lauritzen et at. 196S) and was as previously described (Shackleton & Mitchell 1967;
Shackleton et al. 1968). Briefly, the urine was extracted with ether-ethyl acetate after
being subjected to hydrolysis by Helix pomatia enzyme followed by ethyl acetate solvo-
lysis. Steroid separation was done by thin-layer chromatography and assay was by
direct reflectance densitometry of the coloured bands produced by spraying with anti¬
mony trichloride and blue tetrazolium reagents. Cortisol was assayed by comparing
visually with standards, the absorption of its chromatographic band in ultra-violet light
of wavelength 254 rn«.
Identification
Since the only investigated chromatographic band of material showing an increase
after stimulation was that containing DHA it was considered important to identify
fully the material present in this band after stimulation. The band was eluted from the
silica gel with ether, the silica gel having first been deactivated with a drop of water.
The trimethylsilyl ether was prepared and subjected to gas-liquid chromatography
using an E 301 column. Only one major peak was present (the total area of other minor
peaks was less than 5 per cent of the major peak) and this had the retention time of
DHA trimethylsilyl ether. It was collected and gas chromatography-mass spectroscopy
was carried out using an LKB 9000 instrument (LKB Produkter AB, Stockholm, Sweden)
operated at electron energy 70 E. V. The column was packed with 1 % SE-30 on
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silanized Gas Chrom P and operated at 232° C. The spectrum produced was identical
with that of authentic DHA.
RESULTS
In Table I the results obtained for the 3/?-hydroxy-zl5 steroids assayed have
been averaged for the three days prior to treatment and for the three days
Table 1.
Urinary steroid excretion in the newborn, averaged for the first three days of life with
no treatment and for days 4, 5 and 6 during which HCG was administered (fig/24 h).














None 64 30 10 90 50 170 230 260 110 150
1 HCG 148 8 4 110 220 330 250 280 330 290
°/o Increase 131 -73 -60 22 340 94 9 8 200 93
None 70 7 30 60 20 270 250 410 280 500
2 HCG 160 10 40 60 10 290 250 120 220 460
°/o Increase 129 43 33 0 -50 7 0 -71 14 -8
None 50 60 28 110 60 460 520 480 730 650
3 HCG 150 19 20 130 40 370 470 200 640 840
°/o Increase 200 -68 -29 18 -33 -20 -10 -58 -12 29
None 80 <20 <20 45 20 170 200 160 520 450
4 HCG 170 <20 1490 108 68 360 450 310 1170 640
°/o Increase 113 0 >7350 140 240 112 125 94 125 42
None 210 <50 <50 450 180 1300 1170 460 1630 620
5 HCG 270 <50 903 410 210 1570 1570 230 1840 260
% Increase 29 0 >1706 -9 17 21 34 -50 13 -58
None 90 <12 60 80 90 390 660 560 1130 290
6 HCC 120 <12 460 60 20 290 510 410 670 220
% Increase 33 0 667 -25 -78 -26 -23 -27 -41 -24
None 100 <12 20 50 90 320 550 340 530 150
7 HCG 100 <12 110 30 120 180 390 240 430 180
%>Increase 0 0 450 -40 33 -44 -29 -29 -19 20
* Recently identified (Shacklelon et al. 1968).
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during the administration of HCG. Neither Cortisol nor any of the bands of
material shown up with either blue tetrazolium or Zimmermann reagent showed
any increase, and the values found are not reported.
The individual results for DHA in the four infants displaying an increase
are shown in histogram form in Fig. 1. Since 16a-OH-DHA is normally the
major metabolite of DHA in infant urine, its excretion rate is also shown.
DISCUSSION
Of the steroids investigated, only DHA shows on average an increased rate of
excretion after stimulation by HCG. The effect is not consistent, however; no
response was obtained in the first three infants studied, and the increase in
excretion for the remaining four was variable. A similar variation in response
was found by Lauritzen 8c Lehmann (1965, 1967) measuring DHA only, but on


















16 a - OH-DHA
Ll ri I h-i
1 2 3 4 5 6 123456 123456 123456
DAY OF LIFE
Fig. 1.
Daily excretion of DHA and 16a-OH-DHA by infants treated with HCG.
Only those infants showing an increase in DHA excretion have been included.
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no occasion did they obtain no response. The somewhat higher values found
by them for DHA may be accounted for by the different methodology used.
In the previous investigation, where stimulation was by corticotrophin
(Lauritzen et al. 1968), there was a considerable increase in the excretion of
Cortisol and its metabolites, but the increase in the excretion of the 3/5-
hydroxy-zl5 steroids was only comparable with that obtained for the 17-oxo-
steroids in older individuals. It was suggested then that in order to produce
large quantities of 3/5-hydroxy-zl5 steroid in ntero and in early infancy a dif¬
ferent or more complex control mechanism must exist.
The function of the large quantities of HCG produced in pregnancy is not
known but the opinion has been held that it is not intended for use by the
foetus because although it is produced in the trophoblast it tends to be se¬
creted unidirectionally into the maternal circulation (Lanman 8c Dinerstein
1959; Bruner 1951). Lauritzen 8c Lehmann (1967) have shown, however, that
the concentration of HCG in umbilical cord blood is higher in the arterial than
in the venous, suggesting a net uptake by the foetus. Rotter (1949) and Jones
(1955) have suggested that HCG is the stimulant for the foetal adrenal, and
Niemi et al. (1967) have pointed out that since the maximal output of urinary
chorionic gonadotrophin during pregnancy just precedes maximal enzyme
activity, and the maximal volume of interstitial cell tissue in the testes in male
foetuses (maximal activity between the 12th and 16th week), it may provide
the stimulus for this activity and thus be responsible for the masculinisation
of the male foetus. In support of this Brody 8c Carlstrom (1965) have shown a
connection between HCG and the sex of the foetus; mothers with male foetuses
have a significantly lower level of serum HCG in the last trimester of preg¬
nancy than those producing female infants.
The possible implication of HCG in the stimulation of the foetal adrenal
has been discussed previously (Lauritzen 8c Lehmann 1967) and reasons were
then given in favour of the view that the increase of DHA noted following
HCG injection stems from the adrenals and not from the gonads. The finding
that the stimulation is highly selective for DHA now complicates the question
since it has been generally assumed that the low level of excretion of DHA by
the infant, subsequent to there being a high concentration in umbilical cord
blood, is due to the high activity of liver 16-hydroxylase (Mitchell 1967). It is
not impossible for HCG to suppress 16-hydroxylation, but no concomitant fall
in the excretion of 16a: or /5-hydroxy DHA is evident.
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ABSTRACT
Extracts from 1-3 day-old infant urine which had been hydrolysed
by Helix pomatia enzyme followed by solvolysis, were subjected to
thin-layer chromatography. A band of material giving the 3(3-
hydroxy- A steroid colour reaction with antimony trichloride staining
reagent and previously named "U^", was purified by further thin-
layer chromatography and identified as l6p-hydroxydehydroepi-
androsterone. Proof of identity was obtained by comparing the
chemical and physical characteristics of the chemically synthesized
compound, with those of the unknown. Techniques used were: thin-
layer and paper chromatography in 5 systems, gas chromatography,
mass spectroscopy, infrared spectroscopy and high temperature
catalytic reduction. It is excreted in infant urine mainly as a di-
conjugate.
INTRODUCTION
Infant urine has been shown to contain a large number of steroids
and steroid-like compounds which are undetectable in later life, many
of these being present in considerable quantity (l). [for review see
Mitchell (2)J . Due to a relative lack of the enzyme 3(3-hydroxysteroid
dehydrogenase in the adrenal in utero and in early infancy, many of
5
these compounds have the (S configuration. The separation and
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measurement of 8 such compounds by thin-layer chromatography
followed by antimony trichloride staining has been reported previously
(3) and two compounds, then unidentified, were labelled and U^.
The more polar of these (U^,) has now been identified as 3p, 16(3-
dihydroxyandrost-5-en-17-one (l6[3-hydroxy-DHA). The l6a epimer
has already been reported as being a major component of fetal blood
(4, 5) and infant urine (3,6,7). The newly identified compound is
excreted in infant urine at an average rate of approximately 600 p.g/
24 hr. during the first 6 days of life (3).
ISOLATION AND PURIFICATION
Hydrolysis (by Helix pomatia enzyme and solvolysis), followed by
extraction and thin-layer chromatography, was carried out as
previously described (3). For preparation purposes extracts were
streaked along the origin of the chromatogram plate and the positions
of the bands after chromatography determined by carrying out the
antimony trichloride reaction only on the two outer edges of the plates.
The band of material in the centre, thus delineated, was eluted from
the silica-gel with ether; the silica-gel having first been deactivated
with a drop of water.
After separation in the thin-layer systems used for the normal
assay technique (3), the band of material previously referred to as
was further purified by re-chromatography on silica-gel once in the
system; chloroformrabsolute ethanol (95:5 v/v) and twice in
cyclohexane:ethyl acetate (50:50 v/v).
PREPARATION OF AUTHENTIC l6p-HYDROXY-DHA
The preparation of 3p, l6p-diacetoxyandrost-5-en-17-one from 3P~
acetoxy-5o', 6p-dichloroandrostan-1 7-one has been described by
Aoki et al. (8) but the preparation of the free ketol has not so far been
reported. In the method of Aoki et al. (8) the 17-enol acetate is
prepared and treated with lead tetraacetate to give 3p, l6p~diacetoxy-
5a, 6p-dichloroandrostan-l 7-one which is then dechlorinated with zinc
in acetic acid.
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Hydrolysis of the 16(3-acetate is difficult since only mild
conditions must be used if isomerisation of the sensitive ketol is to
be minimised. The best yields were obtained by the use of aqueous
acidic methanol at 30 for 60 hr. The product was purified by
fractional crystallization from two solvent systems. Identification
was by infrared and nuclear magnetic resonance spectroscopy. The
n. m. r. spectrum (in pyridine) showed that the compound was free
from the 17p-hydroxy-16-oxo epimer (C-18 methyl of 3p,17p~
dihydroxyandrost-5-en-l6-one resonates at T 9.08 in pyridine).
Experimental
3p, l6p-Diacetoxyandrost-5-en-17-one (330 mg) was dissolved in
methanol (180 ml), water (20 ml) and concentrated HC1 (5 ml) and
left at 30 for 60 hr. A further 30 ml. of water was added and the
solution evaporated to 100 ml m vacuo at 30 . The crystalline product
which formed during this evaporation was filtered off, washed well
with water and dried. The material was then dissolved in excess
boiling methanol and the solution allowed to cool, the precipitate was
discarded and the solvent evaporated to dryness. This treatment was
repeated twice using aqueous methanol as the solvent; the total weight
of discarded material from the three operations was 120 mg. The
final residue was recrystallized twice from acetone-hexane to give
53 mg of pure material; m. p. 187 - 192 [or] - 19 (c 0. 1, dioxan);
infrared (see Fig. l); n. m. r. (pyridine) T 8.96 ^C-19 methyl),
T 9. 00 (C-18 methyl).
Instruments used were as follows: melting points - Kofler block,
optical rotation - Perkin Elmer polarimeter 141, infrared spectrum -
Unicam S. P. 200 spectrophotometer with thallous-bromide-iodide
internal reflection plate, n. m. r. spectrum - Perkin Elmer R10
(60 mc/s).
IDENTIFICATION
Considerable difficulty was experienced during the purification
of compound U since, as found by Layne and Marrian (9) during the
isolation of l6p-hydroxyestrone, many of the procedures used
resulted in its partial isomerization to the more stable ff-ketol, in
this case 3(3 , 1 7p-dihydroxyandrost-5-en- 16-one (l 6-oxoandrostene-
diol). This spontaneous conversion was proved by separating 16-
oxoandrostenediol from compound and recording its infrared
spe ctrum. The isomerization proceeds especially rapidly in alkaline
conditions and these were avoided as much as possible. It was not
however possible to avoid bringing the urine to pH 11.5 before
hydrolysis and extraction since this is an important step in the
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essential removal of phosphate and sulfate ions (10) which would
otherwise inhibit the enzyme hydrolysis. In an experiment in which
water containing pure 16|3-hydroxy-DHA was treated identically to
urine, only 16-oxoandrostenediol could be isolated from the final
extracts. It is assumed that when natural l6p~hydroxy-DHA is
present as the diconjugate it is immune to isomerization before
hydrolysis.
Gas chromatography could not be used for purification because the
compound was destroyed on the column when chromatographed in the
free form.
Polarity on thin-layer chromatography
The compound has identical Rf values to 16p-hydroxy-DHA on
silica-gel in the following thin-layer systems:-
chloroform:absolute ethanol (95:5 v/v) Rf = 0.30
benzene :absolute ethanol (95:5 v/v) Rf = 0.15
cyclohexane :ethyl acetate (50:50 v/v) Rf = 0.20
and on paper in the systems:-
toluene:methanol:water (100:75:25 v/v) Rf = 0.450
light petroleum (b. p. 100-120 ):benzene:methanol:water
(66:33:80:20 v/v) Rf = 0.068
In all the systems mentioned it is slightly more polar than l6a-
hydroxy-DHA and 3p, 1 7p-dihydroxy-5-en-16-one. On thin-layer
alumina it isomerizes to 16-oxoandrostenediol.
Chemical reactivity
Blue tetrazolium was reduced, indicating the presence of an
of-ketolic group. On reduction with potassium borohydride a
compound was produced with the polarity on thin-layer chromatography
of 3{h,lba, 17a (or 16p , 1 7p)-trihydroxyandrost-5-ene (the two epimers
were inseparable in the systems used). Since the original compound
was an u-ketol and both 16 and 17-oxo groups are reduced to 16p -
and 17p~hydroxy groups by borohydride it may be presumed that the
l6p, 17p-epimer was forrAed.
A blue colour typical for a 1 7-oxosteroid was produced with the^
Zimmermann reagent and a red colour typical for a 3p-hydroxy A
steroid was produced with the antimony trichloride reaction on a
thin-layer chromatogram (3).
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Infrared spectroscopy
Samples of and authentic l6(3-hydroxy-DHA were dissolved in
acetone and smeared on both sides of a thallous bromide-iodide internal
reflection plate. The infrared spectrum was then recorded in a
Unicam SP 200 spectrophotometer. Owing to the difficulty, mentioned
previously, of isomerism taking place during purification it has proved
impossible to record a perfect infrared spectrum of U^. The spectrum
shown in Fig. 1 was produced from a purified sample specially
prepared by enzyme hydrolysis of the conjugate obtained from infant
urine by Sephadex chromatography.
Gas chromatography
The free compound was unstable on the column but the trimethyl-
silyl ether (TMSE) derivative of gave the following retention time
on a 1% SE-30 column. Derivatives of related compounds are shown
for comparison:-























Figure 1. Infrared spectra of (top) authentic 16p-hydroxy-DHA and
(lower) compound U^. The spectra were obtained by the
use of a thallous bromide-iodide internal reflection plate.
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These data show clearly that is not 16ff-hydroxy-DHA: they do not
distinguish it from 16-oxo-androstenediol, but the mass spectrometric
data (see below) rule out this structure.
gas chromatography-mass spectrometry
The TMSE derivatives of 16-oxo-androstenediol, 16cr-hydroxy-DHA,
l6p-hydroxy-DHA and U were subjected to gas chromatography-mass
spectrometry using an LKB 9000 instrument (LKB Produkter AB,
Stockholm, Sweden) operated at electron energy 70 E. V. The column
was packed with 1% SE-30 on silanized Gas Chrom P and operated at
232 . As with infrared spectrometry, it proved impossible to record
a spectrum of compound completely free from l6-oxo-androstene-
diol. It will be seen from the results shown in Fig. 2 that the peak at
m/e 129 in the spectrum produced by compound is slightly larger
than in the authentic spectrum - an effect readily ascribed to the small
proportion of 16-oxo-androstenediol derivative present as contaminant.
The trimethylsilyl ethers of l6a- and 1 6p-hydroxy-DHA give
closely similar mass spectra, which are however quite different from
that of the 16-oxo-androstenediol derivative. The latter spectrum is
dominated by the peak at m/e 129 characteristic of 3-trimethylsilyloxy-
A -steroids (11, 12): there are no abundant ions above m/e 200 except
at m/e 448 (M) and m/e 433 (M-15). In contrast, the 16-trimethylsilyl-
oxy-1 7-ketones give (in addition to the peak at m/e 129) strong,
characteristic peaks at m/e 214 and 304. The exact origin of these has
not been established: a formal possibility, which accounts also for the
ion at m/e 17 5, is indicated below.
Dec. 1968 STEROIDS 711
Figure 2. Maes spectra diagrams tor trimethyl silyl ethers of
authentic 16-oxoandrostenediol, 16or-hydroxy-DHA, 16(3-
hydroxy-DHA and compound U^. The peaks at m/e 7 3
were off scale.
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High temperature catalytic reduction
The compound was subjected to high temperature catalytic
reduction by passing it with hydrogen, in a manner similar to that used
for gas chromatography, through a siliconized glass tube containing
1-3% (w/w) platinum on siliconized glass beads at a temperature of
200 . The trapped products were then examined by gas chromatography
on both 1% NGA and 1% SE-30 columns (13). Reduction products were
produced similar to those from l6a- and 1 6p-hydroxy-DHA and l6-oxo-
androstenediol; the main products having retention times, relative to
5a-androstane, of 1. 0 and 0. 34 on both columns. This evidence is thus
consistent with the original compound being 16(3-hydroxy-DHA. The
specific pattern of reduction products was unique for 16 oxygenated
steroids amongst many similar steroids studied.
CONJUGATION
It has been shown by Sjovall and Vihko (14) that free and mono- and
di-conjugated steroids may be clearly and reliably separated on Sephadex
LH 20 (Pharmacia, Uppsala, Sweden). Elution volumes using this
technique were checked with a range of authentic free and conjugated
steroids and the method was subsequently used to fractionate the free
steroids and conjugates in infant urine. Separation of the steroid
components of each fraction was achieved by enzyme hydrolysis followed
by thin-layer chromatography.
21-hydroxy-pregnenolone











, t -<ixo-androstenediol(3(3, 17(3)
1 ba - h ydroxy - DHA
16(3-hvdroxy-DHA
16a-hy droxv-pre gnenolone
Figure 3. Thin-layer silica-gel chromatography of 1, the standard
compounds indicated; 2, the mono-conjugated steroid fraction
from infant urine; and 3, the di-conjugated fraction. Colour
development was by SbCl^ reagent.
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To separate the free, mono- and di-conjugated steroids, 10 ml
from a pool of urine from 1-3 day-old infants was extracted twice with
2 volumes of ether, and the extract of free steroids was evaporated to
dryness. The aqueous phase was added to 4 volumes of ethanolracetone
(50:50 v/v) to precipitate protein, the precipitate was washed with one
volume of ethanol:acetone and the combined extracts were evaporated to
dryness on a rotary evaporator at 45 . The dried extract was dissolved
in 1 0 ml of methanol:chloroform (50:50 v/v) saturated with NaCl, and
the whole applied to a Sephadex column [ prepared by standing 17 g of
Sephadex LH 20 (Pharmacia Uppsala, Sweden) in methanol:chloroform
(50:50 v/v) saturated with NaCl for 1 hour, pouring into a 2 cm diameter
column and passing further solvent through for 6 hr before use].
Elution was carried out by adding more NaCl saturated methanol:
chloroform. Mono-conjugates were found to be contained in the 50-
150 ml fraction of eluate and di-conjugates in the fraction 250-400 ml.
After evaporation to dryness, hydrolysis of the conjugates by Helix
pomatia enzyme was carried out as previously described (3). In neither
fraction could further free 16(3-hydroxy-DHA be obtained by solvolysis.
Extracts containing tlje free fraction and the hydrolysed conjugates
were chromatographed by running 3 times in the system, ethanol:
benzene (5:95 v/v). No 16p-hydroxy-DHA could be detected in the free
fraction and it will be seen from Fig. 3 that the major proportion is
di-conjugated. In the urine specimens studied 34% was mon^o and 66%
di-conjugated. Fig. 3 also shows that of the 3P-hydroxy- A steroids
staining with SbCl^ and hydrolysed by Helix pomatia enzyme, 16p —
hydroxy-DHA is the major compound present as the di-conjugate.
Another major unknown compound (unknown l) is also indicated.
DISCUSSION
The proven presence of l6p-hydroxy-DHA in infant urine plus the
known fact that under certain conditions it spontaneously isomerizes
to the more stable 16-oxoandrostenediol, now raises the question as to
what extent 16-oxo-androstenediol, which has been reported as one of
the major components of infant urine (3, 15) and tentatively identified
in umbilical cord blood (16), has been produced during extraction and
purification as an artefact.
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An explanation for the presence of 16(3-hydroxy-DHA in quantity in
infant urine and its use by the fetus is not immediately apparent.
l6a-hydroxy-DHA in quantity is readily aromatized by placentas when
perfused in situ, to form estriol (3p, l6a, 17P-trihydroxyestra-l,3,5
(lO)-triene (17) and 1 6p-hydroxy-DHA might similarly form 16-
epiestriol, l6p~hydroxyestrone (3, l6p-dihydroxyestra-l, 3, 5(l0-trien-
17-one) or its isomer l6-oxoestradiol (3, 1 7P-dihydroxyestra-l, 3, 5
(1 0)-trien-1 6-one), though the urinary output of these compounds in
pregnancy is not great, being respectively 0. 8, 0. 7 and 1. 1 mg/24 hr
(18).
The presence of both 16a- and 16p-hydroxylase for DHA has been
demonstrated in fetal liver (19), though it is not known in what ratio the
two epimers are produced. The formation of 16p — from l6a-hydroxy-
DHA must not be discounted since a high activity of a l6a to a 16p
epimerizing system has been demonstrated for estriol in avian liver
(20), and for 16a-hydroxyestrone in human placenta and other tissues(2l).
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